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Germ cells are responsible for transferring genetic information from parents to 
offspring, highlighting the significance of normal germ cell development. Epigenetic 
modifications, which modify gene expression without changing the underlying DNA 
sequence, can affect the fate of germ cells. Abnormal epigenetic reprogramming will 
facilitate abnormal germ cell development; therefore, understanding of epigenetic 
reprogramming mechanisms can contribute to the discovery of medical interventions 
for reproductive disease. DNA methylation and histone modification are two main 
components of epigenetic modifications. Both of them play important roles in 
mammalian germ cells development. In human germ cells, very few observations 
about these epigenetic modifications have been reported. Therefore, this report aims 
to form the major epigenetic reprogramming study conducted in human fetal germ 
cells, establishing an accurate timeline of events pertaining to this process in human 
fetal germ cells. Specifically, this research is divided into understanding (1) the 
process of histone modifications in human fetal germ cells; (2) the reprogramming of 
DNA methylation and its related modifiers in human germ cell development; (3) the 
impact of chemical DNA demethylation in the expression of germ cell-specific genes 
and the meiotic genes in human in vitro and ex vivo. 
Studies in human fetal gonads indicated that histone modifications changed 
dynamically during human fetal germ cell development. Experiments addressing 
DNA methylation reprogramming in human fetal germ cells collectively reveal a 
trend towards DNA demethylation and reductions in 5-methylcytosine (5mC), in the 
instance of both fetal ovarian and testicular germ cells alike. Furthermore, 5mC was 
re-detected in human fetal testicular germ cells at fetal stage, but in human fetal 
ovarian germ cells after birth. The studies in human germ cells here demonstrated 
that the existence of 5mC and 5-hydroxymethylcytosine (5hmC) were synchronous 
rather than alternate. Determination of the levels of TET (ten-eleven translocation) 
proteins (TET 1, 2 and 3) reveal higher levels during the 1st trimester, with 
subsequent reductions in levels with gestations. Additional findings, from the studies 
in a human testicular germ cell tumor cell line, TCam-2 cells, and human fetal 
gonads, showed that treatments with DNA demethylating agents are linked to the 
activation and increase of post-migratory germ cell-specific genes along with meiotic 
genes in human.  
To conclude, the results from this study demonstrate that epigenetic changes, such as 
histone modification and DNA methylation, are dynamic in human germ cells, the 
precise nature of which necessitates further research.  
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Normal germ cells development is important, as it will affect the normal 
development of next gestation. The fate of germ cells can be affected by epigenetic 
modification. Epigenetic modification refers to external modifications to chromatin 
that turn genes "on" or "off" without changing the underlying DNA sequence. 
Abnormal epigenetic modification will facilitate abnormal germ cell development. 
Therefore, understanding of epigenetic reprogramming mechanisms can contribute to 
understanding the mechanisms of germ cell disease. In mammalian germ cells, 
epigenetic modifications changed dynamically and have been found to play 
important roles in germ cell development. However, very few observations about 
these epigenetic modifications have been reported. Hence, this study attempts to 
carry out epigenetic reprogramming research on human fetal germ cells. The 
research findings here showed that epigenetic changes are dynamic in human germ 
cells. However, the biological significances of these dynamic epigenetic 
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Chapter 1. Literature Review   
1.1 General introduction 
For the vast majority of multicellular organisms, germ cells are unique among a 
variety of cell types. Germ cells represent the mechanism by which parental organisms 
transmit their genetic material to the next generation. Therefore, normal germ cell 
development is very important for the health of their offspring (Allegrucci et al., 2005; 
Morgan et al., 2005; Surani et al., 2007).  
In mammals, germ cell lineage is cast apart from somatic lineages in very early 
embryonic development. Relying on genetic and epigenetic mechanisms (the 
definition of epigenetic is showed in Section 1.4), germ cells express their specific 
genome to prepare for totipotency and germ cell fate (Allegrucci et al., 2005; Morgan 
et al., 2005; Surani et al., 2007). Furthermore, germ cells can facilitate the 
continuation of genetic and epigenetic information to offspring through fertilization 
(Allegrucci et al., 2005; Morgan et al., 2005; Surani et al., 2007). Any inappropriate 
epigenetic reprogramming during germ cell development may lead to abnormal 
epigenotypes in germ cells, which may undergo aberrant development and apoptosis 
(Stringer et al., 2013). In addition, germ cells with epigenetic abnormalities may pass 
down the abnormal epigenetic information to their next generation and influence the 
development of their offspring (Allegrucci et al., 2005; Morgan et al., 2005; Surani et 
al., 2007). To sum up, understanding accurately the epigenetic reprogramming during 
human germ cell development is important for further investigation of germ cell 
tumors, infertility and reproductive disorders that may have an epigenetic origin in 
germ cells (Stringer et al., 2013).  
However, due to lack of human fetal tissue, most germ cell studies were performed in 
murine models before being identified in human. Therefore, the key processes of fetal 
germ cell development and the epigenetic modifications in germ cells will be 
discussed mainly in mice, with some limited data in human. 
1.2 Specification and Differentiation of Mouse Fetal Germ cells 
The processes of fetal gonad development are similar in human and mouse, including 
germ cell specification and migration, gonadal formation, sex determination and 
meiotic initiation. The table below summarizes the time course of gonadal 
development in human and mouse (Table 1.1).  
The length of gestation is 20 days in mouse (Lanman and Seidman, 1977) and 40 
weeks in human (Guerrero and Florez, 1969). In the study presented here, the age of 
human pregnancy is measured by week of gestational age (wga), which is calculated 
from the last normal menstrual period (Lynch and Zhang, 2007).  
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EVENT Mouse Human 
Germ Cell 
Specification 
E 5.5-7.5 (Saitou, 2009) ≤5wga (Falin, 1969) 
Germ Cell Migration 
E 7.75-9.5 (Anderson et al., 
2000) 
6-7wga (Fujimoto et al., 
1977) 
Gonadal Colonization E 10.5 (Molyneaux et al., 2001) 7wga (Francavilla et al., 
1990) 
Sexual Differentiation E 12.5 (Koopman et al., 1991) 8-10wga (Moore, 1967) 
Meiotic Initiation 
 
E 13.5 (Hilscher et al., 1974) 11wga (Gondos et al., 
1986) 
Length of Gestation 
20-21days (Lanman and 
Seidman, 1977) 
40wga (Guerrero and 
Florez, 1969) 
Table1.1.Gestational comparison of gonadal development between human and mouse 
(Abbreviations: E, embryonic day; wga, week of gestation age) 
1.2.1 Primordial Germ Cell Specification in Mouse  
In mouse embryo, a small number of pluripotent proximal epiblast cells are induced 
by specific signals to become the founders of the germ cell lineage (Lawson and Hage, 
1994). The figure below represents the processes of germ cell specification (Fig 1.1). 
At around E5.5, visceral endoderm (VE) and extraembryonic ectoderm (ExE), which 
surround the epiblast, start to secrete Bone morphogenetic proteins (Bmp) 2, 4 and 8b 
(Lawson et al., 1999; Ying et al., 2000; Ying et al., 2001; Ying and Zhao, 2001) (Fig 
1.1). These three Bmp proteins have been identified as key inductive signals for the 
generation of germ cell precursors in mice (Lawson et al., 1999; Ying et al., 2000; 
Ying et al., 2001; Ying and Zhao, 2001). Once exposed to these inductive signals, 
some proximal epiblast cells are instructed to develop towards specified primordial 
germ cells (PGCs).  
Under the induction of Bmps, Fragilis is expressed in the proximal epiblast cells from 
E6.0 (Saitou et al., 2002; Tanaka and Matsui, 2002) (Fig 1.1). At around E6.25, small 
portions of these Fragilis-positive cells start to express Blimp1 (B-lymphocyte-induced 
maturation protein 1), encoding a key transcriptional regulator for PGC specification 
(Ohinata et al., 2005; Vincent et al., 2005) (Fig 1.1). The expression of Blimp1 marks 
the origin of germ cell lineage, and these Blimp1-positive cells have been proven to be 
PGC precursor cells by genetic lineage tracing studies (Yabuta et al., 2006). From E6.5, 
the Blimp1-positive cells start to express Prdm14 (PR domain-containing protein 14), 
which encodes another transcriptional regulator (Yamaji et al., 2008). At around E7.25, 
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Stella, (a definitive marker of founder PGCs), is expressed specifically by the 
Fragilis-positive and Blimp1-positive cells (Saitou et al., 2002; Sato et al., 2002) (Fig 
1.1). During germ cell specification, the somatic genes Hoxb1 and Hoxa1 are 
repressed in these Fragilis-positive and Stella-positive PGC precursor cells (Saitou et 
al., 2002) (Fig 1.1).  
During the establishment of founder PGCs, some pluripotency-related genes are also 
upregulated in the Blimp1-positive cells (Yabuta et al., 2006). Sox2 (Sry Box protein 2) 
and Nanog are re-activated in PGCs from E6.75 (Yabuta et al., 2006). After E7.75, 
another pluripotency-associated gene Pou5f1 (POU domain, class 5, transcription 
factor 1), encoding Oct4 protein (octamer-binding transcription factor 4), is 
progressively restricted to the germ line cells and expressed throughout PGC 
development in mice (Pesce et al., 1998).  
Figure 1.1 Formation of primordial germ cells in mice. During E5.5-6.0, some proximal 
posterior epiblast cells are inducted by Bmps signals and start to express Fragilis. At around 
E6.25, small portions of Fragilis-positive cells begin to express Blimp1. These 
Blimp1-positive cells start to generate the Stella-positive founder PGCs at around E7.25. 
Figure reproduced from (Hayashi et al., 2007). (Abbreviations: ExE, extraembryonic 
ectoderm; VE, visceral endoderm; DVE, distal visceral endoderm; AVE, anterior visceral 
endoderm; PGCs, primordial germ cells; A, anterior; P, posterior.) 
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1.2.2 Primordial Germ Cell Migration and Gonadal Colonization in Mouse 
Once specified, PGCs begin to migrate towards the genital ridges to form the gonads 
in mice. At around E7.5, PGCs initially migrate from the posterior primitive streak 
into the adjacent posterior endoderm (future hindgut)(Anderson et al., 2000). Once the 
PGCs have arrived at the hindgut endoderm, they migrate along the hindgut between 
E8.0-9.5 (Anderson et al., 2000). Between E9.0 and 9.5, PGCs migrate from the 
hindgut toward the dorsal mesentery and finally enter into the genital ridges at around 
E10.5 (Anderson et al., 2000). Soon after PGCs arrive in the genital ridges, at around 
E10.5, they start to lose their motility and change their morphology to a larger and 
rounded profile with prominent nucleoli (Molyneaux et al., 2001).  
Migrating PGCs start to proliferate on their way to genital ridges, and continue to 
proliferate upon arrival to the gonads. The number of PGCs rises from 10–100 at E9.5 
to about 25,000 at E13.5 (De Felici et al., 1992; Molyneaux et al., 2001; Tam and 
Snow, 1981).  
1.2.3 Sexual Determination and Differentiation in Mouse  
The bipotential genital ridges are the primordia of testes and ovaries, there are no 
morphological or functional differences between male and female gonads before sex 
determination (Wilhelm et al., 2007).  
The presence of Y chromosome gene Sry (Sex Determining Region Y) activates male 
sex determination and differentiation (Koopman et al., 1991). At the beginning of 
E10.5, the precursors of somatic supporting cells in the XY gonads start to express low 
levels of Sry. Afterwards, the expression of Sry increases and peaks at around E11.5; 
finally, it ceases at around E12.5 (Hacker et al., 1995; Jeske et al., 1995). Sry gene is 
necessary for male sexual differentiation, as XY gonads lacking Sry fail to activate the 
testis-determining pathway and form ovaries (Bullejos and Koopman, 2005). Soon 
after the expression of Sry, its direct downstream target Sox9 (SRY box containing 
gene 9), is expressed by XY pre-Sertoli cells (Sekido et al., 2004; Wilhelm et al., 
2005). Sox9 is necessary for male sexual differentiation, as loss of Sox9 leads to XY 
sex reversal in XY transgenic mice (Barrionuevo et al., 2006).  
In the absence of Y chromosome, no Sry expression occurs in XX gonadal ridges. 
Without the expression of Sry, female-specific genes such as Wnt4 (wingless-type 
MMTV integration site family, member 4) and Foxl2 (forkhead box L2) start to be 
expressed in XX genital ridges at around E11.5-12.5. The XX gonadal ridges 
differentiate into ovaries, with differentiation of the precursors of granulosa cells and 
theca cells, production of oocytes and formation of ovarian follicles (Koopman et al., 
1991; Palmer and Burgoyne, 1991). 
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1.2.4 Regulation of Germ Cell Meiosis in Mouse  
Before sex determination, PGCs are bipotential and can differentiate into either 
oogonia or spermatogonia (McLaren and Southee, 1997). The sexual fate of PGCs is 
not determined by their sex chromosome composition (XX or XY), but by the 
molecular signals from the surrounding gonadal environment (Adams and McLaren, 
2002; Bowles et al., 2006). Exposure to an ovarian environment results in the 
differentiation of PGCs into oogonia (Adams and McLaren, 2002; McLaren and 
Southee, 1997), while exposure to a testicular environment leads to the differentiation 
of PGCs into spermatogonia (Adams and McLaren, 2002).  
In mammals, the germ cells in ovary and testis enter into meiosis asynchronously. At 
around E12.5, the ovarian germ cells start to express Stra8 (stimulated by retinoic acid 
8), which encodes a protein required for pre-meiotic DNA replication and meiosis 
initiation (Baltus et al., 2006). Between E13.5 and E14.5 in mouse, ovarian germ cells 
stop proliferating and enter into meiotic prophase I (Hilscher et al., 1974; McLaren 
and Southee, 1997). The germ cells in mouse fetal ovary progress through leptotene 
(condensation of the chromosomes), zygotene (pairing of homologous chromosomes), 
pachytene (initiation of recombination) and arrest at the diplotene stage (paired 
homologous chromosomes start to separate but remain bound at chiasmata) at the time 
of birth (Borum, 1961; Speed, 1982). During this period, the expression of meiotic 
markers such as Sycp3 (Synaptonemal Complex Protein 3) and Dmc1 (the Dosage 
suppressor of mck1 homologue 1) are upregulated in the ovarian germ cells (Bullejos 
and Koopman, 2004; Menke et al., 2003; Yao et al., 2003). Soon after the initiation of 
meiosis, the levels of pluripotency genes, like Pou5f1 and Nanog, are downregulated 
in the fetal ovaries (Bullejos and Koopman, 2004; Pesce et al., 1998). On the other 
hand, the germ cells in the testis do not enter into meiosis during fetal life. Instead, 
they enter mitotic arrest at around E13.5, stay in the G0/G1 phase of cell cycle for the 
remaining embryonic period and do not initiate meiosis until puberty (Hilscher et al., 
1974; Western et al., 2008). During mitotic arrest, the fetal testicular germ cells do not 
express Stra8 and express low levels of Sycp3 and Dmc1 (Chuma and Nakatsuji, 2001; 
Nakatsuji and Chuma, 2001). 
1.2.4.1 Molecular mechanisms of germ cell meiosis: retinoic acid synthesis and 
degradation 
Recent studies have revealed that retinoic acid (RA) is an essential extrinsic signal for 
the induction of meiosis in both male and female mouse germ cells (Bowles et al., 
2006; Koubova et al., 2006; Li and Clagett-Dame, 2009) (Fig 1.2). The critical role of 
RA in meiotic initiation has been demonstrated by the studies using Vitamin A 
deficient (VAD) rodent models (Ghyselinck et al., 2006; Li and Clagett-Dame, 2009; 
Li et al., 2011). RA is a biologically active derivative of vitamin A; therefore the 
endogenous levels of RA are low in VAD rodents. With low levels of RA, the germ 
cells in the VAD rodents do not induce Stra8, fail to enter meiosis and remain in an 
undifferentiated state in both sexes (Ghyselinck et al., 2006; Li and Clagett-Dame, 
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2009; Li et al., 2011). In vitro culture experiments also showed that exogenous RA 
could induce meiosis in isolated XY germ cells (Ohta et al., 2010; Trautmann et al., 
2008). All these studies suggest that RA is required for the initiation of meiosis in 
mice germ cells.  
Between E11.5 and E13.5, the RA-synthesizing enzymes Aldh1a2 (retinaldehyde 
dehydrogenase 2) and Aldh1a3 (retinaldehyde dehydrogenase 3), which catalyze the 
oxidation of retinaldehyde into RA, are expressed in the mesonephros (Bowles et al., 
2006; Mu et al., 2013). In mice, mesonephros-synthesized RA diffuses into the 
adjacent ovary in an anterior-to-posterior wave (Bullejos and Koopman, 2004; Menke 
et al., 2003). The ovarian germ cells in the anterior portion of the gonad, which 
connects to the mesonephric tubules directly, enter into meiosis earlier than those in 
the posterior end (Bullejos and Koopman, 2004; Menke et al., 2003). Consistent with 
this meiotic pattern, the increase of meiosis-specific genes and the decrease of 
pluripotency-associated genes occur in an anterior-to-posterior wave by germ cells 
(Bullejos and Koopman, 2004; Menke et al., 2003). 
In fetal mouse testis, RA is mainly cleared by Cyp26b1 (cytochrome P450, family 26, 
subfamily b, polypeptide 1), a retinoid-degrading enzyme, which can catabolize RA 
into inactive oxidized metabolites (Bowles et al., 2006; Koubova et al., 2006; 
MacLean et al., 2001) (Fig 1.2). By E11.5, the levels of Cyp26b1 are low in the 
gonads of both sexes. Afterwards, Cyp26b1 expression decreases to an undetectable 
level in mouse ovary by E12.5 (Bowles et al., 2006; Koubova et al., 2006). Without 
Cyp26b1, ovarian germ cells are exposed to high levels of RA, which eventually 
induces the initiation of meiosis in mouse fetal ovarian germ cells. Conversely, after 
the onset of sex determination, the expression of Cyp26b1 is upregulated in the mouse 
fetal testis. High expression of Cyp26b1 prevents the entry of germ cells into meiosis 
in fetal mouse testis by degrading the endogenous RA (Bowles et al., 2006; Koubova 
et al., 2006). 
Cyp26b1-knockout studies in mice have confirmed the importance of Cyp26b1 in 
meiosis inhibition (Bowles et al., 2006; MacLean et al., 2007; Yashiro et al., 2004). In 
Cyp26b1-null XY fetal gonads, endogenous RA is increased, indicating that Cyp26b1 
is required for the repression of RA. With the presence of ectopic RA, meiosis-related 
genes Stra8, Sycp3, and Dmc1 are greatly upregulated in Cyp26b1-null XY germ cells, 
which enter and progress through meiosis by E16.5 (Bowles et al., 2006; MacLean et 
al., 2007; Yashiro et al., 2004).  
According to the studies above, the balance between retinoid synthesis and 
degradation determines the levels of RA, which will thus control the onset of meiosis 
in mice. 
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Figure 1.2 Regulation of meiotic initiation in mouse germ cells. A. At around E11.5, RA is 
synthesized in mesonephros, low levels of Cyp26b1 and Dazl are present in the bipotential 
gonad. Ba. Once Sry is expressed in the XY gonad, expression of Cyp26b1 is increased and 
protects testicular germ cells from the RA activity. Bb. At around E13.5, the testicular germ 
cells enter into mitotic arrest. Ca. In the female gonad, the expression of Cyp26b1 is decreased 
by E12.5. With the induction of RA, the ovarian germ cells enter into meiosis and start to 
express Stra8. Cb. The meiotic markers Sycp3 and Dmc1 increased in ovarian germ cells by 
E13.5. Figure reproduced from (Bowles and Koopman, 2007).  
1.2.4.2 The Meiotic Gatekeeper Gene Stra8 
Stra8 was first identified as a RA-responsive gene in mouse P19 embryonic carcinoma 
cells (Bouillet et al., 1995; Oulad-Abdelghani et al., 1996). RA induces the expression 
of Stra8 by binding to RAR (retinoic acid receptors) and RXR (retinoid-X receptors), 
which bind to RAREs (retinoic acid response elements) in the Stra8 promoter (Duester, 
2008). In vitro culture experiments have shown that these RA receptors are necessary 
for the induction of Stra8 and the initiation of meiosis in both sexes (Boulogne et al., 
1999; Bowles et al., 2006; Dufour and Kim, 1999; Koubova et al., 2006). When 
treated with RAR antagonists, fetal ovarian germ cells fail to induce Stra8 and fail to 
enter the meiotic cell cycle (Bowles et al., 2006; Koubova et al., 2006). Conversely, in 
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testis culture experiments, the presence of RAR agonists activates the expression of 
Stra8 in fetal testicular germ cells (Boulogne et al., 1999; Dufour and Kim, 1999). 
The key role of Stra8 as meiotic gatekeeper has been confirmed in both 
spermatogenesis and oogenesis by gene knockout studies (Anderson et al., 2008; 
Baltus et al., 2006; Mark et al., 2008). In Stra8-deficient female mouse embryos, 
ovarian germ cells retain pre-meiotic morphology and do not undergo any of the 
meiotic chromosomal events. There is no pre-meiotic DNA replication, and no meiotic 
chromosome condensation, cohesion, synapsis and recombination in Stra8-deficient 
ovarian germ cells (Anderson et al., 2008; Baltus et al., 2006). In the presence of 
exogenous RA, germ cells in Stra8-null fetal ovaries fail to initiate the subsequent 
meiotic process, indicating that the Stra8 is the trigger for meiotic initiation (Anderson 
et al., 2008; Baltus et al., 2006). In Stra8-deficient testis, impaired meiosis also has 
been observed (Anderson et al., 2008; Mark et al., 2008). However, whether meiotic 
disruption occurs before or after meiotic initiation in the Stra8-deficient testis is not 
consistent between the studies of Anderson et al. (Anderson et al., 2008) and Mark et 
al. (Mark et al., 2008).  
Molecular hallmarks of meiotic chromosome cohesion, synapsis and recombination 
have been investigated in Stra8-deficient ovaries and testes (Anderson et al., 2008; 
Baltus et al., 2006). Normally, the meiosis-specific cohesion protein Rec8 (Meiotic 
recombination protein) (Eijpe et al., 2003; Lee et al., 2003) and the synaptonemal 
complex protein Sycp3 (Moens and Spyropoulos, 1995) are localized along the 
lengths of chromosomes in meiotic germ cells (Prieto et al., 2004). However, in 
Stra8-null ovarian germ cells, Rec8 and Sycp3 are not properly localized along 
chromosomes (Anderson et al., 2008; Baltus et al., 2006), suggesting that Stra8 is 
required for the formation of meiotic cohesion and synaptonemal complex in mice 
germ cells (Anderson et al., 2008; Baltus et al., 2006). During prophase I of meiosis, 
homologous recombination is initiated by DNA double-strand breaks (DSBs), which 
are formed by protein Spo11 (Baudat et al., 2000; Romanienko and Camerini-Otero, 
2000) and repaired by Dmc1 (Pittman et al., 1998; Yoshida et al., 1998). In response to 
DNA DSBs, γ-H2AX is deposited at the sites of DNA damage generated during 
meiotic recombination (Rogakou et al., 1998). In Stra8-deficient ovaries and testes, 
the staining of γ-H2AX, and mRNA levels of Spo11 and Dmc1 were all undetectable, 
suggesting that germ cells lacking Stra8 fail to form or repair meiotic DSBs, and thus 
fail to initiate meiotic recombination (Anderson et al., 2008; Baltus et al., 2006).   
Recently, Saba and colleagues (Saba et al., 2014) generated mouse embryos with the 
double knockout of Cyp26b1 and Stra8. Meiosis in XY germ cells, which was induced 
in the Cyp26b1-null mice (Bowles et al., 2006; MacLean et al., 2007; Yashiro et al., 
2004), was inhibited in the Cyp26b1−/−/Stra8−/− XY germ cells (Saba et al., 2014). 
In this double knockout study, the meiotic markers Sycp3 and γH2AX were 
up-regulated in the Cyp26b1−/−/Stra8+/+ male gonads, but not observed in the 
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Cyp26b1−/−/Stra8−/− male gonads and Cyp26b1+/+/Stra8+/+ control (Saba et al., 
2014). All these experiments indicate the indispensable role of Stra8 for meiotic 
initiation in mice (Anderson et al., 2008; Baltus et al., 2006; Mark et al., 2008; Saba et 
al., 2014).  
1.2.4.3 Intrinsic Factor involved in meiotic entry 
In addition to extrinsic signals, an intrinsic meiotic competence factor is also 
necessary for meiosis initiation (Lin et al., 2008). Dazl (Deleted in azoospermia-like), 
a germline-specific RNA-binding protein, is required for germ cells to respond to RA 
signals (Lin et al., 2008; Lin and Page, 2005). In the post-migratory mouse germ cells, 
Dazl mRNA is first detected at around E11.5 (Seligman and Page, 1998); the Dazl 
protein is localized to the cytoplasm of mouse fetal germ cells (Ruggiu et al., 1997).  
In both male and female mice, targeted deletion of Dazl results in germ cell loss (Lin 
et al., 2008; Lin and Page, 2005; Ruggiu et al., 1997; Saunders et al., 2003). In 
Dazl-knockout mice, the expression of pluripotency-related genes is not 
downregulated in the germ cells, and they remain in an undifferentiated PGC-like state 
(Lin et al., 2008; Lin and Page, 2005). Deficiency of Dazl leads to failure to enter 
meiosis in these PGC-like ovarian germ cells (Lin et al., 2008; Saunders et al., 2003). 
The mRNA levels of Stra8 are drastically decreased in surviving Dazl-deficient 
ovarian germ cells, suggesting that Dazl is responsible for the initiation of meiosis in 
the fetal mouse ovary (Lin et al., 2008). Germ cells in Dazl-deficient ovaries do not 
form DNA DSBs, and fail to initiate homologous recombination, as the surviving 
Dazl-null ovarian germ cells do not express Spo11 and Dmc1, and are negative for γ
-H2AX staining (Lin et al., 2008). In the Dazl-null mouse ovarian germ cells, Sycp3, 
the translation of which is regulated by Dazl (Reynolds et al., 2007), is markedly 
downregulated at mRNA and protein levels (Lin et al., 2008). Similarly, Rec8 mRNA 
is undetectable in Dazl-deficient ovaries (Lin et al., 2008). Therefore, Dazl is also 
essential for the formation of meiotic cohesion and synaptonemal complex in mice 
fetal ovarian germ cell (Lin et al., 2008). When Dazl-deficient testes were exposed to 
exogenous RA, the germ cells were unable to induce Stra8 and failed to enter meiosis 
(Lin et al., 2008).  
The studies detailed above identify Dazl as an essential intrinsic competence factor for 
meiotic initiation in mice (Lin et al., 2008). 
1.2.4.4 Challenging the retinoic acid theory 
In 2011, the theory that meiotic induction is dependent on RA has been challenged. In 
the study by Kumar et al. (Kumar et al., 2011), meiotic induction was investigated in 
the Aldh1a2-single knockout (Aldh1a2−/−) and Aldh1a2/Aldh1a3-double knockout 
(Aldh1a2−/−/Aldh1a3−/−) mouse embryos. Despite the absence of these two major 
RA-synthesizing enzymes, the expression of Stra8 was still induced in ovarian germ 
cells, which also entered into meiosis (Kumar et al., 2011). In these Aldh1a2−/− and 
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Aldh1a2-/-/Aldh1a3−/− mouse ovaries, RA was undetectable by transgenic 
RARE-LacZ reporter mouse line, which is sensitive to 25nM RA and above (Kumar et 
al., 2011). The data in this study led Kumar et al. to conclude that meiotic initiation is 
completely independent of RA (Kumar et al., 2011).  
However, Griswold et al. (Griswold et al., 2012) has alternative explanations for this 
study. He argued that another RA-producing enzyme Aldh1a1, which is expressed in 
the ovary, might contribute to the RA synthesis in these Aldh1a2−/− and 
Aldh1a2-/-/Aldh1a3−/− embryos (Griswold et al., 2012). It also has been proven that 
very small amounts of RA (around 1nM) are sufficient to induce Stra8 expression and 
subsequent meiosis (Ohta et al., 2010; Zhou et al., 2008). Recently, an in-vitro study in 
cultured mouse fetal ovaries has indicated that the Aldh1a1-synthesized RA can 
initiate meiosis (Mu et al., 2013). Therefore, within Aldh1a2−/− and 
Aldh1a2-/-/Aldh1a3−/− ovaries, Aldh1a1 may locally produce low levels of RA, 
which is sufficient to induce the expression of Stra8, but not high enough to be 
detected by the RARE-LacZ reporter mouse line (Griswold et al., 2012; Mu et al., 
2013).  
1.3 Germ cell specification and differentiation in human  
1.3.1 Generation of Primordial Germ Cells in Human  
In human embryos, some PGC precursor cells have been identified in the dorsal wall 
of the yolk sac at around 5wga (Falin, 1969; Fuss, 1912; Witschi, 1948). PGCs can be 
distinguished from other cells by their large size, spherical shape, round nucleus with 
prominent nucleoli, and pale cytoplasm (Falin, 1969; Fuss, 1912; Witschi, 1948). 
Due to lack of accessibility to early human tissues, the process of human PGC 
specification is not clear. In order to investigate the molecular mechanisms controlling 
PGC formation in humans, human embryonic stem cells (hESCs) have been used as an 
important in vitro system (Clark et al., 2004; Tilgner et al., 2008). The in vitro studies 
in hESCs have shown that human BMPs may be involved in the formation of human 
PGCs (Kee et al., 2009; Kee et al., 2006), as they were in mice (Lawson et al., 1999; 
Ying et al., 2000; Ying et al., 2001; Ying and Zhao, 2001). In hESCs, the 
transcriptional repressor BLIMP1 has been found to induce the PGC formation by 
switching off the pluripotency-related gene SOX2 (Lin et al., 2014). The studies in 
hESCs (Lin et al., 2014) and 16-22wga human fetal gonads (Eckert et al., 2008) have 
indicated that BLIMP1 might be associated with early PGC development in humans, 
as it was in mice (Yabuta et al., 2006). The findings mentioned above suggest that the 
mechanisms involved in PGC formation may be evolutionarily conserved between 
human and mouse; however, this need further investigation. 
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1.3.2 Differentiation of Human Fetal Germ Cells  
At around 6wga, human PGCs migrate from the yolk sac to the hindgut endoderm 
(Fujimoto et al., 1977). The migrating PGCs reach the dorsal mesentery early in 7wga, 
and continue to move and pass beyond the primitive mesonephros (Fujimoto et al., 
1977). At around the end of 7wga, most of the human PGCs have reached the genital 
ridges and the gonadal primordia are colonized by 8wga (Francavilla et al., 1990; 
Fujimoto et al., 1977).  
In the early migration stage, human germ cells proliferate by mitotic division, and 
continue to increase in number after they reach the genital ridges. From 7wga to 
11wga, the number of germ cells increases from around 1000 to about 250,000 in 
females and around 75,000 in males (Baker, 1963; Bendsen et al., 2006; Mamsen et al., 
2011). At the end of the proliferative phase at around 20wga, the number of human 
ovarian and testicular germ cell number rises to approximately 5,000,000 and 
1,500,000, respectively (Baker, 1963; Bendsen et al., 2006; Mamsen et al., 2011).  
Before sexual differentiation in humans, the newly colonized genital ridges are 
indistinguishable between males and females. From 8wga, with the activation of SRY 
on the Y chromosome, human XY gonads undergo testis-specific differentiation and 
form testicular cords (Hanley et al., 2000). The expression of human SRY is 
maintained in the testicular cords throughout the embryonic period and beyond 
(Hanley et al., 2000), which is different from the expression observed in mouse 
(Hacker et al., 1995; Jeske et al., 1995). As the first morphological sign of male sex 
differentiation, the testicular cords are gradually formed during 8 and 10wga 
(Pelliniemi, 1993). At around 9wga, the mesonephric origin pre-Sertoli cells migrate 
into the central regions of the testis and surround the testicular PGCs (Heyn et al., 
2001) (Fig 1.3). With the differentiation of Sertoli cells, the differentiated peritubular 
myoid cells, which migrate from the mesonephros, enclose the mix of Sertoli cells and 
PGCs to form the testicular cords (Pelliniemi, 1993; Wartenberg, 1981) (Fig 1.3). 
During these periods, the testicular androgen-producing Leydig cells undergo 
proliferation and occupy the spaces between the testicular cords (DeFalco et al., 2011; 
Murray et al., 2000) (Fig 1.3). The testicular PGCs are referred to as gonocytes after 
they are enclosed in testis cords (Gaskell et al., 2004; Wartenberg, 1981). The human 
gonocytes are inhibited from meiosis; without any apparent arrest, some of them 
undergo several rounds of mitosis and further differentiate into more mature 
prespermatogonia (Bendsen et al., 2003; Gaskell et al., 2004). During 13-20wga (2nd 
trimester), both gonocytes and prespermatogonia are visible in the same human testes 
cords (Gaskell et al., 2004). The smaller, round gonocytes are usually present in the 
center of a cord, while the larger, irregular prespermatogonia are usually observed in 
groups at the periphery of a cord (Gaskell et al., 2004) (Fig 1.3). 
Conversely, without the expression of SRY, human XX gonads differentiate into 
ovaries (Hanley et al., 2000). Following sex determination in humans, germ cells in 
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the nascent ovaries continue to proliferate for several weeks and differentiate into 
oogonia (Wartenberg, 1982). At 8-9wga, the ovaries contain only undifferentiated 
PGCs, which distribute throughout the ovary and integrate with somatic cells in an 
unorganized pattern (Byskov, 1986) (Fig 1.3). During rapid mitotic proliferation, 
clusters of human oogonia undergo incomplete division of cell body and form clusters 
of interconnected germ cell nests (Gondos et al., 1986; Gondos and Zamboni, 1969; 
Wartenberg, 1982) (Fig 1.3). Groups of oogonia in the germ cell nests are joined via 
intercellular bridges (Gondos and Zamboni, 1969). At roughly 12wga, the somatic 
pre-granulosa cells integrate with germ cells and become part of the germ nests; 
meanwhile, streams of mesenchymal somatic cells run amongst the nests (Wartenberg, 
1982) (Fig 1.3). Around 11-12wga, some clustered oogonia located in the inner cortex 
of the ovary begin to enter meiotic prophase I (Gondos et al., 1986), while the smaller 
germ cells in the periphery of ovary continue to proliferate via mitosis (Gondos et al., 
1986; Le Bouffant et al., 2010). With the development of human fetal ovary, meiosis 
spreads radially towards the periphery of the ovary in human (Gondos et al., 1986; Le 
Bouffant et al., 2010), which is different from the anterior-to-posterior meiotic entry in 
mouse ovarian germ cells (Bullejos and Koopman, 2004; Menke et al., 2003). By the 
time of birth, nearly all of oocytes have progressed through meiotic prophase I and 
arrested at the diplotene stage before birth (Gondos et al., 1986). Following the 
initiation of meiosis, breakdown of the germ-cell nests occurs, accompanied with 
apoptotic death of about two-thirds of the oocytes (De Pol et al., 1997; Fulton et al., 
2005; Vaskivuo et al., 2001). The surviving oocytes interact with the surrounding 
pre-granulosa cells to initiate the formation of primordial follicles (Stoop et al., 2005; 
Tingen et al., 2009). From around 17wga onwards (the late 2nd trimester), primordial 
follicle is formed with one oocyte surrounded by a single layer of pre-granulosa cells 
(Stoop et al., 2005; Tingen et al., 2009) (Fig 1.3).  
During 13-20wga, the ovarian germ cells at different developmental stages are 
distributed radially in human ovaries. During this period, the undifferentiated 
PGC-like cells are located in the outer cortex of human fetal ovary; while the mature 
ovarian germ cells settle in the central cortex and medulla of fetal ovary (Anderson et 
al., 2007; Stoop et al., 2005). During 17-20wga, the proliferative PGC-like cells, 
pre-meiotic oogonia, meiotic oocytes and primordial follicles can be simultaneously 
detected in the same human ovary (Fulton et al., 2005; Stoop et al., 2005). These 
observations suggest that differentiation of human fetal germ cells occurs in an 
asynchronous way, which is different from the more synchronous differentiation of 
mouse germ cells (Bullejos and Koopman, 2004; Menke et al., 2003).  
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Figure 1.3 Schematic of fetal human ovarian and testicular development. Ovaries: In 1st 
trimester, PGCs distribute throughout the ovary and integrate with mesenchymal somatic cells 
and pre-granulosa cells in an unorganized pattern. In early 2nd trimester, clusters of oogonia 
form the germ cell nests with pre-granulosa cells. Streams of mesenchymal somatic cells run 
amongst the nests. In late 2nd trimester, the nests break down, and oocytes become 
surrounded by a single layer of pre-granulosa cells to form primordial follicles. Testes: In 1st 
trimester, PGCs are distributed throughout the testis and integrate with Sertoli cells in an 
unorganized pattern; the testicular cords start to be formed at this stage. In early 2nd trimester, 
testicular cords are distinct. A layer of peritubular myoid cells encloses the Sertoli cells and 
gonocytes into the cords. The Leydig cells are located between the cords. The centrally located 
gonocytes gradually move to the periphery of the cords as they differentiate into 
prespermatogonia. This pattern becomes more obvious in the late 2nd trimester. Figures are 
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1.3.3 Expression of Pluripotent Marker OCT4 and Germ Cell-specific 
Marker VASA in Human Fetal Ovary and Testis 
In humans, the pluripotency-associated gene POU5F1 (also known as OCT4), which 
encodes the OCT4 protein, is detectable in both male and female fetal gonads 
(Anderson et al., 2007). In human fetal ovary, the expression of POU5F1 is in a high 
level at 1st trimester; and slightly declines at 2nd trimester. In human fetal testis, no 
significant difference has been observed between different gestations (Anderson et al., 
2007). 
During 1st trimester, the PGCs in the human fetal ovary and testis all express this 
pluripotency-associated marker OCT4. At this stage, OCT4-positive PGCs are evenly 
distributed throughout the male and female gonads. With the maturation of germ cells, 
OCT4 expression progressively decreases in ovaries and testes (Anderson et al., 2007; 
Kerr et al., 2008a; Kerr et al., 2008b). During 2nd trimester, OCT4 is repressed 
asynchronously in human fetal ovary, in which the ovarian germ cells are 
differentiated asynchronously (Anderson et al., 2007; Stoop et al., 2005). During this 
period, a subpopulation of PGC-like cells in the periphery of fetal ovary still maintain 
the OCT4 expression; while the central located oocytes, which have already entered 
meiotic prophase I, have lost the expression of OCT4. The mature oocytes in 
primordial follicles are OCT4-negative as well. The asynchronous down-regulation of 
OCT4 has also been observed in human 2nd trimester fetal testes, in which a mixture of 
OCT4-positive and OCT4-negative germ cells has been observed in the same 
testicular cords (Anderson et al., 2007; Kerr et al., 2008b). This observation in human 
testis is different to that in mouse, in which the expression of OCT4 is reduced 
synchronously in all testicular germ cells (Pesce et al., 1998; Zayed et al., 2007). 
VASA, a member of the DEAD-box family, was first identified in Drosophila (Lasko 
and Ashburner, 1988). Study in 2000 indicated that VASA was expressed in migratory 
PGCs in the region of the gonadal ridge (Castrillon et al., 2000), earlier than occurred 
in mouse (Toyooka et al., 2000). However, in later studies, VASA has been identified 
as a mature germ cell-specific marker in human gonads (Anderson et al., 2007; Kerr et 
al., 2008a; Kerr et al., 2008b). During 1st trimester, VASA is present at very low levels 
or barely detectable in human fetal gonads. At 2nd trimester, the expression of VASA is 
significantly upregulated in both ovary and testis, although the increase in testis is less 
substantial than that in ovary. During 1st trimester, the VASA protein is undetectable in 
human ovary and testis (Anderson et al., 2007). From the early 2nd trimester, an 
asynchronous increase in VASA also has been observed in both ovarian and testicular 
germ cells (Anderson et al., 2007; Kerr et al., 2008a; Kerr et al., 2008b). In 2nd 
trimester human fetal ovaries, the mature oocytes, which are negative for OCT4, 
display intense cytoplasmic VASA staining. Meanwhile, the PGC-like cells, which are 
positive for OCT4, do not display VASA staining. This observation indicates that the 
expression of VASA is restricted to the maturing oocytes rather than PGC-like cells. In 
2nd trimester human fetal testes, a mixture of VASA-positive and OCT4-positive germ 
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cells has been observed at the same testicular cords. Similar to the ovarian germ cells, 
the more differentiated OCT4-negative testicular germ cells are VASA-positive; while 
the OCT4-positive gonocytes are VASA-negative (Anderson et al., 2007; Kerr et al., 
2008b).  
The asynchronous decrease of OCT4 and increase of VASA in human fetal ovary and 
testis further demonstrates that the human fetal germ cells differentiate in an 
asynchronous way (Anderson et al., 2007; Fulton et al., 2005; Kerr et al., 2008a; Kerr 
et al., 2008b; Stoop et al., 2005). The mutually exclusive expression of OCT4 and 
VASA in human 2nd trimester gonads further supports that VASA is a specific marker 
of germ cell maturation (Anderson et al., 2007; Kerr et al., 2008a; Kerr et al., 2008b).  
1.3.4 Meiotic Regulators in Human Fetal Gonads 
Following the initiation of meiosis, human oocytes undergo chromosome condensation, 
homologous chromosome synapsis, homologous recombination and finally arrest at 
the diplotene stage of meiotic prophase I before birth (Hunt and Hassold, 2008).  
During these periods, multiple meiosis-related genes are upregulated in human fetal 
ovary (Childs et al., 2011; Houmard et al., 2009; Le Bouffant et al., 2010). At around 
the onset of meiosis, the pre-meiotic gene STRA8, which is present at low levels in 
early human fetal ovaries (8-9wga), is markedly increased (Childs et al., 2011; 
Houmard et al., 2009; Le Bouffant et al., 2010). In addition to STRA8, the expression 
SPO11, which is required for meiotic recombination; SYCP1 and SYCP3, which 
encode essential structural components of synaptonemal complex; are all sharply 
increased in human fetal ovaries from 12wga onwards (Childs et al., 2011; Houmard 
et al., 2009; Le Bouffant et al., 2010). Another meiotic gene DMC1, which encodes a 
meiotic homologous recombination protein, is elevated later at 17wga in human fetal 
ovaries (Le Bouffant et al., 2010). Between 12-20wga, SYCP3 protein has been 
observed in the human fetal ovaries (Childs et al., 2012; Jorgensen et al., 2012), which 
corroborates the observation on SYCP3 gene expression (Childs et al., 2011; Houmard 
et al., 2009; Le Bouffant et al., 2010). During these stages, the meiotic oocytes display 
intense nuclear SYCP3-staining; while the oogonia, which do not enter into meiosis, 
are negative for SYCP3 (Childs et al., 2012; Jorgensen et al., 2012). 
During the process of meiotic prophase I, any errors occurred can alter the expression 
of these meiotic genes, and further affect the formation of haploid gametes causing 
fertility problems, miscarriage and birth defects in human (Zheng et al., 2010). 
Therefore, it is important to understand the mechanisms that regulate meiotic initiation 
and meiotic prophase in human fetal ovary. However, due to the difficulty in obtaining 
human fetal ovarian samples, knowledge about human female meiosis is limited.  
The critical role of RA in meiotic initiation has been demonstrated in human fetal 
ovaries by Childs et al and Le Bouffant et al’s studies (Childs et al., 2011; Le Bouffant 
et al., 2010). Unlike the mouse (Bowles et al., 2006; Koubova et al., 2006), the local 
gonadal RA synthesis rather than diffusion of RA from the mesonephros may drive the 
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initiation of meiosis in human fetal ovary; as the gonadal produced RA-producing 
enzyme ALDH1A can synthesize RA locally (Childs et al., 2011; Le Bouffant et al., 
2010). At around 2nd trimester, nuclear-localized RA receptors RARα, RARβ and 
RXRα are all detectable in human ovarian germ cells (Childs et al., 2011). RA 
receptors have been found to be essential for retinoid signals transduction (Kastner et 
al., 1997). The nuclear localization of these receptors in human fetal ovarian germ 
cells suggests that higher local RA concentration is existed in these cells. 
Conversely, meiosis is inhibited in human fetal testis (Bendsen et al., 2003; Gaskell et 
al., 2004). The expression of STRA8 is barely detectable in human fetal testes. In 
addition to STRA8, the mRNA levels of other meiotic genes SPO11, SYCP1, SYCP3 
and DMC1 are all expressed at very levels across all the detected gestations in human 
fetal testes (Childs et al., 2011; Houmard et al., 2009; Le Bouffant et al., 2010). The 
knowledge about the mechanism of meiotic inhibition in human fetal testis remains 
limited. Cyp26b1-mediated RA degradation has been proposed to be involved in the 
prevention of meiosis in mouse fetal testis (Bowles et al., 2006; Koubova et al., 2006). 
However, in human fetal testis, there is no any really evidence to support that 
CYP26B1 play an important role in the inhibition of meiosis (Childs et al., 2011; 
Jorgensen et al., 2012; Le Bouffant et al., 2010). In male, the nuclear-localization of 
RA receptors has been detected in human fetal testicular germ cells (Childs et al., 
2011). This observation indicates that these human fetal testicular germ cells are 
receiving RA signals and the RA-degrading enzyme CYP26B1 does not effectively 
block the RA signals in these cells (Childs et al., 2011). Different from the observation 
in mice (Bowles et al., 2006; Koubova et al., 2006), CYP26B1 does not specifically 
increase in human fetal testis (Childs et al., 2011). The expression of CYP26B1, which 
is relatively similar in the early human fetal testes and ovaries, is unexpectedly higher 
in the human fetal ovary during 14-16wga. CYP26B1 protein is also detectable in both 
human fetal ovary and testis (Childs et al., 2011). All these observations suggest that 
CYP26B1 may not be the main meiotic inhibition factor in human fetal testes. Some 
other mechanisms of meiotic inhibition may be involved in human fetal testis, which 
need to be further investigated. 
In addition to RA and its RA-degrading enzyme Cyp26b1, Dazl also has been 
identified as an essential intrinsic meiotic competence factor for RA response in mice 
(Lin et al., 2008). In humans, DAZL is a candidate fertility factor, as mutations of 
DAZL may be linked to infertility in males and females (Dorfman et al., 1999; Seboun 
et al., 1997; Tung et al., 2006; Yen et al., 1996). In vitro studies in human germ cells 
differentiated from hESCs and human iPSCs (Induced Pluripotent Stem Cells) have 
demonstrated that overexpression of DAZL and/or its closely-related gene BOLL can 
enhance the entry into and progression through meiosis (Kee et al., 2009; Medrano et 
al., 2012; Panula et al., 2011).  
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The mRNA expression of DAZL is present at a very low level in both human fetal 
ovary and testis during the 1st trimester. Following the onset of meiosis, ovary-specific 
DAZL upregulation has been observed (Anderson et al., 2007). DAZL protein is 
initially localized in the nucleus of human ovarian PGCs. With the development of 
human ovary, the DAZL protein is re-located from nucleus to cytoplasm in the more 
differentiated oocytes (Anderson et al., 2007). The expression and distribution of 
DAZL has been further investigated in human fetal ovary (He et al., 2013). In meiotic 
human oocytes, DAZL was expressed in the early stages of meiotic prophase I, after 
that, DAZL was downregulated, and then replaced by another DAZ-family protein 
BOLL. Finally, at the end of meiotic prophase I, the expression of BOLL was erased 
and DAZL re-expressed. DAZL protein also has been found to co-localize with the 
meiotic markers SYCP3 in some human fetal oocytes (He et al., 2013). According to 
the observations mentioned above, the role for DAZL in regulating the meiotic entry is 
conserved in humans and mice (Lin et al., 2008).  
1.4 Epigenetics and Inheritance  
The growth process of multicellular organisms demands the close regulation of gene 
expression. If unregulated, gene expression can have significant adverse effects on the 
phenotypes, leading to the development of various diseases in humans, including 
cancer (Alberts, 2008).  
Changes in gene expression can be inherited without altering the underlying DNA 
sequence. This phenomenon has been identified as epigenetic modification, which can 
be transferred to daughter cells or next generation by mitosis and meiosis (Bird, 2007; 
Goldberg et al., 2007). The development of a multicellular organism from a totipotent 
zygote is the most compelling case of epigenetic modification. The main feature of a 
totipotent zygote is its capacity for differentiation into any cell type, including neural, 
muscle, epithelium and germ cells (Reik, 2007). Although all of the cells in a 
multicellular organism contain identical DNA sequences, different types of cells only 
express the genes required for their particular functions. These tissue and cell specific 
gene expression patterns are not dependent upon intracellular DNA sequence, but on 
epigenetic modifications, which can either trigger gene expression or inhibit it (Reik, 
2007).  
Epigenetic modifications are relatively stable in the mammalian somatic cells. The 
epigenetic state can be transmitted to the daughter cells by cell division in order to 
recall active or repressive transcriptional states (Reik, 2007). In general, the majority 
of epigenetic modifications in somatic cells only take place within the course of one 
individual organism's lifetime and can’t be transmitted to the following generation 
(Reik, 2007). However, in mammalian germ cells, epigenetic modifications are subject 
to reprogramming throughout the genome (Seki et al., 2005). Epigenetic changes can 
be passed on to the following generation if they take place in a germ cell that is 
involved in fertilisation (Reik, 2007). Thus, the next generation may exhibit incorrect 
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epi-genotypes due to disruption of the epigenetic status in germ cells, and as a result, 
the embryo may develop abnormally (Reik, 2007; Seki et al., 2005). This underscores 
the importance of having comprehensive knowledge of the epigenetic modifications 
during the development process of germ cells. 
Of the known epigenetic mechanisms, the most significant epigenetic modifications 
are caused by DNA methylation and histone modifications (Berger et al., 2009). 
During the complex biological process, DNA methylation and histone modifications 
affect the specific epigenetic phenomenon independently; they also interact with each 
other and jointly determine gene transcriptional status during this process.  
1.5 Histone modification 
1.5.1 Chromatin Structure and Modification of Histone Proteins 
In eukaryotes, chromatin, which consists of complexes of DNA and proteins, can 
compress the DNA to fit in the cell nucleus (Kornberg, 1974; Kornberg, 1977).  
Heterochromatin and euchromatin are the two distinct geographically regions of 
chromatin, the former being largely transcriptionally inactive, while the latter is 
largely active (Dillon, 2004; Nicholson and Wood, 2006). The genes in eukaryotes are 
not activated unless RNA polymerase and transcription factors can access them. The 
initiation of gene transcription depends on the interaction between the transcription 
factors and gene segments known as promoter regions (Alberts, 2008). In the 
compressed heterochromatin, transcription factors cannot access the promoter regions 
and therefore cannot activate gene expression (Dillon, 2004; Grewal and Jia, 2007). 
Thus, heterochromatin is usually associated with gene silencing. In order to activate 
gene expression, the heterochromatin structure has to be loosened up in a specific and 
regulated way. This loose chromatin structure has been identified as euchromatin 
(Nicholson and Wood, 2006). Usually, but not always, euchromatin undergoes active 
transcription because it is not as compressed as heterochromatin, thus permitting 
access of gene regulatory proteins to the DNA (Nicholson and Wood, 2006). 
The fundamental subunit of chromatin in eukaryotes is nucleosome, which consists of 
the nucleosome core particle, linker DNA, and linker histone (Kornberg, 1974; 
Kornberg, 1977). In every nucleosome core particle, around 147 base pairs of DNA 
envelope a histone octamer in 1.65 left-handed superhelix turns (Luger et al., 1997). 
The histone octamer core in the nucleosome is formed by eight subunits, two 
molecules of each histone proteins (H2A, H2B, H3 and H4). Each histone protein has 
a structured basic domain, known as the histone fold, which consists of three α-helices 
linked by two unstructured loops (Arents and Moudrianakis, 1993; Arents and 
Moudrianakis, 1995). During the process of nucleosome assembly, the histone folds 
undergo the so-called handshake interaction, in which they attach to each other to 
create two sets of H3-H4 and H2A-H2B dimers. Subsequently, tetramers are formed 
from the combination of the H3-H4 dimers and they in turn combine with two 
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H2A-H2B dimers to create the compact octamer core, thus accomplishing the 
assembling process (Arents and Moudrianakis, 1993; Arents and Moudrianakis, 1995). 
All core histones display an conserved amino (N)-terminal amino acid tail that 
projects from the globular section of the DNA-histone core and make contact with 
adjacent nucleosomes (Luger and Richmond, 1998). Within a single nucleosome, such 
histone tails are unstructured and highly flexible. Furthermore, they are subject to a 
variety of posttranslational modifications (e.g. acetylation, methylation, 
phosphorylation and biotinylation) in a number of areas, especially at lysine and 
arginine residues (Berger, 2001; Luger and Richmond, 1998). In 2001, a hypothesis 
known as the ‘histone code’ was been proposed (Jenuwein and Allis, 2001). According 
to this theory, single or combined histone modifications build a code that affects the 
gene transcriptional status (Jenuwein and Allis, 2001). Two categories of biochemical 
activities are outlined by this histone code hypothesis (Jenuwein and Allis, 2001; 
Strahl and Allis, 2000). In the first category, the code is written by specific enzymes, 
which can add or remove particular modifications (e.g. acetylation, methylation, 
phosphorylation and biotinylation) in certain histone areas. In the second category, 
specific effector proteins can read the histone code and translate them into biological 
functions. These proteins can recognize the modified histones via special protein 
domains. Through interaction with the appropriate histone modifications, these 
specific effector proteins can alter chromatin structure, and hence change the 
transcriptional activity (Jenuwein and Allis, 2001; Strahl and Allis, 2000).  
Modifications in histone tails can influence the DNA accessibility and protein/protein 
interactions, and thus affect transcription levels (Berger, 2001; Luger and Richmond, 
1998). Histone modifications can have two effects - they make chromatin either more 
relaxed and accessible or more condensed and less accessible for replication and 
transcription (Kouzarides, 2007). Due to this, a number of fundamental biological 
processes, such as gene transcription, DNA replication, repair, and chromosome 
condensation, are affected by histone modifications (Kouzarides, 2007; Wolffe and 
Hayes, 1999; Wu and Grunstein, 2000).  
Several factors have been identified to affect the outcome of histone modifications, 
including the modified organism, modification type, the modified residue, the level of 
modification, and the chromatin context (Kouzarides, 2007). Sections 1.5.2 and 1.5.3 
discuss two histone modifications that have been extensively studied. 
1.5.2 Histone Acetylation and Deacetylation  
In eukaryotic cells, the conserved lysine (K) residues at the N-terminal tail of histone 
proteins can be acetylated and deacetylated by histone acetyltransferases (HATs) and 
histone deacetylases (HDACs), respectively (Kuzmichev and Reinberg, 2001; Roth et 
al., 2001). Histone acetylation and deacetylation are essential for gene regulation (Kuo 
and Allis, 1998; Struhl, 1998).  
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In the process of histone acetylation, HATs utilize Acetyl Coenzyme-A (Acetyl-CoA) 
as cofactor and catalyse the transfer of an acetyl functional group to the histone lysine 
residues (Struhl, 1998). Notably, acetylation occurs on numerous histone lysine 
residues on histone 3 and 4 (H3 and H4) (Kouzarides, 2007). Modification of histone 
tails by acetylation has been found to promote transcriptional activity and be 
associated with euchromatin (activated genomic regions) (Hebbes et al., 1988; 
Mikkelsen et al., 2007; Roh et al., 2005). Mechanistically, histone octamers derive 
their positive charge primarily from lysine, which thus plays a key role in the binding 
of the negatively-charged DNA phosphate-sugar backbone (Allfrey and Mirsky, 1964; 
Van Holde, 1989). Through neutralizing the positive charge of lysine residues on 
histone tails, histone acetylation weakens the affinity between DNA and histones 
(Allfrey and Mirsky, 1964; Turner, 2000). By loosening the chromatin structure, 
histone acetylation makes the DNA promoter areas more accessible to transcription 
factors and RNA polymerases, and thus enhances the activation of transcription 
process (Mikkelsen et al., 2007; Roh et al., 2005). Furthermore, as a posttranslational 
modification, histone acetylation also provides a binding site for protein binding 
(Cheung et al., 2000). The acetylated histone tails can act as protein recognition sites 
where bromodomain-containing transcription factors interact with the acetylated 
histone tails via bromodomain, an acetyl-lysine binding domain (Yang, 2004). After 
recognizing the acetylated histone tails, the transcription initiation factors help recruit 
extra nucleosomal remodelling complexes that contribute to chromatin relaxation 
(Hassan et al., 2002).  
On the other hand, HDACs can reverse histone acetylation by removing the acetyl 
group from the acetylated lysine residues (Kuo and Allis, 1998; Kuzmichev and 
Reinberg, 2001). By deacetylating the histone tails, the lysine’s positive charge is 
restored, and hence DNA becomes more tightly wrapped around the histone cores. 
This makes the transcription factors harder to bind to the DNA and leads to 
transcriptional repression and finally silences gene expression (de Ruijter et al., 2003; 
Gallinari et al., 2007; Struhl, 1998). 
1.5.3 Histone Methylation 
In eukaryotes, both lysine (K) and arginine (R) residues located in the N-terminal tails 
of Histone H3 (H3) and Histone H4 (H4) can be dynamically modified by histone 
methyltransferases (HMTs) and histone demethylases (HDMs), the former adding 
methyl groups to the histone tails, while the latter removes them (Aletta et al., 1998). 
Multiple methyl groups can be added to a single amino acid residue. Every K residue 
can take up to three methyl groups (giving mono-(me), di-(me2) or tri-(me3) 
methylated forms), whereas R residues can be mono- or di-methylated (Bannister et al., 
2002; Zhang and Reinberg, 2001). In accordance with the location of the methylated 
residue and the degree of methylation, the outcome of histone methylation can be 
either gene activation or suppression (Bannister et al., 2002; Lachner and Jenuwein, 
2002).  
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Histone lysine methylation is not likely to affect the chromatin structure directly, as it 
does not change the charge of the histone tails as it is by acetylation. Instead, histone 
methylation creates binding sites for the recruitment of regulatory proteins, which 
recognize methylated residues through chromo-domains (Kouzarides, 2007). 
So far, methylation within the lysine 4, 9 and 27 of histones H3 has been functionally 
characterized. In general, H3K9 and H3K27 methylation has been implicated in 
transcriptional silencing; whereas, H3K4 methylation is associated with 
transcriptionally active regions (Hublitz et al., 2009). 
1.5.3.1 Methylation of H3 on lysine 9 
Methylation of H3 on lysine 9 (H3K9) is largely associated with silencing and 
repression in many species. The pervasive assumption is that H3K9 is involved in 
euchromatic gene silencing, as well as in heterochromatin formation (Nielsen et al., 
2001).  
H3K9 mono- and di-methylation are facilitated by a heteromeric complex consisting 
of H3K9 methyltransferases G9a and Glp (G9a-related protein) (Tachibana et al., 
2005). Mutation of either G9a or Glp leads to significant reduction of mono- and di 
methylated H3K9 (H3K9me1 and H3K9me2) levels in mouse ESCs (Peters et al., 
2003; Tachibana et al., 2005). In mammals, H3K9me2, acts as a repressive histone 
mark, and is associated with silent domains within euchromatic regions (Peters et al., 
2003; Rice et al., 2003); while H3K9me1 is closely related to active transcriptional 
start sites (Barski et al., 2007). In differentiating mouse ESCs, the promoter region of 
Oct3/4 is enriched in H3K9me2, suggesting that the presence of H3K9me2 is essential 
for the suppression of this pluripotency gene (Feldman et al., 2006).  
Methylated by H3K9 tri-methyltransferases Suv39h1 and Suv39h2, tri-methylated 
H3K9 (H3K9me3) is specifically enriched in heterochromatin (Kouzarides, 2007; 
Lachner et al., 2001; Lehnertz et al., 2003). H3K9me3 can be bound by 
Heterochromatin protein 1 (HP1) via its N-terminal chromodomain, and this leads to 
the formation of compacted chromatin that physically inhibits the access of the 
transcriptional machinery to the underlying DNA (Bannister et al., 2001; Lachner et al., 
2001). In turn, HP1 serves as a docking site for the recruitment of additional 
repressive factors to heterochromatin, such as Suv39 (Lachner et al., 2001; Smallwood 
et al., 2007). During DNA replication, HP1, through the recruitment of Suv39, can 
also promote the deposition of the me3 mark onto H3K9 residues in the newly 
synthesized histones of the replicated chromatin, thus ensuring the inheritance of the 
mark. Therefore, the binding of HP1 to H3K9me3 is important for the establishment 
and maintenance of heterochromatin (Bannister et al., 2001; Lachner et al., 2001).  
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1.5.3.2 Methylation of H3 on lysine 27 and lysine4 
Methylation on lysine 27 of histone H3 (H3K27) is largely associated with silenced 
genes (Boyer et al., 2006; Cao et al., 2002; Lee et al., 2006; Zhang et al., 2004). Three 
states of methylation, mono-, di-, and tri-, are observed on H3K27 (Schwartz and 
Pirrotta, 2007). Polycomb repressive complex 2 (PRC2), a chromatin-remodelling 
complex, is primarily responsible for catalysing H3K27 trimethylation (H3K27me3) 
through its catalytic subunits enhancer of zeste homologue 2 (Ezh2) (Cao et al., 2002; 
Kuzmichev et al., 2002; Muller et al., 2002). A close correlation between H3K27me3 
and inactive gene promoters has been confirmed in ESCs by chromatin 
immunoprecipitation with DNA microarray technology (ChIP-chip). In ESCs, 
numerous genes essential for development and differentiation are suppressed by 
H3K27me3 mark (Boyer et al., 2006; Bracken et al., 2006; Cao et al., 2002; 
Kuzmichev et al., 2002; Lee et al., 2006; Muller et al., 2002; Shen et al., 2008; Vire et 
al., 2006). It also has been shown that removal of PRC2 results in a loss of H3K27me3 
and loss of pluripotency in ESCs (Boyer et al., 2006; Chamberlain et al., 2008; Shen et 
al., 2008). Therefore, it is believed that H3K27me3-mediated repression is essential 
for maintenance of ESC pluripotency (Boyer et al., 2006; Lee et al., 2006).  
Generally, methylation of histone 3 on lysine 4 (H3K4) is most often associated with 
transcription activation or permissive chromatin regions, and is thus considered as an 
activating mark (Berger, 2007; Bernstein et al., 2005; Chi et al., 2010; Turner, 2007). 
The association of H3K4 mono-, di- and tri- methylations (H3K4me, H3K4me2 and 
H3K4me3) with transcription activation has been validated by ChIP-chip and 
ChIP-sequencing (ChIP-Seq) (Barski et al., 2007; Schneider et al., 2004). H3K4me3, 
which is catalysed by SET1 complexes or the MLL (mixed lineage leukemia protein) 
complexes (Santos-Rosa et al., 2002; Vermeulen and Timmers, 2010; Yokoyama et al., 
2004), is enriched in promoter regions of active genes (Barski et al., 2007; Bernstein et 
al., 2005; Heintzman et al., 2007; Santos-Rosa et al., 2002).  
Interestingly, a unique chromatin domain known as “bivalent domain” is found in 
mouse ESCs (Bernstein et al., 2006). In pluripotent mouse ESCs, many genes 
involved in differentiation are enriched in activating mark H3K4me3 as well as 
repressive mark H3K27me3 (Bernstein et al., 2006). During the stage of pluripotency, 
repressive mark H3K27me3 silences the genes related to development and 
differentiation. Though silent, the genes present in these bivalent domains can become 
activated rapidly in response to downstream developmental signals, and do not require 
epigenetic reprogramming at the loci (Bernstein et al., 2006). Upon differentiation, 
PRC2 occupancy is lost and H3K27me3 is removed while H3K4me3 is maintained, 
permitting expression of differentiation genes (Boyer et al., 2006). The bivalent 
domains that exist in undifferentiated ESCs are therefore assumed to dictate a ‘poised 
state’ for rapid gene activation during differentiation, with H3K4me3 serving for rapid 
activation upon removal of H3K27me3 (Bernstein et al., 2006; Mikkelsen et al., 2007). 
Co-modification of development-associated genes by the bivalent histone marks 
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H3K27me3 and H3K4me3 has also been observed in undifferentiated human ESCs 
(Pan et al., 2007). In addition, during human ESC differentiation, the expression of 
pluripotency-associated genes is repressed by the transition from H3K4me3 
modification to the bivalent modifications with both H3K27me3 and H3K4me3 (Pan 
et al., 2007).  
1.5.3.3 Crosstalk between histone modifications  
For the establishment of gene expression states, intense crosstalk occurs between 
different histone modifications. Cross-regulation of histone modifications can occur on 
the same histone residue (in situ crosstalk), on the same histone tail (in cis crosstalk), 
between different histones within the same nucleosome (in trans crosstalk) or across 
different nucleosomes (nucleosome crosstalk) (Briggs et al., 2002; Wang et al., 2001).  
In situ cross-regulation is the first level of posttranslational crosstalk. Several different 
types of covalent modifications (e.g. acetylated, methylated or ubiquitylated) can 
target the same residues, such as lysine residues. If more than one modification 
pathway is targeting the same site, different marks on the same amino acid cannot 
co-exist; and therefore, they antagonize each other (Kouzarides, 2007; Wang et al., 
2008). In eukaryotes, H3K9 methylation normally opposes the functions of H3K9 
acetylation in gene regulation (Nakayama et al., 2001; Rea et al., 2000). The mutually 
exclusive methylation or acetylation of H3K9 is a well-studied example of in situ 
crosstalk (Turner, 2005). An acetyl group must be removed before a methyl group can 
be added, and vice versa. Furthermore, a coupling of H3K9 methylation and histone 
deacetylation has been identified (Czermin et al., 2001; Vaute et al., 2002; Zhang et al., 
2002). Deacetylation of H3K9 and other sites in the H3 tail facilitates H3K9 
methylation, which in turn promotes HP1 binding and recruits HDACs and HMTs to 
promote heterochromatin formation (Czermin et al., 2001; Vaute et al., 2002; Zhang et 
al., 2002).  
Antagonism between different modifications also exists on the same histone tail. For 
example, methylation of H3K4 can inhibit the recruitment of repressive factors (e.g. 
HP1) to methylated H3K9 (Beisel et al., 2002; Nishioka et al., 2002; Zegerman et al., 
2002). On the other hand, one histone modification may promote the deposition of 
another modification (Kouzarides, 2007; Wang et al., 2008). Methylation on H3K4 can 
promote the subsequent acetylation of H3 by P300 (Wang et al., 2001), and acetylation 
of H3K9 and H3K14 can stimulate the methylation of H3K4 by MLL (Milne et al., 
2002; Nakanishi et al., 2008). 
According to the observations above, each histone modification ought to be 
considered as a component of a complex interconnected mechanism, rather than as an 
independent regulatory mark (Suganuma and Workman, 2008). 
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1.6 Histone modifications and Germ cell development 
A range of dynamic changes in the type and level of epigenetic modifications takes 
place during the development of germ cells. It is thought that these changes act as 
reprogramming processes that the germ cells need to confer totipotency to the zygote 
following fertilization. 
1.6.1 Histone modifications in the migratory PGCs 
Upon establishment of the germ-cell fate, the newly formed germ cells and the 
adjacent somatic cells have an identical epigenetic status. The germ cells are subject to 
dynamic global histone modifications following the specification process (Seki et al., 
2005; Seki et al., 2007). Not long after the germ cell fate is established, there is an 
initial wave of global histone modification, characterized by H3K9me2 
down-regulation and H3K27me3 up-regulation (Seki et al., 2005; Seki et al., 2007) 
(Fig 1.4). PGCs are located in the allantois around E7.75, as they start to migrate there 
is a non-uniform, gradual loss of H3K9me2 (Seki et al., 2005; Seki et al., 2007). As a 
result, by E8.75, the PGCs display less H3K9me2 than the adjacent somatic cells (Seki 
et al., 2005; Seki et al., 2007) (Fig 1.4). H3K9me2 was reported to serve as an 
epigenetic barrier, suppressing the expression of germ cell-specific genes in 
pluripotent ESCs (Maeda et al., 2013). In the case of ESCs, germ cell-specific genes 
are inhibited by the transcription factor Max, which also exhibits interaction with the 
H3K9 di-methylating enzymes Glp and G9a. A reduction in Max expression in ESCs 
through RNA interference (RNAi) resulted in a decline in H3K9me2 levels at the 
promoter areas of PGC-related genes, ultimately leading to the selective activation of 
germ cell-related genes in undifferentiated ESCs due to repressor inhibition (Maeda et 
al., 2013). The findings above indicate that the removal of H3K9me2 may be 
important for germ cell-specific genes to enhance their expression in PGCs. 
Significant and long-standing controversy surrounds the issue of the mechanism by 
which H3K9me2 is demethylated in mouse PGCs. Histone demethylase Jmjd1a, a 
JumonjiC (JmjC)-domain-containing protein, is responsible for direct H3K9me2 
demethylation (Klose et al., 2006). Before H3K9me2 demethylation, the expression of 
Jmjd1a is not specifically upregulated in murine PGCs, as the level of Jmjd1a is 
similar in PGCs and their neighboring somatic cells (Seki et al., 2007). It can thus be 
inferred that the genome-wide removal of H3K9me2 in early mouse PGCs is not based 
on histone demethylase Jmjd1a. Formed by histone methyltransferases G9a and Glp, 
G9a-Glp complex mediates the maintenance and dimethylation of H3K9me2 
(Tachibana et al., 2005). Lack of either G9a or Glp alone will lead to the loss of 
function of this enzyme complex and the downregulation of H3K9me2 (Tachibana et 
al., 2005). Therefore, the G9a-Glp complex might be another putative mechanism 
crucial for the genome-wide demethylation of H3K9me2 in PGCs. In order to prove 
this, the expression of G9a and Glp proteins in murine embryos was detected by 
immunofluorescence (Seki et al., 2007; Yabuta et al., 2006). As a candidate for this 
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putative mechanism, Glp is specifically downregulated in murine PGCs as early as 
E7.25 (Fig 1.4), immediately prior to the global demethylation of H3K9me2 in PGCs 
(Seki et al., 2007; Yabuta et al., 2006). By contrast, the expression of G9a was 
significantly reduced in PGCs at around E9.5 (Fig 1.4), following H3K9me2 
demethylation (Seki et al., 2007). Therefore, Seki et al. (Seki et al., 2007) concluded 
that the suppression of Glp from the G9a-Glp complex was essential for the H3K9me2 
removal during early murine germ cell development.  
From a low level in the epiblast, H3K27me3 levels begin to increase after H3K9me2 
downregulation and reach a maximum level by E9.5 in PGC nuclei, which is then 
maintained until E11.5 (Seki et al., 2005) (Fig 1.4). It is proposed that this 
upregulation of H3K27me3 may be due to the stable expression of H3K27 
tri-methyltransferase Ezh2 in PGCs until E8.25 (Seki et al., 2007) (Fig 1.4). The stable 
expression of Ezh2 is important for the upregulatioof H3K27me3.  
H3K27me3 upregulation and H3K9me2 removal are most likely reciprocal, 
contributing to the maintenance of a proper repressive mode in early PGCs, and 
therefore playing an essential role in the development processes of early PGCs 
(Hajkova et al., 2008). This is supported by the case of PGCs that lack Prdm14 
(Yamaji et al., 2008). In this Prdm14-negative PGC research, increase in H3K27me3 
and reduction of H3K9me2 are not observed, and it is notable that these PGCs 
undergo abnormal development and completely disappear by E12.5 (Yamaji et al., 
2008). This research confirms that the decrease of H3K9me2 and increase of 
H3K27me3 may be crucial for appropriate PGC development. 
Compared to adjacent somatic cells, early germ cells exhibit a lower level of 
heterochromatin mark H3K9me3, which remains consistent all through the early 
development of germ cells (Seki et al., 2005) (Fig 1.4). Suv39h HMTases, which are 
required to direct H3-K9 trimethylation, have been found to have a complex 
correlation with DNA methylation systems (Section 1.7) in mammals (Lehnertz et al., 
2003). Both these methylation systems are important in maintaining and preserving 
the stability of heterochromatic subdomains subsequently owing to this action there is 
protection of the genome integrity (Lehnertz et al., 2003). Therefore, the low level of 
H3K9me3 in early mouse germ cells may be associated with the DNA methylation 
systems (Section 1.7) and the genome integrity (Lehnertz et al., 2003). Another 
explanation for the low level of H3K9me3 may be the pluripotency-related gene 
expression in early PGCs, since no connection was observed between undifferentiated 
ESCs and H3K9me3 methyltransferase Suv39h.  
Migrating germ cells and neighboring somatic cells display similar levels of the 
transcriptional active marks H3K4me and H3K9ac until the arrival of the germ cells at 
the genital ridge (Seki et al., 2005) (Fig 1.4). Pluripotency-related gene expression in 
early PGCs may be due, to some extent, to the stable expression of H3K4me and 
H3K9ac. High levels of active histone modifications, like acetylated histones and 
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methylated H3K4me, are involved in the regulation of the flanking regions of OCT4 
and NANOG, just as in PGC-like cells derived from human ESCs (Pan et al., 2007; 
Tilgner et al., 2008). 
The epigenetic modifications mentioned above occur only in the nascent PGCs before 
they enter the genital ridges and not in the adjacent somatic cells (Seki et al., 2005; 
Seki et al., 2007). Such significant epigenetic changes taking place in early germ cells 
may act as a prerequisite for subsequent specific epigenetic reprogramming and 
possibly related to the regain of underlying totipotency in PGCs (Seki et al., 2005; Seki 
et al., 2007; Surani et al., 2007).  
 
Figure 1.4 Dynamics epigenetic changes during PGC specification and differentiation. A 
number of changes in DNA methylation, histone modifications and expression of their 
epigenetic modifiers, and related cellular events occur during PGC development. Figure 
reproduced from (Mochizuki and Matsui, 2010). 
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1.6.2 Histone modification in the post-migratory PGCs 
Subsequently, when the majority of PGCs arrive at the genital ridges, the levels of 
histone modifications undergo further fluctuation (Hajkova et al., 2008; Seki et al., 
2005). Upon arrival at the genital ridge, levels of the permissive marks H3K9ac and 
H3K4me first increase significantly then diminish permanently by E12.5 (Hajkova et 
al., 2008; Seki et al., 2005) (Fig 1.4). Furthermore, at about E11.0-E12.0, there is a 
brief decrease in the repressive marks H3K9me3 and H3K27me3, whilst after E12.5; 
H3K9me3 displays a rapid increase (Hajkova et al., 2008; Seki et al., 2005) (Fig 1.4). 
The decline of H3K27me3 levels at about E10.5-E11.0 is probably associated with the 
re-establishment in the expression of some pluripotency and PGC-specific genes. This 
decrease appears to be important for germ cell development, as deficiency of Utx, a 
H3K27 demethylase, causes abnormal histone modification and failure of germ cell 
development (Mansour et al., 2012). In PGCs that lack Utx, timely erasure of 
H3K27me3 does not occur at about E11.0; and there is reduced expression of the 
pluripotency markers Nanog, Sal4, Oct4 and SSEA-1, as well as of of later germ 
cells-specific mark Mvh compared to wild-type PGCs. By E12.5, PGC development is 
interrupted by such aberrant expression of genes, resulting in abnormal germ cell 
development in mice lacking Utx (Mansour et al., 2012).  
The functional implications of the histone modifications in germ cell development are 
yet to be clarified, but the significant repressive modifications in developing germ 
cells after E12.5 are likely not only to impede the transcriptional activation at genome 
level in the subsequent stages of germ cell development, but also to participate in the 
appropriate expression of genes related to differentiated germ cell (Hajkova et al., 
2008; Seki et al., 2005). 
1.6.3 Histone modifications in the germ cells after sex determination 
Remarkable sexual dimorphism is observed in mouse germ cells after E13.5. The 
ovarian germ cells stop proliferating and enter prophase I meiosis while the testicular 
germ cells undergo meiotic arrest (Hilscher et al., 1974; McLaren and Southee, 1997). 
Meanwhile, the sex-specific epigenetic reprogramming is also observed in mouse 
germ cells after E13.5 (Abe et al., 2011). 
Using immunocytochemistry, (Abe et al., 2011) reported that fetal germ cells of male 
and female mice displayed sex-related histone modifications after E13.5, , in contrast 
to the gonadal somatic cells used as a control. The dynamic changes in histone 
modifications were more pronounced in male than female fetal germ cells between 
E13.5 and E17.5 (Abe et al., 2011).Unlike somatic cells throughout the development 
stage, both male and female germ cells showed strong H3K9ac staining. Abe et al. 
(Abe et al., 2011) reported that, whereas female germ cells did not exhibit any 
noticeable change, male germ cells displayed an increase in H3K9ac levels, which 
peak at E15.5. There were close similarities between the levels of H3K4me3 in female 
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germ cells and in somatic cells. In male germ cells, H3K4me3 levels increased at 
E15.5 relative to E13.5 and subsequently was found to increase further by E17.5 in 
comparison to E15.5 and E13.5 (Abe et al., 2011). 
During this interval, male and female germ cells showed comparable H3K9me2 
changes. H3K9me2 staining was weak in fetal germ cells at all stages apart from 
E15.5, when staining was maximal in male as well as female germ cells (Abe et al., 
2011). Through every detected stage of fetal development, male and female germ cells 
exhibited higher levels of H3K9me3 than somatic cells. At E15.5 and E17.5, male 
germ cells showed much higher levels of H3K9me3 when compared to E13.5, while 
the female germ cells did not (Abe et al., 2011). In male germ cells, H3K27me3 levels 
increased significantly at E15.5 when compared to the E13.5 germ cells. At the same 
time it was concomitantly decreasing in female germ cells (Abe et al., 2011). 
Following sex determination, such global changes in histone modifications were 
present exclusively in male germ cells. Considering that, these chromatin 
modifications occur before or simultaneously with global DNA de novo methylation 
(Section 1.8.2) in fetal testicular germ cells, these dynamic male-specific histone 
modifications may provide a framework for the male-specific global DNA de novo 
methylation in fetal testicular germ cells. 
1.6.4 The role of histone methyltransferases in mouse germ cell meiosis 
Different epigenetic modifiers are involved in the strict regulation of meiotic prophase 
development, particularly during the pachytene stage. Mouse germ cell meiosis may 
depend to a significant degree on histone methyltransferases, the functions of which 
have been outlined in gene-knockout studies in mice (Hayashi et al., 2005; Peters et al., 
2001; Tachibana et al., 2007). It has been found that the H3K9 tri-methylating enzymes 
Suv39h1/2 (Peters et al., 2001), H3K4 tri-methylating enzyme Meisetz (Hayashi et al., 
2005), and H3K9 mono and di-methylating enzymes G9a (Tachibana et al., 2007) are 
the enzymes that actively participate in the meiotic prophase.  
Empirical research has reported that pericentric H3K9me3 was absent in mutant 
spermatocytes due to double mutations of the H3K9 trimethyltransferase genes 
Suv39h1 and Suv39h2 in mouse testis. Impaired chromosome synapsis and pericentric 
heterochromatin modification were the result of Suv39h mutations. At the pachytene 
stage, the mutant testicular germ cells underwent arrest, followed by pronounced 
spermatocyte apoptosis. It can thus be inferred that proper meiotic development relies 
on Suv39h and its modified chromatin H3K9me3. Although the molecular 
characteristics of Suv39h deficiency have not been clarified in female germ cells, the 
meiotic aberrations were also observed in the double-mutant female mice (Peters et al., 
2001). 
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A H3K4 tri-methyltransferase, was formerly known as Meisetz now known as PRDM9 
(PR domain-containing protein 9) (Eram et al., 2014). PRDM9 has been found to be 
an essential enzyme that is involved in the progression of early meiotic prophase 
(Eram et al., 2014).  Serious impairment of the DSB repair pathway, impaired sex 
body formation and incorrect pairing of homologous chromosomes have been 
observed in Meisetz-/- mice, which is sterile in males and females (Hayashi and 
Matsui, 2006; Hayashi et al., 2005). The DSB repair, which was normally to be 
accomplished by pachytene, was not completed in Meisetz-/- spermatocytes (Hayashi 
and Matsui, 2006; Hayashi et al., 2005). This impaired DSB repair was accompanied 
by inadequate recruitment of the meiosis-related DSB repair protein DMC1 to DSB 
sites in the nuclei of Meisetz-/- spermatocytes. In wild-type mice, γH2AX (which 
marks sites of DSBs) was absent from autosomal areas of synapsed chromosomes, 
concentrating around the sex chromosomes and contributing to the formation of the 
sex body (Mahadevaiah et al., 2001). However, it has been observed that in Meisetz-/- 
mice, each chromosome including autosome in the germ cells of both sexes 
inappropriately retained γH2AX. This subsequently points to the formation of an 
impaired sex body (Hayashi and Matsui, 2006; Hayashi et al., 2005). At the same time, 
Meisetz-/- mice displayed the pachytene chromosomes that were frequently branched 
and linked to other chromosomes, suggesting impairment of homologous chromosome 
pairing as well (Hayashi and Matsui, 2006; Hayashi et al., 2005). 
Tachibana et al. (Tachibana et al., 2007) noted that the developmental impairment of 
germ cells lacking G9a occurs at the pachytene stage , and numbers of germ cells were 
severe reduced or absent after the pachytene stage . As a result of germ-lineage 
specific deletion of G9a, sperm or oocytes were significantly reduced or lost altogether, 
causing the mice to become infertile. Moreover, in the early pachytene stage and in 
meiotic prophase, G9a mutation in mouse germ cells resulted in a flawed chromosome 
synapsis. Additionally, during the meiotic prophase, the G9a deficiency in the 
germ-lineage was accompanied by the loss of H3K9me1 and H3K9me2 in male and 
female germ cells. G9a-deficient germ cells also exhibited upregulation of its target 
genes, which are suppressed in normal meiotic germ cells; this led Tachibana et 
al.(Tachibana et al., 2007) to conclude that meiotic prophase progression requires 
epigenetic gene inhibition facilitated by G9a. 
The functional importance of histone methyltransferases in germ cell meiosis clearly is 
evident from the above information. Nonetheless, further research is required to 
determine the extent to which their modified chromatins H3K9me1, H3K9me2, 
H3K9me3 and H3K4me3 contribute to changes in germ cell meiosis. 
1.7 DNA Methylation  
1.7.1 Methylation of DNA in mammals 
DNA methylation, an inactive epigenetic mark, is addition of a methyl group to the 
DNA (Holliday and Pugh, 1975; Riggs, 1975; Wolffe and Matzke, 1999). Bird (Bird, 
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1984) suggested that suppression of transcription and the heritable preservation of a 
silent chromatin state are the two key functions fulfilled by DNA methylation in 
mammalian organisms. In the case of multicellular eukaryotes, DNA methylation takes 
place at the fifth position of the cytosine pyrimidine ring and its outcome is 
5-methylcytosine (5mC) (Su et al., 2011). 
In mammals, DNA methylation occurs almost exclusively at cytosine-guanine 
dinucleotides (CpG) (Bird, 1980; Bird, 1986). High concentrations of CpGs are cluster 
into regions known as CpG islands, which are often found at promoters of genes 
(Branciamore et al., 2010; Ioshikhes and Zhang, 2000). Compared to the majority of 
CpG sites which are typically methylated, these CpG islands tend to retain 
unmethylated (Deaton and Bird, 2011). The patterns of CpG methylation found in the 
gene promoter areas are a significant source of epigenetic information related to gene 
expression. DNA methylation causes chromatin to condense, leading to promoter 
inactivation, which is marked by the presence of 5mC in a CpG island; on the other 
hand, gene expression is activated when the DNA of gene promoter regions areis 
non-methylated (Deaton and Bird, 2011; Meissner et al., 2008).  
How does DNA methylation lead to gene silencing? There are probably several 
mechanisms by which this can happen. However, the primary mechanism is thought to 
involve the methylation of CpGs, as methylated CpGs can be bound by methylated 
CpG binding proteins (MBPs), which have a DNA binding domain and transcriptional 
repression domain, and can recruit other factors that condense the chromatin (Bird and 
Wolffe, 1999).  
In mammals, DNA methylation has been found to play an essential role in numerous 
biological processes (Bird, 2002; Egger et al., 2004; Stringer et al., 2013). During the 
development of ESCs, DNA methylation acts as an important epigenetic control 
mechanism that restricts differentiation. During mitosis, DNA methylation acts as an 
epigenetic barrier to prevent differentiated cells from returning to an undifferentiated 
state (Messerschmidt et al., 2014). Since numerous vital cellular functions are 
underpinned by CpG methylation, abnormal DNA methylation patterns are associated 
with various pathologies, including development of cancer, vulnerability to disease, as 
well as aging (Bird, 2002; Egger et al., 2004).  
1.7.2 Enzymes Inducing DNA Methylation in Mammalian Organisms 
DNA methyltransferases represent the key enzymes of targeting and maintaining of 
global DNA methylation in all organisms (Chen and Li, 2006; Siedlecki and 
Zielenkiewicz, 2006). There are two types of DNA methylation: maintenance and de 
novo (Siedlecki and Zielenkiewicz, 2006). 
During the process of DNA replication, DNA methylation is maintained by a chief 
maintenance methyltransferase Dnmt1 (Damelin and Bestor, 2007). Dnmt1 is 
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responsible for transmitting methylation signals from the parent DNA strand to the 
newly synthesised daughter DNA strand (Jones and Liang, 2009; Robert et al., 2003). 
When DNA is replicated, hemi-methylated DNA is generated, with the parent strand is 
methylated and the daughter strand is not. Dnmt1 has a preference for 
hemi-methylated DNA. Dnmt1 binds this hemi-methylated DNA, and Dnmt1 lays 
down methylation on the daughter strand to generate a fully methylated CpG 
dinucleotide (Jones and Liang, 2009; Robert et al., 2003).   
Dnmt3a and Dnmt3b, control the de novo methylation of unmethylated DNA. Though 
closely similar, each of the two enzymes is characterized by different target 
specificities and patterns of expression (Okano et al., 1999). Expressed early in 
embryonic development, Dnmt3b performs DNA re-methylation during the 
implantation stage. By contrast, Dnmt3a is expressed in more developed embryos as 
well as in differentiated cells (Okano et al., 1999). Dnmt3a and Dnmt3b do not just 
function as de novo methyltransferases, but also interact with Dnmt1 for the 
maintenance of DNA methylation during the process of replication in areas that 
Dnmt1 has overlooked (Jones and Liang, 2009; Liang et al., 2002). In ESCs lacking 
Dnmt3a and Dnmt3b, hemimethylated CpGs occurred in a greater proportion and 
methylation is gradually lost during cell division (Liang et al., 2002). A cofactor of the 
Dnmt3 enzymes is Dnmt3L, which is responsible for promoting the catalytic action of 
de novo DNA methyltransferases (Chedin et al., 2002; Gowher et al., 2005; Jia et al., 
2007; Ooi et al., 2007).  
1.7.3 The DNA Demethylation-related roles of Tets and 5hmC 
There are two types of mechanisms through which DNA demethylation can take place, 
namely, active and passive mechanisms, which are respectively DNA replication 
independent and dependent (Ohno et al., 2013; Ooi and Bestor, 2008). Passive 
demethylation occurs when insufficient expression, or lack of key cofactors, causes 
Dnmt1 to function improperly, leading to the progressive demethylation of methylated 
DNA following multiple cell divisions (Bostick et al., 2007; Ohno et al., 2013). Active 
DNA demethylation is an enzymatic process in which a carbon-carbon bond is broken 
and consequently a methyl group on a cytosine residue is removed (Ooi and Bestor, 
2008).  
Recently, a potential DNA demethylation mechanism, reliant on the ten-eleven 
translocation (Tet) proteins and 5-hydroxymethylcytosine (5hmC), has been identified 
(Ito et al., 2010; Tahiliani et al., 2009). 5hmC is considered to be an important 
epigenetic control mechanism for the DNA methylation process (Kriaucionis and 
Heintz, 2009).  Tahiliani et al. (2009) has noted the existence of 5hmC, a novel 
epigenetic DNA modification, in Purkinje neurons and mouse ESCs.  
The Tet (ten-eleven translocation) proteins are members of the 2-oxoglutarate and Fe 
(II)-dependent dioxygenases superfamily (Ito et al., 2010; Ko et al., 2010; Tahiliani et 
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al., 2009). The three Tet enzymes (Tet1, Tet2, and Tet3) in mammalian organisms can 
catalyze the conversion of 5mC to 5hmC in vitro (Ito et al., 2010) and in vivo (Ko et al., 
2010). Tet proteins show tissue-specific differential expression, with Tet1 being highly 
expressed in ESCs, whereas are Tet2 and Tet3 are more ubiquitously expressed 
(Szwagierczak et al., 2010; Tahiliani et al., 2009). Tahiliani et al. (Tahiliani et al., 2009) 
reported that TET1 expression in human ESCs repressed the expression of 5mC and 
increased the expression of 5hmC. In differentiated ESCs, the expression of TET1 is 
repressed, and this results in reduction of 5hmC and upregulation of 5mC levels. 
Consistent with this, Tet1 over expression leads to a decline of 5mC in ESCs (Tahiliani 
et al., 2009). Wossidlo et al. (Wossidlo et al., 2011) suggested that Tet3 might be 
responsible for oxidation of 5mC to 5hmC in fertilized zygotes, since it is the only Tet 
protein with a high expression in the fertilized zygotes.  A direct correlation was 
found between the decrease in 5mC levels in the paternal genome and the emergence 
of 5hmC in fertilized zygotes (Gu et al., 2011). By contrast, in zygotes without Tet3, 
the level of 5mC stays unchanged because the paternal genome is unable to convert 
5mC into 5hmC (Gu et al., 2011).  
As key regulators in the roles conversion of 5mC to 5hmC, Tet family proteins may 
participate in the DNA demethylation either passively or actively (Hackett et al., 2013; 
Ito et al., 2010; Vincent et al., 2013). When 5hmC is converted from 5mC, the majority 
of 5mC-binding proteins, including Dnmt1 (Valinluck and Sowers, 2007), do not 
recognize 5hmC, thus, 5hmC may be diluted from the DNA following its replication, 
since it is not recognized by Dnmt1(Valinluck and Sowers, 2007).  Hence, Inoue et 
al.(Inoue and Zhang, 2011) proposed that the conversion of 5hmC to cytosine could be 
performed passively on the basis of DNA replication (Ohno et al., 2013). 
Active demethylation may also be responsible for the conversion of 5hmC to cytosine. 
Through further oxidation by TET enzymes, 5hmC is converted to 5-formylcytosine 
(5fC) and 5-carboxylcytosine (5caC) (Ito et al., 2011) (Fig 1.5). Furthermore, 5hmC 
deamination, which is mediated by activation-induced cytidine deaminase (AID), 
results in the formation of 5-hydroxymethyluracil (5hmU) (Hashimoto et al., 2012; 
Nabel et al., 2012) (Fig 1.5). Thymine DNA glycosylase (TDG) then mediates the 
excision not only of 5hmU, but also 5fC and 5caC to abasic sites. The base excision 
repair (BER) mechanism subsequently repairs the formed abasic sites to unmodified 
cytosine (Cortellino et al., 2011; He et al., 2011; Inoue et al., 2011) (Fig 1.5). Since it 
can be converted to cytosine, 5hmC may serve as a temporary mediator in the process 
of DNA demethylation (Branco et al., 2012). 
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Figure 1.5 Possible biological roles of TET proteins and 5hmC in DNA demethylation. 
TET enzymes can oxidize 5mC to 5hmC, 5fC, and 5caC and facilitate DNA demethylation. 
5hmC can be passively converted to cytosine and depleted from the DNA through its DNA 
replication. 5hmC, as well as 5fC, and 5caC, can be excised by TDG and further repaired to 
unmodified cytosine via BER machinery. Figure reproduced from (Williams et al., 2011).  
1.8 Genome-wide Reprogramming of DNA Methylation in Mouse 
Fetal Germ Cells 
1.8.1 Global erasure of DNA Methylation in Mouse PGCs 
During the early life development of an organism, the genome is subjected to dynamic 
changes in DNA methylation (Smith et al., 2012). Genome-wide DNA demethylation 
occurs once fertilisation is completed, leading to the global hypomethylation of 
embryos in the blastocyst stage and even the inner cell mass. Near the time of 
implantation, the embryonic epiblast is formed as a result of the differentiation of cells 
within the inner cell mass. The epiblast is then subjected to de novo DNA methylation 
to promote embryo differentiation and lineage development before PGC generation 
(Smith et al., 2012).  
By E8.0-E8.5, the parent epiblast cells pass on methylated DNA to PGCs, which in 
this regard are the same as other epiblast cells (Hajkova et al., 2002). To generate germ 
cell potency, the genome-wide erasure and reprogramming of epigenetic patterns are 
necessary, due to the fact that the PGCs developing from the pluripotent epiblast begin 
to assume a somatic course (Hajkova et al., 2002; Saitou et al., 2002).  
Following PGC specification from epiblast precursors and after E8.5, PGCs begin to 
lose 5mC (Fig 1.6), which denotes that genome-wide DNA demethylation takes place 
during PGC migration (Hajkova et al., 2002). The DNA demethylation of PGC 
genome occurs at around E9.5 (Fig 1.6) has been demonstrated by immunostaining 
(Seki et al., 2005) and locus-targeted analysis (Mochizuki et al., 2012). The entrance of 
PGCs into the gonads between E10.5 and E13.5 represents the start of another phase 
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of reprogramming. PGCs are subject to further genome-wide DNA demethylation 
upon arrival at the genital ridges, and by E13.5, germ cells has lost over 90% of their 
methylated DNA (Hajkova et al., 2010; Seki et al., 2005) (Fig 1.6).  
During these periods, genome-wide DNA demethylation is modified by Dnmts and 
their cofactors in mouse germ cells (Seki et al., 2005). Following the establishment of 
germ cell fate, Dnmt1 and its cofactor Np95 undergo a temporary decrease in a subset 
of PGCs (Fig 1.4), which may be associated with passive DNA demethylation (Popp et 
al., 2010; Seki et al., 2005). The de novo DNA methyltransferases Dnmt3a and 
Dnmt3b are poorly expressed in PGCs (Fig 1.4). As speculated by some researchers, 
the low Dnmt3 levels may be associated with the maintenance of the unmethylated 
DNA state (Kagiwada et al., 2013; Seki et al., 2005).  
Since other cell types do not usually exhibit genome-wide DNA demethylation, an 
assumption arose that such significant removal of 5mC from PGC genomes is a 
requirement for the establishment of the germline ground state, including totipotency 
gain after gamete development and ensuing syngamy (Guibert et al., 2012; Saitou et 
al., 2012; Seki et al., 2005).  
1.8.2 Re-Establishment of Sex Specific DNA Methylation Patterns in Mouse 
Fetal Germ Cells 
After the gender has been determined, the re-establishment of DNA methylation 
occurs differently in male and female germ cells (Abe et al., 2011). In the case of male 
embryos, de novo methylation begins from E15.5 in the prospermatogonia that are 
arrested in the G1 mitotic phase, and is completed prior to birth. Therefore, the 
re-establishment of DNA methylation before the initiation of meiosis in male germ 
cells (Abe et al., 2011). In the case of female embryos, oocytes undergo meiosis and 
arrest in the prophase I of meiosis, while the levels of DNA methylation in female 
fetal germ cells remain constantly low and de novo DNA methylation begins 
following birth (Abe et al., 2011).  
1.8.3 Dynamics of Tets and 5hmC during Mouse Germ Cell undergo 
Epigenetic Reprogramming 
Three stages have been outlined in the genome-wide DNA demethylation in PGCs. 
During the first stage, between E8.5 and E9.5, 5mC declines considerably. Given the 
low levels of Tet proteins and 5hmC, this stage is not likely to be Tet-dependent 
(Yamaguchi et al., 2013) (Fig 1.6). Instead, replication-based dilution is the probable 
mediator in this stage, due to the downregulation of cofactor Np95 of Dnmt1 in E8.5 
PGCs (Kurimoto et al., 2008). As massive loss of 5mC takes place about two days 
before the increase of 5hmC, the levels of 5mC and 5hmC are extremely low from 
E8.5 to E9.5. Therefore, PGCs undergo a hypomethylated and 
hypohydroxymethylated state during this stage (Yamaguchi et al., 2013) (Fig 1.6). In 
the second stage, at about E10.5, Tet proteins oxidise the rest of 5mC to 5hmC, Tet1 
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and 5hmC showing a particular increase in PGCs (Yamaguchi et al., 2013) (Fig 1.6). In 
the third stage, during E11.5-E12.5, there is a decline in 5hmC levels. Neither 5fC nor 
5caC display dynamic transformations in this period, while between E8.5 and E12.5, 
TDG is poorly expressed in PGCs as well (Hackett et al., 2013; Seisenberger et al., 
2012; Yamaguchi et al., 2013; Yamaguchi et al., 2012). Yamaguchi et al. (Yamaguchi 
et al., 2013) (Fig 1.6) concluded that the passive elimination of 5hmC in PGCs can be 
achieved based on replication, additional oxidation being unnecessary. 
The regulatory mechanism responsible for Tet enzymatic activity is yet to be identified. 
Nonetheless, it seems that 5mC is removed during PGC reprogramming through 
TET-mediated oxidation and replication-based dilution (Kagiwada et al., 2013; 
Yamaguchi et al., 2013; Yamaguchi et al., 2012) 
RT-qPCR analysis revealed that Tet1 has preferential expression in PGCs, Tet2 
expression occurs in PGCs as well as in somatic cells, while Tet3 expression occurs 
primarily in somatic cells between E9.5 and E13.5 of PGC development (Yamaguchi et 
al., 2012). Although the presence of both Tet1 and Tet2 was confirmed in PGC during 
global epigenetic reprogramming, Tet1 is the only one undergoing upregulation during 
this process (Hackett et al., 2013; Yamaguchi et al., 2012). 
However, as observed by Yamaguchi (Yamaguchi et al., 2012), genome-wide 
demethylation in PGCs is not greatly influenced by Tet1 deficiency. Yet Tet1 
deficiency results in a considerable decrease in the number of female germ cells and 
results in abnormal synapse formation. Furthermore, the germ cells of mice female 
mice with Tet1 deficiency display aberrant meiotic prophase. Tet1 may be crucially 
involved in meiosis control, since Tet1 deficiency is associated with impaired DNA 
demethylation and reduced expression of a series of meiotic genes of female mouse 
germ cells (Yamaguchi et al., 2012). 
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Firgure1.6. Dynamic changes of Tets and 5hmC in PGCs during their global DNA 
reprogramming The global DNA demethylation phases of PGC reprogramming are: loss of 
bulk DNA methylation independent of Tet; Tet1 and possibly Tet2 oxidation of the rest of 5mC to 
5hmC; and 5hmC dilution based on replication. Figure adapted from (Kohli and Zhang, 2013). 
1.8.4 DNA Methylation Involvement in Germ cell-related Gene Expression 
It has been established that the Genome-wide DNA methylation reprogramming in 
PGCs is required to restore a novel epigenetic state, which is compatible with the 
expression of the germ cell-specific genes in PGCs.  
The induction of Blimp1, Fragilis and Stella together with other PGC-related genes 
occurs at or immediately prior to the establishment of PGC fate (Saitou, 2009). Until 
E7.5, the presumed regulatory components of these genes undergo hypermethylation, 
followed by demethylation by E10.5, when the expression of these genes is further 
increased (Mochizuki et al., 2012). The importance of DNA demethylation for gene 
upregulation was clearly demonstrated by the fact that the genes were expressed more 
intensely when Dnmt1 was suppressed in PGC-like cells derived from ESCs 
(Mochizuki et al., 2012). 
Post-migratory genes specific to germ cells are also regulated by DNA methylation. 
Once PGCs enter the genital ridge during E10.5-E11.5, the induction of genes such as 
Mvh, Sycp3 and Dazl occurs. Maatouk et al. (Maatouk et al., 2006a) conducted an 
analysis of DNA methylation in PGCs and found that, after E8.0, DNA methylation 
declined at genome level, yet the methylation of these gene flanking regions was 
maintained at E10.5, undergoing hypomethylation by E13.5 due to high expression. In 
mice embryos with Dnmt1 deficiency, Dazl and Mvh are expressed at E9.5, before 
their usual expression at E10.5-E11.5, indicating that the activation timing of these 
genes is controlled by DNA methylation (Maatouk et al., 2006a). The regulation of 
Dazl expression is undertaken by DNA demethylation of a Sp1-binding site located in 
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the gene’s flanking region, which is present in mouse, porcine and human PGCs. This 
means that Dazl is regulated by similar epigenetic modifications across different 
species of mammals (Linher et al., 2009).  
Prior to E11.5, when genome-wide demethylation occurs, promoter CpG islands of 
genes associated with meiosis exhibit significantly higher methylation. Seisenberger et 
al. (Seisenberger et al., 2012) suggested that the activation of these meiotic genes at an 
appropriate developmental stage is a possible reason for this delayed DNA 
demethylation. 
1.9 Epigenetic modifications in human Primordial Germ Cells  
Similar to the epigenetic reprogramming in mouse PGCs, human PGCs may also 
undergo genome wide epigenetic reprogramming to the totipotency in PGCs and 
prepare for the subsequent germ cell-specific developmental process. There is limited 
literature about the exact mechanisms of epigenetic reprogramming in human cells.  
Wermann et al. (Wermann et al., 2010) studied genome-wide DNA methylation 
patterns by 5mC immunostaining in human germ cells from 15wga to post-pubertal 
age, and found global reprogramming of DNA methylation to be different in human 
female and male gonads. At 15wga, staining of 5mC was absent in both human 
ovarian and testicular germ cells (Wermann et al., 2010). Afterwards, the female germ 
cells were remained unmethylated in the prenatal and postnatal human ovaries. 
However, the absolute numbers of demethylated testicular germ cells in seminiferous 
tubule decreased with increasing gestation. Finally, almost all the postnatal germ cells 
are hypermethylated in human testis (Wermann et al., 2010). According to this study, 
human germ cells have already undergone genome-wide DNA demethylation by 
15wga and the gradual DNA de novo methylation has occurred prenatally in human 
testicular germ cells. But when DNA demethylation happens in human PGCs and 
when DNA de novo methylation happened in human ovarian germ cells are still 
unknown (Wermann et al., 2010).  
Almstrup et al (Almstrup et al., 2010) studied H3K9me2, H3K27me3, H3K4me3 and 
H3K9ac by immunostaining in human fetal testicular germ cells from 21wga to 24wga. 
During this period, H3K9me2 and H3K27me3 were undetectable in the testicular 
germ cells. A small portion of testicular germ cells was H3K4me3 positive, while most 
of the testicular germ cells were stained with H3K9ac at this stage (Almstrup et al., 
2010). Another study in 16-24wga human testes showed very low level of H3K9me3 
in male germ cells (Bartkova et al., 2010). These two studies have identified 5 
important modifications of histones in human male PGCs. However, the gestations 
they studied were quite limited, so the definitive trend of these histone modifications 
neither in human male or female PGCs is still unknown.  
Sofia Gkountela and colleagues tried to identified the timing of major epigenetic 
events in human PGCs by analyzing human embryonic and fetal gonadal samples 
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from 6wga to 20wga (Gkountela et al., 2013). By immunofluorescence, they found 
5mC to be nearly undetectable in human testicular and ovarian PGCs at all stages 
investigated, indicating that genome-wide DNA demethylation has occurred in human 
PGCs before 6wga (Gkountela et al., 2013). In contrast to 5mC, the level of 5hmC 
exhibited dynamic changes in human PGCs. Before 11wga, 5hmC showed punctate 
nuclear staining in human testicular PGCs. Afterwards, testicular PGCs in 13.5-16wga 
gonads were negative for 5hmC, but this was regained in some OCT4A-positive 
testicular PGCs by 17wga. In human fetal ovaries, the staining of 5hmC was variable;, 
it was positive in some but not all OCT4A-positive ovarian PGCs at all the gestations 
examined (Gkountela et al., 2013). The expression of TET genes was detected by 
RNA-Sequencing at 16–16.5wga human fetal gonads and H1 human ESCs (hESCs). 
During this period, all three TETs (TET1, 2 and 3) were expressed by human testicular 
and ovarian PGCs, with a significant enrichment of TET2 when compared to TET1 
and TET3. Relative to H1 hESCs, the expression of TET1 was much lower in PGCs 
(Gkountela et al., 2013). 
This study provided the first outline of major epigenetic reprogramming in human 
PGCs. DNA methylation has been identified being erased in human PGCs by 6wga. 
This study also showed the dynamic changes of 5hmC in human PGCs across different 
gestation, and the expression of TET genes at 16–16.5wga. The definitive trend of 
H3K27me3 during human PGCs development has also been characterized. But when 
the DNA methylation has been erased in human PGCs is still unknown. And the 
definitive trend of other important histone modifications has not been identified in 
human PGCs. 
1.10 Aim of Mphil  
The studies here aim to carry out significant epigenetic reprogramming research on 
human fetal germ cells, establishing an accurate timeline of events pertaining to this 
process in human fetal germ cells.  
The objectives of this research was to  
• Characterize the process of 5 important histone modifications (H3K9me2, H3K9me3, 
H3K27me3, H3K4me3, H3K9ac) in human fetal germ cells during development. 
• Comprehend the reprogramming of DNA methylation and its related modifiers in 
human germ cells 
• Understand whether the chemical DNA demethylation will affect the expression of 
germ cell-specific genes and the meiotic genes in human in vitro and ex vivo 
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Chapter 2. Materials and Methods 
2.1 Human Dissection and Tissue Collection 
Human fetuses (8-20wga) were obtained following both medical and surgical 
termination of pregnancy. Informed consent was obtained according to the national 
guidelines (John Polkinghorne, 1989), and the study was approved by the Lothian 
Research Ethics Committee (LRC08/S1101/1). Medical termination was induced by 
administration of oral mifepristone (200mg), 48h later, followed by vaginal 
misoprostol (800mcg) 3 hourly. Surgical termination was performed after 
administration of vaginal misoprostol (200mg). Prior to the termination, ultrasound 
scan was used to determine the gestation of fetuses. After the specimens were obtained, 
this gestation was subsequently confirmed by direct measurement of either 
crown-rump length in first trimester specimens or foot length in second trimester 
specimens. The appearances of all fetuses were grossly morphologically normal. 
Gonads were removed from the fetuses and then placed in small plastic petri dish with 
Dulbecco’s Phosphate Buffered Saline (DPBS, Gibco，UK) for further dissection. 
Gonads were carefully separated from all extraneous material including the 
mesonephros using sterile 28G needle (BD) attached to 1ml syringe (BD). A small 
piece of non-gonadal tissue (e.g. limb) was taken for SRY polymerase chain reaction 
(PCR) as explained below (Section 2.2) to identify the gender of first trimester fetuses. 
Gonads were generally processed in 3 ways. Gonads were either snap frozen and 
stored at −80 °C for RNA analysis; fixed in Bouin’s Fluid or 4% Neutral Buffered 
Formalin (NBF) solution followed by transferring to 70% ethanol for histology; or 
prepared for tissue culture as described below (Section 2.4).  
2.2 Determination of Fetal Gender by PCR for SRY  
The gender of first trimester human fetus was hard to determine by gonadal or gross 
morphology.  In order to identify whether the dissected gonad was an ovary or testis, 
a small piece of non-gonadal tissue (e.g. the limb) was taken for DNA extraction. PCR 
amplification of the male-specific sex-determining gene SRY (Hanley et al., 2000) was 
performed (The primer sequences of SRY were showed in Table 2.11). 
The non-gonadal tissue was digested in 100μl Extraction Buffer (containing 25mM 
Sodium Hydroxide (NaOH) /0.2mM Ethylenediaminetetraacetic acid  (EDTA)). The 
solution mix was vigorously shaken at 95°C for 20min. Another 100μl Neutralization 
Buffer (containing 40mM Tris HCl) was added to the tissue. After vigorous vortex, 5μl 
of extracted DNA sample was added to the assembled PCR reaction mix (Table 2.1). 
Remaining DNA sample was stored at -20°C for further use. SRY PCR amplification 
was performed on a PTC-100 Thermal Cycler (MJ Research，UK) with the specific 
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Table 2.1 SRY Assemble RT-PCR Reaction Mix 
Reagent Amount Used Manufacturer 
2X ImmoMix Red 12.5μl Bioline 
25μM SRY Forward Primer 0.5μl Eurogentech 
25μM SRY Reverse Primer 0.5μl Eurogentech 
Nuclease-Free Water 6.5μl Ambion 
ImmoMix Red included Pre-mixed DNA polymerase/dNTPs/PCR buffer/gel loading dye. 
 
Table 2.2 SRY PCR Thermocycler Program 
Program Temperature Time 
1.Initial denaturation 95°C 10 min 
2.Denaturation 95°C 30 sec 
3.Annealing 58°C 30 sec 
4.Elongation 72°C 45 sec 
Repeat steps 2-4 for 35 cycles 
5.Final Elongation 72°C 10 min 
 
After the amplification, 10μl of PCR products were run with 100 base pair (bp) ladder 
(Promega) on a 2% Tris-acetate-EDTA (TAE, diluted from 50X stock TAE, Table 2.3) 
agarose (Galileo Bioscience) gel containing 0.01% Gel Red (Biotium) for 
visualization.  
Table 2.3 Compositions of Tris-acetate-EDTA (TAE) Buffer 
1mL Compositions of 50X TAE buffer Manufacturer Final volume 
Tris base Sigma 242 g 
Glacial Acetic Acid Sigma 57.1 mL 
500mM EDTA Sigma 100mL 
 
SRY gene expression was detected by UV transilluminator, the presence of a 300bp 
band determined the specimen to be male, and absence of the band indicates the 
specimen to be female specimen. Known positive and negative controls were loaded to 
ensure successful reaction (See Figure 2.1). 
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Figure2.1 SRY gene expression in different human specimens    
2.3 T-Cam2 cells: culture maintenance and Treatment 
The T-Cam2 cells were cultured in RPMI1640 (Gibco) medium, supplemented with 10%  
heat inactivated Fetal Bovine Serum (FBS, Gibco) and 2mM L-glutamine (L-Gln, 
Gibco，UK). The growth medium was stored in the fridge for up to 1 month and 
pre-warmed to 37°C before use.  
The T-Cam2 cells were maintained in T75 flasks (Corning, UK) at 37°C with 5% CO2 
humidified incubator and passaged every 4-5 days using 0.5% Trypsin/EDTA (Gibco). 
Warm Trypsin/EDTA was added to the cells and incubated at 37°C for several minutes 
to accelerate the detachment. After all the cells came off the flask, the trypsin was 
inactivated by growth medium. For maintenance passage, cells were usually split 1:4.  
In order to identify that whether the DNA demethylation reagent will affect the 
expression of germ cell-specific and the meiotic genes in human fetal germ cells, 
T-Cam2 cells were used as an in vitro model. T-Cam2 cells were divided into 2 main 
groups to optimize the optimum concentration and treatment duration, which has the 
lowest toxicity and highest demethylation efficiency. One of the groups was treated 
with different doses of 5-azacytidine for longer duration treatment; the other one was 
treated with higher concentration for different duration treatment (Table 2.4).  
T-Cam2 cells were divided to a 6-well plate or a 10cm dishes (Corning) 24 hours 
before the treatment to ensure that the cells were actively dividing and reach the 
appropriate cell density at the time of treatment. 24 hours later, T-Cam2 cells were 
treated with different doses of 5-azacytidine (Sigma, UK) with different treatment 
duration (Table 2.4). 5-azacytidine powder (Sigma) was made up to 100mM in 
Dimethyl Sulfoxide (DMSO, Sigma) and the stored at -20°C as stock solution. 
100mM stock 5-azacytidine was diluted in cultured medium to the final concentration 
of 1, 2, 3, 4, and 10μM for further treatment. A control was set up only with 0.05 or 
0.1μl DMSO per mL culture medium which has the same DMSO volume as the 5μM 
or 10μM 5-azacytidine treatment has. As 5-azacytidine is very unstable in aqueous 
solutions and degraded with time, the cultured medium was changed every 24-hour 
with freshly made 5-azacytidine medium.  
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Table 2.4 Different 5-azacytidine treatments in T-Cam2 cells 







0.05μl DMSO /mL culture medium 72h 






0.1μl DMSO /mL culture medium 4h, 12h, 24h 
5-Azacytidine 10μM 4h, 12h, 24h 
 
Demethylated T-Cam2 cells were treated with Retinoic Acid (Sigma, UK) to further 
study whether DNA demethylation reagent was associated with the regulation of 
retinoic acid responsiveness and the activation of germ cell-specific and meiotic genes. 
T-Cam2 cells were divided into 2 groups to to optimize the optimum concentration 
and treatment duration, which has the lowest toxicity and highest Retinoic Acid 
responsiveness. After treated with 5-azacytidine, the demethylated T-Cam2 cells were 
treated with Retinoic Acid; one groups was treated with different doses of retinoic acid 
for 24 hours; the other one was treated with different doses of retinoic acid for 48 
hours (Table 2.5). Retinoic acid was made up to 100mM in DMSO and stored at -20°C 
as stock solution. 100mM stock Retinoic Acid was diluted in DMSO to the final 
concentration of 0.1 and 1nM for treatment. A control containing the same DMSO 
volume as the retinoic acid reagents was set up. Retinoic acid-containing medium was 
kept in the dark, and changed every 24 hours with freshly made medium. After the 
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Table 2.5 Different Retinoic Acid treatments in T-Cam2 cells 
Culture Group Treatment Final Concentration Culture 
Time 
Group 1. 
24 hour Retinoic 
Acid treatment 
with different 
doses of Retinoic 
Acid 
DMSO+DMSO 0.05μl DMSO / mL culture medium+1μl DMSO 









5μM aza +1μl DMSO/ mL culture medium 72h +24h 
5-Azacytidine+
Retinoic Acid 






of Retinoic Acid 
DMSO+DMSO 0.05μl DMSO / mL culture medium+1μl DMSO 









5μM aza +1μl DMSO/ mL culture medium 72h +48h 
5-Azacytidine+
Retinoic Acid 
5μM aza +0.1nM/1nM RA 72h +48h 
2.4 Human Fetal Gonads Culture and Treatment  
Human fetal gonads were treated with 5μM 5-azacytidine (Table 2.6) to study the role 
of DNA demethylation reagent in the expression of germ cell-specific and meiotic 
genes in vivo. After DNA demethylation, the demethylated human fetal gonads were 
treated with 1nM Retinoic Acid (Table 2.7) to further study the relation between DNA 
demethylation reagent and the retinoic acid responsiveness in vivo.  
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Table 2.6 5-azacytidine treatment in human fetal gonads 
Treatment Final concentration Culture Duration 
DMSO (control) 0.05μl DMSO /mL culture medium 96h 
5-Azacytidine 5μM 96h 
 
Table 2.7 Retinoic Acid treatments in human fetal gonads 
Treatment Final concentration Culture Time 
DMSO+ DMSO 0.05μl DMSO / mL culture medium+ 1μl DMSO / 
mL culture medium 
72h+48h 
 
DMSO + RA 
 












MEM-alpha complete medium for human fetal gonads culture was made previously 
(Table 2.8).  1ml of culture medium supplemented with treatment reagent (5μM 
5-azacytidine or 1nM Retinoic Acid) and another 1ml supplemented with control 
reagent (DMSO) were prepared freshly. 900μl of each supplemented medium was 
placed in adjacent wells of a 12 well tissue culture plate (Corning), and then a 
polyester capillary pore membrane (pore size 0.4μm, Greiner Bio-One) was placed 
into each well. A drop (approximately 50μl-100μl) of the corresponding medium was 
place onto the upper surface of each membrane. The remaining wells were filled with 
1ml Dulbecco's Phosphate-Buffered Saline (DPBS, Gibco) to humidify the plate.  
Table 2.8 Compositions of human fetal gonads culture medium 
Compositions of 50mL Culture Medium Manufacturer Final volume 
MEM-ALPHA Gibco 43ml 
KnockOut™ Serum Replacement (KOSR) Gibco 5ml(10% final) 
100mM Sodium Pyruvate Gibco 0.5ml(2mM final) 
100X MEM Non-Essential Amino Acids Gibco 0.5ml(1X final) 
200mM L-Glutamine Gibco 0.5ml(2mM final) 
100X Penicillin-Streptomycin Gibco 0.5ml (1X final) 
500X Insulin-Transferrin-Selenium (ITS) Lonza 0.1ml(1X final) 
Bovine Serum Albumin (BSA) Sigma 150mg(3mg/ml final) 
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Fetal gonads tissues were micro-dissected into small pieces, which were randomly put 
into treatment group and control. Gonads were carefully transferred into the drop of 
medium on the upper surface of the membrane. The culture plate containing the fetal 
gonads was incubated at 37°C in a humidified atmosphere containing 95% air-5% 
CO2. A complete culture medium change was performed every 24h.  
After culture, tissues were washed by DPBS carefully and harvest for further analysis.  
2.5 Gene expression analysis  
The Polymerase Chain Reaction (PCR) technique was used to qualify and quantify the 
mRNA expression level in cells and tissues. These steps involved total RNA extraction, 
RNA concentration measurement, cDNA synthesis, reverse transcription-PCR 
(RT-PCR) and quantitative real-time PCR (qRT- PCR). 
2.5.1 Total RNA Extraction  
RNA from snap frozen samples (-80º C) or cultured cells was extracted by utilizing the 
Nucleospin RNA II Kit (Macherey-Nagel), RNeasy Mini Kit or RNeasy Micro Kit 
(Qiagen) according to manufacturer’s instructions.  
When there were less than 5×106 cultured cells or less than 30mg human tissue, the 
Nucleospin RNA II Kit (Macherey-Nagel) was used. Some of the experiments were 
performed with RNeasy Mini Kit or RNeasy Micro Kit (Qiagen). When there were 
less than 5×106 cultured cells or less than 30mg human tissue, the RNeasy Mini Kit 
(Qiagen) was used. When there were fewer than 5×105 cultured cells or <5mg human 
tissue, the RNeasy Micro Kit was used.  
Extracted RNA was immediately placed on ice. RNA was quantitated by NanoDrop TM 
1000 Spectrophotometer (Thermo Scientific) by measuring ultraviolet absorbance at 
260nm and 280nm. The A260/A280 ratio is generally between 1.9 and 2.1, indicating 
purity of the RNA. Extracted RNA was frozen at -20℃ for short-term storage and -80℃ 
for long-term storage.  
2.5.2 First Strand cDNA Synthesis  
First strand cDNA synthesized from 200ng RNA using the Maxima First Strand 
complementary DNA (cDNA) Synthesis Kit (Thermo Scientific) or SuperScript® 
VILO™ cDNA Synthesis Kit (Invitrogen) according the manufacturer’s instructions. 
The components of these two Kits are show in the table (Table 2.9). The first strand 
cDNA synthesis reaction mixes were performed as an individual reaction or as a series 
of parallel reactions with different RNA templates. Reverse transcription (RT) 
-negative samples were prepared similar to normal sample except adding reverse 
transcriptase enzymes. RT-negative samples were used to ensure the RNA used was 
free of DNA contaminants. No template control (NTC) lacking RNA template was 
prepared to assess reagent contamination (Table 2.9).  
Dynamic Epigenetic Modifications during Human Fetal Germ Cell Development 




After the master mixtures were prepared, all the tubes were arranged in a PTC-100 
Thermo cycler (MJ Research) and the program “Maxima” or “SurperScript” was run 
(Table 2.10). After the completion of the program, the first strand cDNA was used 
directly for PCR or stored at -20℃.  
Table 2.9 Components of the cDNA Synthesis Kits 
Maxima First Strand cDNA Synthesis Kit RT+ RT- NTC 
Maxima Enzyme Mix 2μl 0μl 2μl 
5X Reaction Mix 4μl 4μl 4μl 
Nuclease-free Water 6μl 8μl 14μl 
Template RNA 100ng-500ng 100ng-500ng 0ng 
Total volume 20μl 20μl 20μl 
 
SuperScript® VILO™ cDNA Synthesis Kit RT+ RT- NTC 
10X SuperScript® Enzyme Mix 2μl 0μl 2μl 
5X VILO™ Reaction Mix 4μl 4μl 4μl 
Nuclease-free Water 6μl 8μl 14μl 
Template RNA 100ng-500ng 100ng-500ng 0ng 
Total volume 20μl 20μl 20μl 
 
Table 2.10 Thermocycler Program for cDNA synthesis 
Program in PTC-100 Thermo cycler Maxima program SuperScript program 
Step 1. Anneal 25℃ for 10min 25℃ for 10min 
Step 2. Extend 50℃ for 15min 50℃ for 30min 
Step 3. Inactivate Reverse  
Transcriptase 
85℃ for 5min 85℃ for 5min 
Step4. Hold 4℃ to hold 4℃ to hold 
2.5.3 Primer Design  
Most of the primers that I used (Table 2.11) were designed and donated by the Richard 
Anderson’s lab (University of Edinburgh, UK). 
Among the primers used here, TET1, 2, and 3 were designed by myself using Primer3 
input software, version 0.4.0. Primers were designed to: I) be between 18 and 28 
nucleotides in length; II) have a GC content within the range of 20-80 %; III) have a 
Tm of 58-60 ̊C; and IV) amplify 50-150bp of DNA. During RNA extraction, DNase 
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has already digested the DNA in cells and tissues. Meanwhile, in the later PCR 
experiments, the mRNA levels rather than the DNA levels were detected, so the intron 
spanning was not performed during the primer design.  
Table 2.11 Primers used for RT-PCR or qRT-PCR 
Genes  Forward Primer Reverse Primer  Size 
TET1 AAATGTTGCCCGAGAATGT TTGATCTTGGCTTCCATTCC 264bp 
TET2 GAGACGCTGAGGAAATACGG TGGTGCCATAAGAGTGGACA 258bp 
TET3 CAGAACGCTGTGATCGTCAT AACTTGCGAGGTGTCTTGCT 263bp 
NANOG CAGCTGTGTGTACTCAATGATAGATTT ACACCATTGCTATTCGGCCAGTTG 132bp 
OCT4 ACATCAAAGCTCTGCAGAAAGAAC CTGAATACCTTCCCAAATAGAACCC 126bp 
DAZL GAAGGCAAAATCATGCCAAACAC CTTCTGCACATCCACGTCATTA 186bp 
STRA8 CTCAAAGTGGCAGGTTCTGAA TCCTCTAAGCTGCTTGCATGC 126bp 
SYCP3 AGCCGTCTGTGGAAGATCAG CAACTCCAACTCCTTCCAGC 198bp 
SYCP1 GCAGCAGGTGTCTGCGGTG CAACCTGCTCAAGCACGG 191bp 
DMC1 AGCAGCAAAGTTCCATGAAG TGAGCTCTCCTCTTCCCTTT 314bp 
VASA AAGAGAGGCGGCTATCGAGATGGA CGTTCACTTCCACTGCCACTTCTG 238bp 
B2M ACTGAATTCACCCCCACTGA CCTCCATGATGCTGCTTACA 114bp 
BOLL TATAAGGATAAGAAGCTGAACATTGGT CGAAGTTACCTCTGGAGTATGAAAATA 171bp 
REC8 TGAGGGTGAATGTGGTGAAA CTGGGATTGCAGCCTCTAAG 393bp 
CYP26B1 TCGAGCTTGATGGTTTCCAGA TGCTATACATGACACTCCAGCCTT 51bp 
RPL32 CATCTCCTTCTCGGCATCA AACCCTGTTGTCAATGCCTC 100bp 
AFP TGCAGCCAAAGTGAAGAGGGAA ATAGCGAGCAGCCCAAAGAAGA 216bp 
mStra8 GGAGAAAAAGGCCAGACTCC GACATATGCTGGGCCTCACT 228bp 
SRY ACAGTAAAGGCAACGTCCAG ATCTGCGGGAAGCAAACTGC 300bp 
 
2.5.4 Reverse Transcription Polymerase Chain Reaction (RT-PCR) 
RT-PCR was used to qualitatively detect gene expression through creation of cDNA 
transcripts from RNA. The cDNA was diluted 1 in 5 and then used as a template for 
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exponential amplification using RT-PCR. The master mix (Table 2.12) containing 
appropriate primers (Table 2.11) was added to each PCR tube. 1μl of the RT+ or RT- 
cDNA reaction was added to each PCR tube with 19μl master mix. PCR tubes were 
put in a PTC-100 Thermo cycler (MJ Research) for the “Immo” amplification program 
(Table 2.13).  
The RT-PCR products were analyzed with gel electrophoresis on a 2.5% agarose gels 
(Galileo Bioscience) containing 10% GelRed for visualization. PCR products were 
observed by UV light and images were captured using Gel-DOC programme 
(Bio-Rad). The 10μl of 100bp DNA ladder (New England Biolab) was used to 
determine size of PCR products.  
Table 2.12 Compositions of RT-PCR master mix 
Reagent Amount Used Manufacturer 
ImmoMix Red 10μl Bioline 
25μM Forward Primer 0.5μl Eurogentech 
25μM Reverse Primer 0.5μl Eurogentech 
Nuclease-free water 8μl Ambion 
ImmoMix Red (Pre-mixed DNA polymerase/dNTPs/PCR buffer/gel loading dye) 
 
 
Table 2.13 “Immo” RT-PCR amplification program 
Program Temperature Duration of Cycle 
1.Initial denaturation 95°C 10 min 
2.Denaturation 95°C 30 sec 
3.Annealing 58°C 30 sec 
4.Elongation 72°C 45 sec 
Repeat steps 2-4 for 35 cycles 
5.Final Elongation 72°C 10 min 
2.5.5 Quantitative Real-time Polymerase Chain Reaction (qRT- PCR) 
qRT-PCR was performed to analyze gene expression using 25μM each of the primer 
pairs (Table 2.11) and Brilliant III SYBR Green Master Mix (Agilent Technologies, 
Wokingham, UK) (Table 2.14). The reaction was place in the ABI7900HT Fast 
Real-Time PCR System with SDS2.4 software (Applied Biosystems, Warrington, UK), 
and the appropriate PCR program was run as the table below (Table 2.15), the 
instrument was set to detect and report fluorescence at each cycle during 60°C 
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annealing/extension step. For each gene of interest, each RT (+) sample was analyzed 
in triplicate and a single RT (−) reaction was performed as a negative control.  
In order to determine amplification efficiency, standard curves for B2M, TET1, 2 and 3 
were generated using a series of increasing dilutions (from 1/10 to 1/10,000) of 14wga 
human fetal ovarian cDNA. The resulting slope of the standard curves is a measure of 
the efficiency of the PCR reaction and was all close to −3.3 (equivalent to 100% PCR 
efficiency or two-fold amplification per cycle) (Hartley et al., 2002), allowing 
quantification using the 2−ΔΔCt method (Bayne et al., 2009).  
Melt curve analysis of each run confirmed expected product sizes. Signal acquisition 
was performed for 40 amplification cycles followed by continuous melt curve analysis 
to ensure product accuracy. For quantification, cDNAs were used at 1/20 dilutions 
with all amplification reactions performed in triplicate. In order to allow quantitative 
comparisons between cDNAs, gene-of-interest expression was normalized to that of 
the housekeeping gene B2M, which remained stable across gestation and between 
treatments. 
Table 2.14 Compositions of qRT-PCR master mix 
Reagent Amount Used Manufacturer 
2x Brilliant III SYBR Green Mix 5μl Agilent Technologies 
25μM Forward Primer 0.2μl Eurogentech 
25μM Reverse Primer 0.2μl Eurogentech 
Diluted Reference DYE 
(Diluted 1/50 in H2O) 
0.15μl Agilent Technologies 
Nuclease-free water 2.45μl Ambion 
Sample (diluted 1/20 in H2O) 2μl -- 
 
 
Table 2.15 Program for qRT-PCR 
Program Temperature Duration of Cycle 
Step 1. Hot start 95°C 3 min 
Step2. Denaturation 95°C 5 sec 
Step3. Anneal/Extension 60°C 15 sec 
Repeat steps 2-3 for 40 cycles 
Dissociation curve 95°C 15 sec 
60°C 15 sec 
95°C 15 sec 
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2.5.6 Statistical analysis 
Statistical analysis was performed using ABI SDS2.4 software (Applied Biosystems, 
Warrington, UK), Microsoft Excel 2003 and GraphPad Prism 5 software (La Jolla, CA, 
USA). Data presented represent mean ± standard error of the mean (SEM) of at least 
three independent biological replicates. P values of less than 0.05 were considered 
statistically significant. 
Gestational comparison data were analyzed using one-way ANOVA; data were 
analyzed as described for further analysis. Data were then analyzed utilizing the 
Newman-Keuls Multiple Comparison post-test to determine significant changes 
between gestational values. Some data was also analyzed using a post-test for linear 
trend; this test was performed when data were in a natural order (ie across gestation).  
Data were analyzed using paired t-tests compared the treated cells/gonads to the 
control cells/ gonads   
2.6 Tissue Fixation, Processing, and Sectioning  
Fixation is an important step before the immunostaining, as the right fixation way not 
only immobilizes antigens but also facilitate the access of antibodies. The fixation 
method is chose by the balance between morphological preservation and antigen 
accessibility to antibody. Bouin’s fixation was usually used for fetal gonads as it 
usually gave both good morphological preservation and good antigenicity preservation. 
4% Neutral Buffered Formaldehyde (NBF，Clintec, UK) also gave good antigen 
preservation, but the morphological preservation of human gonads in NBF was 
substantially inferior to preservation in Bouins.  
In the experiments here, tissues were fixed in Bouins solution or 4% NBF and then 
transferred to 70% ethanol (VWR) for further processing (Table 2.16).  
Table 2.16 Tissue fixation for human fetal gonads 
Fixation 
method 
First trimester human gonads Second trimester human gonads 
Bouins Gonads was fixed 1-2 hours before being 
transferred to 70% ethanol 
Gonads was fixed 2-3 hours before 
being transferred to 70% ethanol 
4% NBF Gonads was fixed overnight before being transferred to 70% ethanol 
 
The fixed tissues were paraffin processed to make the tissues firm enough to be cut on 
a microtome. Tissue processing was usually done on an automated tissue processor 
(Leica TP1050). Following processing, tissues were embedded in molten paraffin wax.  
Paraffin blocks were cut into 5μm thick sections via a paraffin microtome (Leica) and 
floated onto a heated water bath at 45°C to promote smooth tissue transfer. Sections 
were mounted on electrostatically charged glass slides (Thermo-scientific or Leica). 
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The slides were dried at 50°C overnight to ensure the tissue adhered to the slide 
surface. 
2.7 Haematoxylin and Eosin Staining 
Hematoxylin and Eosin staining (H&E) is the most common staining technique in 
histology laboratories. In order to determine tissue quality and orientation, every 10th 
slide was taken from each specimen for H&E staining. The staining of Haematoxylin 
is purplish blue and aimed at DNA in the nucleus and RNA in ribosomes; the staining 
of Eosin is pink and aimed at proteins in the cytoplasm.  
Sections were deparaffinized in xylene (VWR) twice for 5 min each, and then 
rehydrated through graded alcohol (VWR) for 20 sec each (From absolute alcohol, 95% 
alcohol to 70% alcohol). Sections were rinse in tap water for further process.  
Sections were incubated in haematoxylin (Leica) for 30-60 sec to counterstain nuclei. 
A very quick incubation in acid alcohol was performed to remove non-specific 
cytoplasmic staining. Sections were further immersed in Scott’s tap water for 30 sec to 
allow the haematoxylin to develop. Slides were immersed in Eosin (BD, UK) for 1 
min to stain cytoplasm. Slides were then rinsed in the water to remove excess staining 
between every step. After counterstaining, slides were transferred through baths of 
progressively increasing concentrated alcohol to dehydrate the tissues. The slides were 
then immersed in the hydrophobic clearing agent xylene twice for 5 min. After 
dehydration, a glass coverslip (VWR, UK) was cover with a small amount of Pertex 
glue (Histolab, UK), and the slide was mounted on its section side down. The slides 
were left to dry and stored in dry storage at room temperature. 
2.8 Chromogenic Immunohistochemistry (IHC)  
Immunohistochemistry was used to identify the distribution of target proteins in 
tissues of interest.  
2.8.1 Deparaffinization and Rehydration  
Sections were deparaffinized and rehydrated as described above, and were transferred 
to antigen retrieval after rinsing in water.  
2.8.2 Antigen Retrieval 
Before immunohistochemistry, the masked antigenicity needs to be break by Antigen 
retrieval, through which some tissues was exposed to a heated buffer solution. Citrate 
buffer of pH6.0 was the most commonly used retrieval solution.  
0.1M stock Citrate Buffer was prepared with 42.02g Citric Acid (Sigma) being 
dissolved in 1900mL distilled water, and the pH was adjusted to 6.0 with 1N NaOH.  
Dewaxed slides were immersed in 0.01M Citrate Buffer, and  heated to 125℃ for 
30sec and then cooled down to 90℃ in a Decloaking Chamber (Biocare Medical, 
UK).  
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2.8.3 Non-Specific Blocking 
When HRP conjugated antibody is used, non-specific background will be detected in 
some tissues, which contain endogenous peroxidase. In order to reduce this 
non-specific background, hydrogen peroxide (H2O2) blocking was used prior to HRP 
conjugated antibody. Sectioned tissues were incubated in 3% Hydrogen peroxide 
(H2O2, Fisher Scientific) diluted in methanol (VWR, UK) to block endogenous 
peroxidase activity. 
After 30 min peroxidase blocking, sectioned tissues were washed in pH7.6 wash 
buffer Tris-buffered saline (TBS, 0.05M Trizma base, 0.9% Sodium Chloride, (Sigma)) 
twice for 5 min. 
Normal serum was used as a common blocking reagent to block non-specific binding 
of immunoglobulin. The blocking serum must be taken from the species that 
secondary antibody was generated in rather than the species of the primary antibody. 
Slides were incubated in a blocking buffer for 30 min (including 1 part of normal 
serum (NS (Biosera, UK), 4 parts of TBS and 5% Bovine serum albumin (BSA, Sigma) 
(NS/TBS/BSA)). 
Endogenous biotin results in non-specific background staining when an avidin-biotin 
detection system is used. This non-specific background can be significantly reduced 
by treating tissues with avidin/biotin blocking reagents prior to the incubation of 
biotinylated antibody. This blocking step was performed immediately after normal 
serum blocking and before primary antibody incubation. 
Sections were incubated in strepavidin blocking solution (Vector, UK) for 15 min 
followed by a brief rinse in TBS, and then blocked in biotin blocking solution (Vector, 
UK) for 15 min. The sections were briefly rinsed in TBS and processed for primary 
antibody blocking. 
2.8.4 Primary Antibody 
The concentration, incubation time and incubation temperature of primary antibodies 
are all important impact factors for immunohistochemistry. In order to get specific 
staining and lowest background, optimization is needed for each antibody and tissue. 
Longer incubation periods (overnight) and lower temperatures (4 °C) were often 
employed to ensure penetration through tissue sections to promote specific staining. 
Primary antibody concentration optimization was achieved by varying dilution on 
standard tissue to find the maximum level of detection while minimizing non-specific 
background staining. The primary antibody was diluted in blocking serum 
(NS/TBS/BSA) with the optimum concentration. The sections were incubated in the 
primary antibody overnight at 4° C. The table below (Table 2.17) showed the 
antibodies used and the optimum concentrations for human fetal tissues. 
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Non-immunized blocking serum omitting primary antibody was used as negative 
control to test the specificity of the primary antibody involved. 













NGS/TBS/BSA 1:700 GARB+Streptavidin-HRP 
+DAB 
NGS/TBS/BSA 1:150 GARBfab + ABC 
Streptavidin-AP+ Fast 
Blue 





NGS/TBS/BSA 1:2000 Anti-rabbit ImmPRESS 
kit +DAB 

















NGS/TBS/BSA 1:150 Anti-rabbit ImmPRESS 
kit +DAB 
















NGS/TBS/BSA 1:50 Anti-rabbit ImmPRESS 
kit +DAB 
GARB: goat anti-rabbit biotinylated secondary antibody 
CARBfab: goat anti-rabbit biotinylated conjugated FAB fragment secondary antibody 
2.8.5 Streptavidin Detection Method  
After overnight incubation, slides were washed twice in TBS for 5 min to remove 
primary antibody. A biotinylated secondary antibody was used to link primary 
antibodies to an avidin-biotin-peroxidase complex. A biotinylated secondary antibody 
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(diluted 1:200 in blocking serum), with specificity against the primary antibody (Table 
2.17), was applied to the tissue samples and incubated at room temperature for 30 min.  
The secondary antibody was rinsed in the TBS twice for 5min.  
A biotinylated enzyme, Streptavidin-horseradish peroxidase (HRP) (Vector), was 
diluted 1:1000 in TBS and applied to the slides for 30 min incubation. The 
avidin-biotin-peroxidase complex was bound to the biotinylated antibody that was 
already bound to the tissue and the visualization of antibody was developed as 
described below (Section 2.11.7).  
2.8.6 ImmPress Polymer Detection Method 
For antibodies that were not readily detectable with standard secondary antibodies, 
ImmPress Polymer Detection Reagents (Vector) was used. This ImmPress Polymer 
staining system uses novel conjugation and micropolymer chemistries to produce a 
highly sensitive, low background, non-biotin detection system. Avidin/Biotin blocking 
steps were eliminated by ImmPress detection system even in tissues containing 
endogenous biotin.  
The staining procedure for ImmPress kit was simple. Following the normal horse 
serum-blocking step, primary antibody was diluted in normal horse serum and the 
section tissues were incubated with primary antibody as described above. After 
primary antibody incubation, the appropriate ImmPress reagent was added to the 
sections and incubated for 30 min. Section were rinsed with TBS and the visualization 
of antibody was developed as described below (Section 2.9.7).  
2.8.7 Visualization of Antibody 
3, 3′-diaminobenzidine tetrahydrochloride (DAB; DAKO) was used to detect the 
bound antibodies. 1 drop (or 20μl) of the DAB Chromogen was added to 1mL of 
Substrate Buffer. Sections were then incubated with DAB until staining was optimally 
detected (determined via observation by light microscope). The sections were 
immersed in water to stop the reaction. 
2.8.8 Counterstaining, Dehydration, and Slide Mounting 
After antigen detection, the slides were counterstained using haematoxylin (no eosin) 
and mounted as described previously. 
2.9 Fluorescent Immunohistochemistry  
Fluorescent immunohistochemistry was used to detect the distribution of specific 
proteins within the cell or tissue. Fluorescent dyes are conjugated to secondary 
antibodies or probes to visualize the location of the primary antibodies to detect target 
antigens; this technique has the ability to generate high-resolution images for specific 
proteins localization studies and the capacity to quantitate the fluorescent signal.  
The general protocol for fluorescent immunohistochemistry was similar to that of 
DAB Immunohistochemistry with minor changes for fluorescent detection. 
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2.9.1 Washes Buffer and Blocking Serum 
All washes between each step were performed in phosphate-buffered saline (PBS, 
Sigma) instead of TBS for fluorescent immunohistochemistry. The blocking serum 
comprised of normal serum and BSA was diluted in PBS (NS/PBS/BSA) rather than in 
TBS.  
2.9.2 Primary Antibody 
Primary antibody was diluted in the blocking serum NS/PBS/BSA rather than 
NS/TBS/BSA. As fluorescent immunohistochemistry was more sensitive, the optimum 
concentration of primary antibody was adjusted (Table 2.18). 
 











NHS/PBS/BSA 1:800 Anti-rabbit ImmPRESS 
kit +Tyramide 
NDS/PBS/BSA 1:300  Donkey Anti-Rabbit  






NGS/PBS/BSA 1:800 GAMP+ Tyramide 









NHS/PBS/BSA 1:800 Anti-rabbit ImmPRESS 
kit +Tyramide 





NHS/PBS/BSA 1:700 Anti-mouse 
ImmPRESS kit 
+Tyramide 









NGS/PBS/BSA 1:30000 GARP+ Tyramide 
GAMP: goat anti-mouse peroxidase secondary antibody 
GARP: goat anti-rabbit peroxidase secondary antibody 
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2.9.3 Secondary Antibody and Visualization of Binding Antibody 
There were several methods to detect and visualize the primary antibody. The bound 
primary antibody was detected by fluorophore-conjugated secondary antibody, or by 
Tyramide Signal Amplification (TSA, Perkin Elmer) Detection.  
The fluorophore-conjugated secondary antibody detection approach was the simplest 
form of signal amplification. With this approach, multiple antigens can be labeled 
concurrently when the primary antibodies were raised from different species. A 
fluorophore-conjugated secondary antibody, with specificity against the primary 
antibody, was diluted 1:200 in blocking serum. The section tissues were incubated 
with this secondary antibody for 1 hour at room temperature to allow binding to the 
primary antibody. This incubation was performed in darkness, as the fluorophores 
degrade under light exposure. 
TSA is a patented technology, which can significantly enhance the fluorescent signals. 
It is particularly useful for detection of relatively sparse antigens that other systems 
have difficulty detecting. The TSA system uses a HRP catalyzed reaction to covalently 
attach the tyramide portion of tyramine-protein conjugated to the area around the 
protein of interest.  A peroxidase-conjugated secondary antibody, with specificity 
against the primary antibody, was diluted 1:200 in blocking serum. The section tissues 
were incubated with this secondary antibody for 30 min at room temperature to allow 
binding to the primary antibody. After rinsed in PBS twice for 5 min, a tyramide 
enhancer was diluted 1:50 in its own amplification buffer as described by the 
manufacturer. The slides were then incubated in darkness for 10 min. The TSA was 
removed with PBS in an opaque container to prevent any bleaching of the 
fluorescence. 
2.9.4 Counterstain 
Nuclear counterstaining was performed with 4', 6-diamidino-2-phenylindole (DAPI, 
Invitrogen) or Propidium Iodide (PI, Invitrogen). The counterstain used for 
fluorescence varied depending on the color of detection used for the primary 
antibodies. They were diluted 1:1000 in PBS and applied to the slides for 10 min 
incubation in darkness.  
2.9.5 Mounting 
Dehydration was not need for fluorophore-labeled tissue samples; the samples must be 
mounted with a solution containing an antifade compound to stabilize the fluorescence. 
A small amount of PermaFluor Mounting Medium (Thermo Scientific) was added to a 
glass coverslip (VWR) and the slide was mounted on its section side down. The 
mounted slides were stored at 4°C in the dark for weeks to months.  
Dynamic Epigenetic Modifications during Human Fetal Germ Cell Development 




2.10 Fluorescent immunocytochemistry (ICC) 
Immunocytochemistry (ICC) is a technique used to assess the presence of the target 
specific peptides or protein antigens in the cells by utilizing a specific antibody. Cells 
were cultured in 4-well chamber slides (Thermo Scientific), and attached to the slides 
to allow easy handling in subsequent procedures.  
To ensure free access of the antibodies to all cells and subcellular compartments, the 
cells were fixed and permeabilized. After aspirating culture medium, the cells were 
washed with PBS twice, and fixed with 4% NBF for 10 min. After that, 
permeabilization was performed. The permeabilization method used depended on the 
epitopes and antibodies. 0.2% NP-40 (Sigma) was applied for intracellular epitopes 
when the antibody required access to the inside of the cell to detect the protein. When 
the epitope was in the cytoplasm or the cytoplasmic face of the plasma membrane, a 
milder membrane solubilizer was needed. 0.2% Tween 20 (Bio-rad) was suitable for 
the antigens in the cytoplasmic region. It gave large enough pores for antibodies to 
pass through without dissolving the plasma membrane. The cells were permeabilized 
and blocked in the blocking solvents which included 0.2% NP-40/0.2% Tween 20, 1% 
BSA, 10% Serum and PBS. Cells were incubated with the blocking solvents for 30 
min at room temperature. The target specific peptides or protein antigens in the cells 
were detected by primary antibody, which was diluted in the normal blocking serum. 
After incubated at 4℃ overnight, both fluorochrome-conjugated secondary antibody 
and TSA were used to detect the binding primary antibody. Cells were incubated in PI 
or DAPI for 10 min. Chambers were removed and the slides were mounted with 
PermaFluor Mounting Medium (Thermo Scientific).  
2.11 IHC and ICC for 5-Methyl Cytosine (5mC) and 
5-Hydroxymethyl Cytosine (5hmC) 
The protocol for 5mC and 5hmC detection was similar to the general protocol with 
minor changes. 
For IHC, after peroxidase blocking, the detected tissues were permeabilised by 0.5% 
Triton 100 (Sigma) for 30 min. To further improve binding affinity of the antibodies, 
the DNA was denatured by incubating the tissues in 4N hydrochloric acid (HCl, VWR) 
for 15 min at room temperature. Following denaturation, the tissues were blocked in 
NS/TBS/BSA and then incubated with 5mC (Eurogentec) or 5hmC (Active Motif) 
antibody (Table 2.17). 
For ICC, after permeabilization by 0.5% Triton X100 (Sigma), the cells were 
denatured by 4N HCl. The cells were incubated with NS/PBS/BSA following the 5mC 
or 5hmC antibody incubation (Table 2.18).  
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2.12 Dual Immunohistochemistry and Co-localization by 
immunofluorescence 
For dual immunohistochemistry, detection using the first primary antibodies was 
performed as described above. After DAB detection, the slides were microwaved in 
0.01M Citrate Buffer for 2.5 minutes for second time antigen retrieval. NGS/TBS/BSA 
was used to block the slides before adding second primary antibody (Table 2.17). Goat 
anti-rabbit biotinylated Fab fragments (Abcam) was used as secondary antibody 
diluted 1:200 in NGS/TBS/BSA. The Vectastain ABC alkaline phosphatase kit (Vector) 
was used to bind to the peroxidase antibody that was already bound to the tissue and 
the visualization of antibody was applied by fast blue (Sigma) following the 
manufacturer’s instructions. Slides were then mounted in PermaFluor Mounting 
Medium (Thermo Scientific).  
For dual immunofluorescence, the above protocol (Section 2.11) was followed by 
additional citrate retrieval by boiling in a microwave oven for 2.5 min. After the 
antigen retrieval, the above section was repeated starting from the serum blocking 
stage. Slides were kept in the dark as much as possible to preserve fluorescence, and 
the strongest primary antibody (one used at the highest dilution) was used first. The 
antibodies used in dual fluorescent immunohistochemistry are shown in Table 2.18. 
2.13 Light microscopy and Fluorescent microscopy 
For immunohistochemistry staining, the expression of target proteins were determined 
and photographed by utilizing a Provis AX70 (Olympus) microscope fitted with a 
camera (AxioCam HRc, Zeiss). Scale bars were generated and Adobe Photoshop CS5 
was used to compile the photographic figures shown in the text. 
For immunofluorescence staining, slides were visualized using a LSM710 confocal 
microscope (Zeiss). Scale bars were embedded using the Zeiss software and images 
compiled into figures using Photoshop CS5. 
2.14 Western blot analysis of protein expression 
2.14.1 Protein Extraction and quantification 
Cells were cultured in a 10cm diameter culture dishes. Before harvesting, the cells 
were washed briefly in cold PBS. 500μl of RIPA buffer（containing 25mM Tris HCl 
pH 7.5, 150mM NaCl, 1%Triton X100, 0.1% SDS, 0.05 Sodium Deoxycholate）was 
added to lyse the cells for 5min on ice. The lysed cells were scraped down with a cell 
scraper and the entire lysate was transferred into a 1.5ml tube. Before processing the 
next step, the lysates were homogenized with an electronic pestle (Sigma) with 
disposable tips (Sigma) to ensure maximum protein extraction.  
The concentration of protein extracts were measured by the Bradford protein assay 
which is a spectroscopic analytical procedure (Bradford et al, 1976)  
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Serial dilution of BSA standards (1.0, 0.5 0.25 and 0.125mg/ml) were diluted in 1/10 
RIPA buffer. 1/10 diluted lysate proteins were prepared appropriately for further 
detection. The Protein Assay Components (Bio-Rad) were prepared according to 
manufacturer’s instructions utilizing a 96-well microplate (Corning). All assays 
(standards and test lysates) were incubated with the Protein Assay Components for 15 
min in triplicate. The plates were scanned on a Multiskan EX microplate reader 
(Labsystems) to measure absorbance at 590nm. The absorbance of test lysates was 
compared to a BSA standard curve run on the same microplate to determine the 
concentration of the lysate.  
2.14.2 Western Blot 
The Western Blot is an analytical technique used to qualitatively and 
semi-quantitatively identify specific proteins. 
Protein samples were diluted in RIPA buffer to a final concentration of 20μg and then 
1/3 volume of 4X SDS loading buffer (containing 625mM PH6.8 Tris, 5% Glycerol, 2% 
SDS, 0.0025% Bromophenol Bule and distilled water) with 10% reducing agent β-ME 
(Sigma Aldrich) was added. The samples were denatured at 99° C for 6 min on a 
Thermomixer (Eppendorf) and then cooled on ice.   
Gel electrophoresis was used to separate proteins. The samples were loaded into a 12% 
tris-HEPES-SDS Precise Protein gel (Thermo Scientific) alongside PageRuler Plus 
Prestained Protein Ladder (Thermo Scientific). Gels were run in a protein 
electrophoresis system (Bio-Rad) with running buffer (1x Tris-HEPES SDS Buffer, 
Thermo Scientific) at 125V for 45-60 min until the loading dye had run to the bottom 
of the gel. 
After electrophoresis, the separated molecules were transferred from the 
electrophoresis gel to a polyvinylidene difluoride (PVDF) membrane for further 
detection. The electrophoresis gels were washed in distilled water and then soaked in 
transfer buffer (fast semi-dry buffer, Thermo Scientific) for 10 min. PVDF membrane 
Immobilon-FL Transfer Membrane (Millipore) was cut to the appropriate size for the 
gel. The membrane was dehydrated by soaking in methanol for 30sec, 1min in 
distilled H2O, and then soaked in Fast Transfer Buffer for 15min prior to blotting. 
Immobilon Blotting Filter Paper (Millipore) was prepared by soaking in transfer buffer. 
The protein-containing gel was placed directly onto the Immobilon-FL Transfer 
Membrane and loaded with two filter papers. The blot sandwich was loaded into a 
semi-dry blotter as per manufacturer’s instructions and run at 25V for 7-9min 
depending on protein size to transfer proteins to the membrane.  
The membranes used in western blotting have a high affinity for proteins. Therefore, 
after transferring, a blocking buffer was applied to block the remaining surface of the 
membrane to prevent nonspecific binding of the detection antibodies during 
subsequent steps. The membrane was washed in distilled water, and then blocked in 
blocking buffer (1:1 0.1% PBS tween: Millipore Block-FL) for at least 1 hour at room 
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temperature. Typically, the blocked membrane was probed with a primary antibody 
that recognized a specific protein or epitope on a group of proteins. A DAZL antibody 
raised from rabbit (1:150, 50kDa, Cell Signalling) was used to detect the target protein 
and a α-tubulin antibody raised from mouse (1:3000, 37kDa, Cell Signalling) was used 
as a loading control. Primary antibodies were diluted in blocking buffer and the 
membrane was left to incubate at 4 °C overnight.  
Next day, the membrane was washed in 0.1% PBS tween x4 for 5 min. Anti-rabbit 
Alexa680 conjugated secondary antibody (red signal, life technologies) and 
anti-mouse IRDye800 conjugated antibody (green signal, life technologies) were 
applied to the detected the bound primary antibody. Fluorophore-conjugated 
secondary antibodies diluted in blocking buffer were applied to the membrane. After 
incubating with the secondary antibodies for 1h at room temperature in the dark, the 
membrane was washed in 0.1% PBS tween twice for 5 min and then in PBS twice for 
5 min in the dark. The membrane was directly scanned with the aid of the Li-Cor 
Infrared Imaging System (Odyssey). 
2.15 Plasmid DNA Transfection  
2.15.1 Bacteria Transformation  
A plasmid containing resistance to antibiotic was used as a vector to clone, transfer 
and manipulate genes. The gene of interest was inserted into a plasmid vector, creating 
a newly constructed plasmid. This plasmid was introduced into a bacterium by 
bacterial transformation. The bacterial used for transformation was sensitive to 
specific antibiotic. The bacteria were then spread over a plate that contained specific 
antibiotic. The antibiotic was used as a selective pressure as only bacteria that have 
acquired the plasmid can grow on the plate. Therefore, in order to survive in the plate, 
which contains antibiotic, the bacteria continually replicated the plasmid along with 
the gene of interest that has been inserted to the plasmid. This allows generation of 
large quantities of plasmid.  
All procedures in bacteria transformation were performed under sterile conditions.  
NEB 5-alpha Competent E.Coli Cells (New England BioLabs) were thawed in ice for 
10 min. 100ng plasmid DNA (pEGFP-C1-Stra8, provided by Dr. Andrew Childs) was 
added to the NEB 5-alpha Competent E.Coli Cells on ice as soon as the last ice 
crystals disappeared. In order to maximum the transformation efficiency, cells and 
DNA plasmid were incubated together on ice for 30 min. The cell mixtures were heat 
shocked at exactly 42℃ for 30 sec and then returned to ice another 5 min. 950μl 
S.O.C medium (Invitrogen)  was added to the cell mixtures and shaken vigorously 
(250rpm)  at 37℃ for 1 hour. Outgrowth at 37℃ for 1 hour was best for cell 
recovery and for expression of antibiotic resistance to obtain maximal transformation 
efficiency. The LB Agar plates (Bio-Red) with 100μg/ml Ampicillin or 30μg/ml 
Kanamycin were prepared in advanced and warmed up to 37℃ . After 1-hour 
incubation, several 10-fold serial dilutions of the cell mixtures were made in S.O.C 
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medium (1ng, 10ng, 100ng). 100μl of each dilution was spread onto the antibiotic 
selection plates and incubated overnight at 37℃.  
After 24 hours, the LB agar plates were removed from the incubator to check the 
number of bacterial colonies. A single colony was picked up and inoculated in a 5mL 
starter LB Broth (Fisher Scientific) with the appropriate selective antibiotic (100μg/ml 
ampicillin or 30μg/ml kanamycin). The starter culture LB medium was shaken 
vigorously (300rpm) at 37℃ for 8h.  In order to get enough plasmid DNA for later 
DNA extraction, the starter culture medium with a single colony was diluted into 
250mL LB Broth medium containing the appropriate selective antibiotic. This 250mL 
LB culture medium was shaken vigorously (300rpm) at 37℃ for 16h.  The rest of 
the plates were wrapped in parafilm and kept in a refrigerator for later use.  
2.15.2 Plasmid DNA extraction and purification  
The bacterial cells were harvested by being centrifuged at 6000 g at 4℃ for 10min 
and the supernatant was discarded. Plasmid DNA Purification Kit (Macherey Nagel) 
was used to extract plasmid DNA. 12mL of buffer RES with RNase A was added to 
re-suspend the cell pellet completely. 12mL Lysis Buffer LYS was added and 
incubated at room temperature for 5 min. A NucleoBond Xtra Column together with 
the inserted column was equilibrated with 25mL Equilibration Buffer EQU. EQU 
buffer was applied onto the rim of the column filter and wet the entire filter. The lysate 
suspension was mixed with 12mL Neutralization Buffer NEU and inverted gently for 
several times. The lysate was immediately loaded onto the column. After the column 
was emptied by gravity flow, 15mL Buffer EQU was added to wash the column filter 
and column to wash away the remaining lysate in the filter. The column filter was 
discarded and the column was washed with 25mL Wash Buffer. 15mL Elution Buffer 
ELU was added to the column and the ELU buffer was collected in a 50mL centrifuge 
tube (Corning). 15mL room temperature isopropanol was added to the mixture to 
precipitate the eluted plasmid DNA. The precipitated DNA was loaded slowly with a 
30mL syringe attached to a NucleoBond Finalizer. After discarding all the 
flow-through, the syringe was washed slowly with 5mL ethanol with the attachment 
with the Finalizer. After discarding the flow-through again, the NucleoBond Finalizer 
was dried by passing air through the Finalizer 6 times. Finally, the Finalizer was 
attached to a 1ml syringe, and 750μl re-dissolving Buffer TRIS was added to elute 
plasmid DNA drop by drop by inserting the plunger slowly. The first eluate was 
transferred back into the syringe and eluted into the same collection tube to get a high 
yield of plasmid DNA.  
Plasmid DNA was quantitated by NanoDrop TM 1000 Spectrophotometer (Thermo 
Scientific) through measuring its ultraviolet light (UV) absorbance at 260nm. The 
A260/A280 ratio was generally between 1.9 and 2.1, indicating purity of the DNA. 
For long-term storage, plasmid DNA was frozen at -20℃.  
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2.15.3 The Process of Transfection  
Cells were divided 24 hours before transfection to ensure that the cells were actively 
dividing and at the appropriate cell density at the time of transfection to maximize 
transfection efficiency. The volumes of culture medium and transfection reagent were 
varied according to culture plate used. When the cells were cultured in the 6-well plate, 
2.5μg of DNA from each plasmid (pEGFP-C1-Stra8, pCDNA3-N2MYC-Stra8 vectors 
and empty vector pCMV6-Entry from (OriGene)) and10μl TransIT –LT1 transfection 
reagent (Mirus) were incubated in 250μl serum-free growth medium (Opti-MEM I 
Reduced-Serum Medium (Invitrogen)) for 20min. The solution containing the plasmid 
was then dropped onto the plates with 2.5 mL fresh medium and mixed by gentle 
rocking. 
The cells were incubated overnight with the transfection solution. In order to 
determine the best post-transfection time, the cells were incubated for 24-72 hours. 
The transfections were performed in complete growth medium without a 
post-transfection medium change to yield high transfection efficiency. After 
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Chapter3. Dynamic changes in histone modifications during 
human fetal germ cell development 
3.1 Introduction 
Among the modified histone marks, H3K9ac, H3K4me3, H3K27me3, H3K9me2 and 
H3K9me3 are the most studied.  
The active histone mark H3K9ac has been identified to activate transcription by 
neutralisation the electrostatic interaction between DNA and histones (Nishida et al., 
2006; Turner, 2000). In undifferentiated human ESCs, enrichment of H3K9ac 
contributes to the maintenance of pluripotency-related genes POU5F1, NANOG and 
SOX2 (Pan et al., 2007). Once human ESCs enter into differentiation, the global level 
of H3K9ac is significantly reduced (Krejci et al., 2009).  
Another histone mark H3K4me3 is also tightly associated with active genes (Barski et 
al., 2007; Bernstein et al., 2005). H3K4me3 regulates active transcription by recruiting 
chromatin-remodelling enzymes (Flanagan et al., 2005; Li et al., 2006). In 
undifferentiated human ESCs, high levels of H3K4me3 contribute to maintenance of 
the pluripotency-related genes POU5F1, NANOG and SOX2 before differentiation 
(Pan et al., 2007).  
H3K27me3, a hallmark of condensed heterochromatin, is tightly associated with 
transcriptional repressive genes (Boyer et al., 2006; Margueron and Reinberg, 2011). 
In undifferentiated human and murine ESCs, developmental genes are silenced by 
H3K27me3 and its methyltransferase PRC2 (Boyer et al., 2006; Lee et al., 2006).  
In mammalian cells, H3K9me2, acting as a crucial histone mark for transcriptional 
repression, is enriched within the silent euchromatic regions (Peters et al., 2003; Rice 
et al., 2003). In differentiated murine ESCs, the expression of the 
pluripotency-associated gene Pou5f1 is repressed by high levels of H3K9me2 
(Feldman et al., 2006).  
H3K9me3, which is greatly enriched in heterochromatin, is generally associated with 
transcriptional silence (Bannister et al., 2001; Lachner et al., 2001). In mouse ESCs, 
H3K9 trimethyltransferase Suv39h does not contribute to maintain the undifferentiated 
status (Lehnertz et al., 2003). In addition, Suv39h and its modified chromatin 
H3K9me3 have been found to be critical for germ cell meiosis in mice (Peters et al., 
2001).  
In the mouse embryo, these five histone marks have been identified to change 
dynamically during germ cell development, and may be associated with the normal 
development of mouse fetal germ cells (Abe et al., 2011; Hajkova et al., 2008; Seki et 
al., 2005; Seki et al., 2007; Yabuta et al., 2006). In line with the dynamic histone 
modifications in mouse fetal germ cells, human fetal germ cells may also undergo 
global histone modifications to prepare for the subsequent germ cell-specific 
developmental process. However, observations about histone modifications in human 
fetal germ cells are very limited. In order to identify whether the dynamic changes of 
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these histone marks are similar to those observed in mouse, expression of these five 
important histone modifications was here investigated in human fetal germ cells.  
In order to identify the antibody's antigen-binding specificities, these five histone 
marks were first detected in the seminoma-derived TCam-2 cells, which is obtained 
from a primary testicular seminoma of a 35-year-old patient (Mizuno et al., 1993). 
Seminomatous testicular germ cell tumors are the result of abnormal development of 
early gonocytes during migration or on their arrival in the gonad (Kristensen et al., 
2008). Testicular seminoma cells have similar morphology and maker expression 
patterns as PGCs (Kristensen et al., 2008). Therefore, TCam-2 cells can be used as a 
PGC model in human in-vitro studies (de Jong et al., 2008). Subsequently, these five 
histone marks were investigated in human gonad tissues in vivo.  
3.2 Results 
3.2.1 Distinct distributions of H3K9ac, H3K4me3, H3K9me2, H3K9me3 
and H3K27me3 in NBF fixed TCam-2 cells 
As a negative control, NBF fixed human TCam-2 cells were incubated with 
non-immune serum rather than primary histone antibodies (Fig 3.1F). In control 
TCam-2 cells, the interphase nuclei were stained by PI (Propidium iodide), which 
labeled the condensed chromocenters with stronger and heavier staining (Fig 3.1F, 
white arrow). 
In TCam-2 cells, the active histone mark H3K9ac was evenly distributed across cell 
nuclei and was excluded from the chromocenters (Fig 3.1A). The endogenous levels of 
active histone mark H3K4me3 were also detected in TCam-2 cells. Being absent from 
the condensed chromocenters, H3K4me3 was present in the TCam-2 cell nuclei 
specifically, with a distinct punctuate pattern of staining   (Fig 3.1B). The 
distribution of H3K9me2, a repressive histone mark in the silent euchromatic regions, 
distributed non-condensed throughout the TCam-2 cell nuclei and was also absent 
from the strongly stained chromocenters (Fig 3.1C, white arrow). In TCam-2 cells 
H3K9me3 was present in a speckled staining pattern (Fig 3.1D). H3K9me3 localized 
preferentially to PI-dense (DNA-dense) heterochromatin (Fig 3.1D) and part of the 
chromocenters (Fig 3.1D). Finally, H3K27me3 distributed diffusely throughout the 
TCam-2 cells nuclei (Fig 3.1E) and stained intensely in the chromocenters (Fig 3.1 E).   
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Figure3.1. Distribution of different histone marks in the nuclei of NBF fixed TCam-2 cells. 
A, H3K9ac; B, H3K4me3; C, H3K9me2; D, H3K9me3; E, H3K27me3; F, Negative control. The 
staining for the histone marks is shown in green; the PI nuclear counterstaining is shown in red. 
The white arrows represent the chromocenters in the TCam-2 cells. The scale bars in all 
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3.2.2 Distributions of H3K4me3, H3K27me3 and H3K9me2 in Bouins and 
NBF fixed human ovaries  
In order to determine whether the antigen-binding ability is affected by different 
fixation ways or not, the expression of H3K4me3, H3K27me3 and H3K9me2 was 
examined in both Bouins and NBF fixed 18wga human fetal ovaries (Fig 3.2). 
At 18wga human ovary, which was fixed in either Bouins or NBF, the smaller and less 
differentiated ovarian germ cells located in the peripheral ovary displayed H3K4me3 
staining (Black arrow, Fig 3.2 A and B); while the larger and more mature ovarian 
germ cells located in the central region were H3K4me3-negative (White arrow, Figure 
3.2 A and B), including oocytes in primordial follicles (insert panels, Fig 3.2 A and B).  
At 18wga, H3K27me3 was rarely detectable in both the Bouins and NBF fixed human 
ovarian germ cells (White arrow, Fig 3.2 C and D), involving oocytes in primordial 
follicles (insert panels, Fig 3.2 C and D).  
The Bouins and NBF fixed 18wga human fetal ovaries displayed a similar H3K9me2 
staining, with a mixture of H3K9me2-positive (Black arrow, Fig 3.2 E and F) and 
H3K9me2-negative ovarian germ cells (White arrow, Fig 3.2 E and F) towards the 
edge or the middle of the ovary.  
Bouins and NBF fixed human gonadal sections incubated with non-immune serum 
instead of primary antibody were used as negative control (Fig 3.2 G and H).  
In Bouins and NBF fixed human fetal ovaries, the distributions of H3K4me3, 
H3K27me3 and H3K9me2 were quite similar, suggesting that the antigen-binding 
specificities of these three histone antibodies were not greatly influenced by different 
fixation methods. Meanwhile, the morphological structure was preserved better in 
Bouins fixed gonads than NBF fixed ones. Therefore, these histone marks were 
investigated in Bouins fixed human fetal ovaries and testes across different gestations.   
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Figure 3.2 Distribution of different histone marks in Bouins or NBF fixed 18wga human fetal 
ovaries. A and B, H3K4me3; insert panels in A and B, primordial follicles; C and D, H3K27me3; insert 
panels in C and D, primordial follicles; E and F, H3K9me2; insert panels in E and F, middle of the ovary; 
G, Bouins fixed negative control; H, NBF fixed negative control. Black arrows represent positive staining 
ovarian germ cells, while white arrows represent negative staining ovarian germ cells. The scale bars 
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3.2.3 Global changes of H3K4me3 during human fetal ovarian and 
testicular germ cell development 
DAB immunohistochemical detection was performed to determine the distribution of 
the active histone mark H3K4me3 in Bouins fixed human fetal ovaries and testes 
across different gestations. Overall, the global levels of H3K4me3 in human fetal 
ovarian and testicular germ cells progressively declined as they differentiated (Fig 3.3 
and 3.4). At 9wga, human fetal ovary only contains undifferentiated PGCs; all these 
PGCs displayed nuclear H3K4me3 staining (Black arrow, Fig 3.3 A and B). However 
by 15wga, following the onset of meiosis, most ovarian germ cells had lost this active 
mark and the staining was restricted to the smaller and undifferentiated germ cells at 
the periphery of ovary (Black arrow, Fig 3.3 D-F). The larger, more differentiated 
germ cells at the center of ovary were H3K4me3-negative (white arrow, Fig 3.3D-F). 
At later gestations, this pattern became more pronounced. At 19wga, most germ cells 
were H3K4me3-negative (white arrow, Fig 3.3 G-H)), including oocytes in primordial 
follicles (asterisk, Fig 3.3 I).    
Most of the somatic cells in the ovaries, as well as the pre-granulosa cells in the 
primordial follicles, were H3K4me3-positive (black arrowhead, Figure 3.3). Only very 
few somatic cells in the 2nd trimester were H3K4me3-negative (white arrowhead, 
Figure 3.3). Ovarian sections incubated with non-immune serum rather than 
H3K4me3 primary antibody was used as a negative control (Figure 3.3C).  
In Bouins fixed human fetal testes, parallel changes in H3K4me3 distribution were 
found in testicular germ cells across the same developmental window (Figure 3.4). At 
9wga, all PGCs were H3K4me3-positive (Black arrow, Fig 3.4A). However, by 14wga, 
some large H3K4me3-negative testicular germ cells at the edge of seminiferous cords 
were clearly visible (White arrow, Fig 3.4B), although a sub-population of testicular 
germ cells still retained this modification (black arrow, Fig 3.4B). A similar pattern 
was observed at 18wga (Fig 3.4C).  
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Figure 3.3 Distribution of H3K4me3 in Bouins fixed human fetal ovaries. A and B, 9wga 
human fetal ovarian sections; C, negative control; D, E and F, 15wga; G, H and I, 19wga. Black 
and white arrows represent H3K4me3-positive and negative germ cells, respectively. While 
black and white arrowheads represent H3K4me3-positive and negative somatic cells, 
respectively. The asterisk represents the primordial follicles. The scale bars equal to 5µm in F 
and I panels; 10µm in A, B, E and H panels; 20µm in the C, D and G panels. 
Dynamic Epigenetic Modifications during Human Fetal Germ Cell Development 




Almost all the testicular somatic cells displayed H3K4me3 staining in the 1st trimester 
(black arrowhead, Fig 3.4A).  In the 2nd trimester, Sertoli cells within testicular cords, 
and peritubular myoid cells surrounding cords, were H3K4me3-positive (black 
arrowhead, Fig 3.4B and C) while the Leydig cells located between the testicular cords 
were H3K4me3-negative (white arrowhead, Fig 3.4B and C). The negative control is 
shown in Figure 3.4 D.  
Figure 3.4 Distribution of H3K4me3 in Bouins fixed human fetal testes. A, 9wga human 
fetal testicular section; B, 14wga human fetal testicular section; C, 18wga human fetal 
testicular section; D, negative control. Black and white arrows represent H3K4me3-positive and 
negative germ cells, respectively. Black and white arrowheads represent H3K4me3-positive 
and negative somatic cells, respectively. The scale bar is equal to 10µm in A, B and C panels; 
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3.2.4 Global changes of H3K27me3 during human fetal ovarian and 
testicular germ cell development 
H3K27me3, which is associated with repressed genes, displayed a similar pattern to 
that of H3K4me3 in human fetal ovarian and testicular germ cells, but appeared to be 
erased at an earlier stage (Fig 3.5 and 3.6).  
At 8wga, nearly all the ovarian germ cells displayed H3K27me3 staining (black arrow, 
Fig 3.5 A-C), however, some of the staining was weakly positive (black arrow, Fig 3.6 
B). By 15wga, most of the ovarian germ cells had lost H3K27me3 (white arrow, Fig 
3.5 D and E), with only very few smaller and undifferentiated germ cells at the 
periphery of the ovary displaying nuclear H3K27me3 staining (black arrow, Fig 3.5 D 
and E). By 19wga, all of the germ cells in the human fetal ovary, including 
undifferentiated germ cells located at the periphery of the ovary, did not show 
H3K27me3 staining (white arrow, Fig 3.5 G-H). Oocytes in primordial follicles were 
also completely H3K27me3-negative (asterisk, Fig 3.5 I).  
At 8wga, most of the ovarian somatic cells were H3K27me3-negative or weakly 
positive (white arrowhead, Fig 3.5A-C); however, at later gestations, 
H3K27me3-positive somatic cells were abundant (black arrowhead, Fig 3.5D-E, G-H). 
Pre-granulosa cells in primordial follicles were also mostly H3K27me3-positive (black 
arrowhead, Fig 3.5I). The negative control is shown in Fig 3.5 F.  
With increasing gestation, parallel changes in H3K27me3 distribution were detected in 
Bouins fixed human fetal testicular germ cells (Fig 3.6 A-C). At 9wga, most testicular 
germ cells were H3K27me3-positive, although some of them were only weakly 
H3K27me3-positive (black arrow, Fig 3.6 A). H3K27me3 was completely erased in 
testicular germ cells by 15wga (white arrow, Fig 3.6 B), and remained undetectable at 
19wga (white arrow, Fig 3.6 C).   
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Figure 3.5 Distribution of H3K27me3 in Bouins fixed human fetal ovaries. A, B and C, 
8wga human fetal ovarian sections; D and E, 15wga; F, negative control; G, H and I, 19wga. 
Black and white arrows represent H3K27me3-positive and negative germ cells, respectively. 
While black and white arrowheads represent H3K27me3-positive and negative somatic cells, 
respectively. The asterisk represents the primordial follicles. The scale bars equal to 5µm in B, 
C, E and I panels; 10µm in A and H panels; 20µm in the D, F and G panels. 
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Testicular somatic cells were largely H3K27me3-positive at 9wga (black arrowhead, 
Fig 3.6 A). At 15wga and 19wga, the Sertoli cells within testicular cords showed 
intense positive staining for H3K27me3 (black arrowhead, Fig 3.6 B), whilst 
peritubular myoid cells and Leydig cells were either weakly positive, or showed no 
H3K27me3 staining (White arrowhead, Fig 3.6 B). The negative control is shown in 
Fig 3.6 D. 
Figure 3.6 Distribution of H3K27me3 in Bouins fixed human fetal testes. A, 9wga human 
fetal testicular section; B, 15wga human fetal testicular section; C, 19wga human fetal 
testicular sections; D, negative control. Black and white arrows represent H3K27me3-positive 
and negative germ cells, respectively. While black and white arrowheads represent 
H3K27me3-positive and negative somatic cells, respectively. The scale bars equal to 10µm in 
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3.2.5 Dynamic Changes of H3K9me2 during human fetal ovarian and 
testicular germ cell development 
H3K9me2 displayed a distinct, sex-specific distribution in human fetal germ cells. 
H3K9me2 was undetectable in ovarian germ cells at 9 and 19wga, but was transiently 
detected at 15wga, which was coincident with the early stages of meiosis (Fig 3.7). At 
9wga, the repressive histone mark H3K9me2 was undetectable in most human fetal 
ovarian germ cells (White arrow, Fig 3.7A-B), but some displayed low levels of this 
histone mark (Black arrow, Fig 3.7A-B). At 15wga, H3K9me2-positive ovarian germ 
cells were detected both at the edge (Black arrow, Fig 3.7D and E) and the middle of 
the ovary (Black arrow, Fig 3.7D and F). However, not all ovarian germ cells 
displayed H3K9me2 at this stage (White arrow, Fig 3.7D-F). At 19wga, H3K9me2 
was nearly undetectable in the ovarian germ cells most showed no H3K9me2 staining 
(White arrow, Fig 3.7G-I). Oocytes in primordial follicles were also 
H3K9me2-negative at this stage (Asterisk, Fig 3.7I). In distinction to the dynamic 
changes in human ovarian fetal germ cells, the ovarian somatic cells were largely 
H3K9me2-positive at all gestation (Fig 3.7A-I). The primary antibody was omitted for 
negative controls (Fig 3.7C).  
In contrast, H3K9me2 was undetectable in testicular germ cells at all stages examined 
(White arrow, Fig 3.8A-C). In the testicular somatic cells, the staining of H3K9me2 
was highly dynamic across gestation (Fig 3.8). At around 9wga, almost all the 
testicular somatic cells showed strong H3K9me2-staining (Black arrowhead, Fig 
3.8A). However, during 2nd trimester, the staining of H3K9me2 declined in different 
populations of testicular somatic cells (Fig 3.8 B and C). At 15wga, only some Sertoli 
cells, peritubular myoid cells displayed H3K9me2 staining (Black arrowhead, Fig 
3.8B). Later at 19wga, the number of H3K9me2-positive Sertoli cells increased (Black 
arrowhead, Fig 3.8C), however, most of the Leydig cells remained negative for 
H3K9me2 (White arrowhead, Fig 3.8C). The negative control is shown in Figure 3.8 
D. 
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Figure 3.7 Distribution of H3K9me2 in Bouins fixed human fetal ovaries. A and B, 9wga ; 
C, negative control; D, 15wga; E, the edge of 15wga human fetal ovary; F, the middle of 15wga 
human fetal ovary; G, H and I, 19wga. The asterisk represents the primordial follicles. Black 
and white arrows represent H3K9me2-positive and negative germ cells, respectively. While 
black and white arrowheads represent H3K9me2-positive and negative somatic cells, 
respectively. The scale bars equal to 5µm in E, F, H and I; 20µm in A, B, C, D and G. 
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Figure 3.8 Distribution of H3K9me2 in Bouins fixed human fetal testes. A, 9wga human 
fetal testicular section; B, 15wga human fetal testicular section; C, 19wga human fetal 
testicular section; D, negative control. Black and white arrows represent H3K9me2-positive and 
negative germ cells, respectively. While black and white arrowheads represent 
H3K9me2-positive and negative somatic cells, respectively. The scale bars equal to 10µm in A 
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3.2.6 Global changes of H3K9me3 in human fetal and postnatal ovarian 
germ cells and human fetal testicular germ cells 
Initial investigation of the expression of H3K9me3 in both Bouins and NBF fixed 
human fetal gonads via DAB immunohistochemical detection did not give clear results. 
Therefore, immunofluorescent detection, which has a higher level of sensitivity, was 
performed to identify the distribution of H3K9me3. Unfortunately, the Bouins fixed 
human fetal gonads displayed strong non-specific background immunostaining. NBF 
fixed human fetal gonads however displayed a clear pattern of H3K9me3 staining. 
Thereafter, by immunofluorescence, the distribution of H3K9me3 was detected in 
NBF fixed human gonads across different gestations. 
A distinctly gender-specific distribution of H3K9me3 was observed in NBF fixed 
human fetal gonads (Fig 3.9 and 3.10). In human fetal ovary, the staining of H3K9me3 
was restricted to the ovarian germ cells and progressively increased with developing 
gestations (Fig 3.9). On the other hand, H3K9me3 was present at low levels in 
testicular germ cells across all examined stages (Fig 3.10).  
At 9wga, H3K9me3 was present at a low level in ovarian PGCs (White arrow, Fig 
3.9A), and appeared as 2-3 punctate spots over the nucleus of H3K9me3-positive 
PGCs (Insert panel, Fig 3.9A). At 15wga, after the initiation of meiosis, the more 
mature ovarian germ cells located towards the middle of the ovary started to display 
intense H3K9me3 staining (White arrow, Fig 3.9C). At 17wga, this pattern became 
more noticeable, with most of the centrally-located ovarian germ cells being 
H3K9me3-positive, and only a thin band of cells at the very periphery of the ovary 
displaying no staining  (White arrow, Fig 3.9D). During the later gestations, 
H3K9me3 was found to distribute evenly throughout the nucleus of the mature ovarian 
germ cells (Insert panel, Fig 3.9C and D). Notably, H3K9me3 was undetectable in 
ovarian somatic cells at all examined gestations (Figure 3.9A, C and D). The absence 
of primary antibody was used as negative control (Fig 3.9 B). 
In human fetal testicular germ cells, levels of H3K9me3 were low across all examined 
gestations. This repressive histone mark was restricted to punctate spots within the 
germ cell nucleus through all detected gestations (White arrow, Fig 3.10A-C). At 
9wga, H3K9me3 was more apparent in human fetal testicular germ cells than those in 
the ovary at the same developmental stage, but remained restricted to distinct foci 
within germ cell nucleus (White arrow, Fig 3.10A). In the 2nd trimester, 
H3K9me3-staining was restricted to 1-2 distinct foci (White arrow, Fig 3.10B and C). 
The H3K9me3-negative testicular germ cells were largely restricted to the periphery 
of the testicular cords (White arrow, Fig 3.10B and C). Dual immunostaining with the 
mature germ cell marker VASA confirmed the population of cells with little or 
punctate H3K9me3 staining to be germ cells (White arrow, Fig 3. 10D). The negative 
control, which was absence of primary antibody, is shown in Fig 3.10 C, inserted 
panel. 
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Different from the ovarian somatic cells, H3K9me3 was detectable in the testicular 
somatic cells. At 9wga, testicular somatic cells were initially H3K9me3-negative.  
From 16wga onwards, Sertoli cells were generally H3K9me3-positive (White 
arrowhead, Fig 3.10B and C), while the peritubular myoid cells were all 
H3K9me3-negative. Notably, Leydig cells displayed H3K9me3 staining at 16wga (Fig 
3.10B white arrowhead), but were negative for H3K9me3 at 20wga (Fig 3.10C). The 
negative control was shown in the insert panel in Figure 3.10 C. 
H3K9me3 was also detected in the postnatal ovaries (from 3-year-old to 32-year-old) 
to determine whether the H3K9me3 remained in mature oocytes even after birth (Fig 
3.11). The mature germ cell marker VASA was used to visualize oocytes (Green, Fig 
3.11). In these postnatal ovaries, follicles in different development stages were 
observed. Primordial follicles with an oocyte surrounded by a single layer of 
squamous granulosa cells were observed in the 3-year-old ovary (Fig 3.11 A and B). 
The oocytes became enlarged with the maturation of follicles. In Fig 3.11F, a primary 
follicle with enlarged and cuboidal granulosa cells is shown. Preantral follicles with 
more than one layer of granulosa cells are shown in Fig 3.11 C, D and E. In all these 
postnatal follicles, the oocytes displayed punctuate H3K9me3 staining (Red, Fig 3.11). 
Meanwhile, nearly all the granulosa cells around the oocytes were H3K9me3-positive 
in the postnatal ovaries (Red, Fig 3. 11).    
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Figure 3.9 Distribution of H3K9me3 in NBF fixed human fetal ovaries. A, 9wga human 
fetal ovarian section; insert panel in A, higher power image of H3K9me3-positive PGCs; B, 
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negative control; C, 15wga; insert panel in C, higher power image of 15wga human fetal 
ovary; D, 17wga; insert panel in D, higher power image of 17wga human fetal ovary. The PI 
counterstaining is present in Red, while the H3K9me3 staining is present in Green. White 
arrow indicates H3K9me3-positive germ cells. The scale bars equal to 20µm in A and B; 
50µm in C; 100µm in D. 
 
Figure 3.10 Distribution of H3K9me3 in NBF fixed human fetal testes. A, 9wga human fetal 
testicular section; B, 16wga human fetal testicular section; C, 20wga human fetal testicular 
section; insert panel in C, negative control; D, double-immunostaining of VASA and H3K9me3 
in 20wga human fetal testicular sections. The PI counterstaining is shown in Red, while the 
H3K9me3 staining is shown in Green. White arrows represent H3K9me3-positive germ cells, 
while white arrowhead represents H3K9me3-positive somatic cells. The scale bars equal to 
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Figure3.11 Distribution of H3K9me3 in NBF fixed human postnatal ovaries. A and B, 
primordial follicles in 3-year-old human ovary; C and D, preantral follicles in 12-year-old human 
ovary; E, preantral follicle in 24-year-old human ovary; F, primary follicle in 32-year-old human 
ovary. The DAPI nuclear counterstaining was shown in Blue, H3K9me3 staining was shown in 
Red, and VASA staining was showed in Green. The scale bars equal to 20µm in A and B 
panels, 50µm in C, D, E and F panels.   
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3.2.7 Distribution of H3K9ac in Bouins fixed human fetal germ cells 
Another active histone mark H3K9ac was also detected in Bouins fixed human fetal 
gonads across different gestations. In Bouins fixed human fetal ovarian and testicular 
germ cells, levels of H3K9ac were found to decrease with increasing gestations (Fig 
3.12 and 3.13). 
At 9wga, all the undifferentiated PGCs displayed nuclear H3K9ac staining (Black 
arrow, Fig 3.12A and B). By 14wga, the more differentiated germ cells located at the 
center of the ovary were negative for H3K9ac staining (White arrow, Fig 3.12D-F) 
whilst the smaller undifferentiated germ cells at the periphery of the ovary retained 
this modification (Black arrow, Fig 3.12D-F). At 18wga, there were only very few 
undifferentiated ovarian germ cells displaying H3K9ac staining (Black arrow, Fig 
3.12G); all of the mature germ cells were H3K9ac-negative (White arrow, Fig 
3.12G-I). Oocytes in primordial follicles also were H3K9ac-negative (Asterisk, Fig 
3.12I).   
At 9wga, most of the ovarian somatic cells were H3K9ac-negative (White arrowhead, 
Fig 3.12A and B). The numbers of H3K9ac-positive somatic cells increased as the 
development of fetal ovary; by 18wga, most of the ovarian somatic cells were 
H3K9ac-positive (Black arrowhead, Fig 3.12F-H). Pre-granulosa cells in primordial 
follicles were mostly H3K9ac-positive (Black arrowhead, Fig 3.12I) although some 
immuno-negative pre-granulosa cells could be detected (White arrowhead, Fig 3.12I).  
Human fetal ovarian sections cultured with non-immune serum were used as a 
negative control (Fig 3.12C).  
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Figure 3.12 Distribution of H3K9ac in Bouins fixed human fetal ovaries. A and B, 9wga 
human fetal ovarian sections; C, negative control; D, 14wga human fetal ovarian sections; E, 
the edge part of ovary; F, the middle part of ovary; G,H and I, 18wga human fetal ovarian 
sections. Black and white arrows represent H3K9ac-positive and negative germ cells, 
respectively. Black and white arrowheads represent H3K9ac-positive and negative somatic 
cells, respectively. The asterisk represents the primordial follicle. The scale bars equal to 5µm 
in B, E, F, H and I; 20µm in A, C, D and G. 
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The changes of H3K9ac distribution were similar in Bouins fixed human fetal testes 
(Fig 3.13A-C). Almost all the testicular PGCs were H3K9ac-positive at 9wga (Black 
arrow, Fig 3.13A). However, during 2nd trimester most of the testicular germ cells at 
the periphery of cords had lost H3K9ac staining (White arrow, Fig 3.13B and C), 
while a sub-population of testicular germ cells at the center of cords retained this 
modification (Black arrow, Fig 3.13B and C).  
The number of H3K9ac-positive somatic cells increased with increasing gestation 
(Black arrowhead, Fig 3.13). At the later gestations, most Sertoli cells were 
H3K9ac-positive (Black arrowhead, Fig 3.13B and C), although few of them 
displayed weak H3K9ac staining (White arrow head, Fig 3.13C). During these stages, 
the peritubular myoid cells and Leydig cells were also predominantly 
H3K9ac-positive. No staining was detected in the negative controls (Fig 3.13D). 
Figure3.13 Distribution of H3K9ac in Bouins fixed human fetal testes. A, 9wga human 
fetal testicular section; B, 14wga human fetal testicular section; C, 18wga human fetal 
testicular section; D, Negative control. Black and white arrows represent H3K9ac-positive and 
negative germ cells, respectively. While black and white arrowheads represent 
H3K9ac-positive and negative somatic cells, respectively.  The scale bars equal to 5µm in B 
and C panels; 10µm in A and D panels.  
In the Bouins fixed human fetal gonads, H3K9ac appeared to be restricted to the 
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dual-immunohistochemistry with the immature germ cell (PGC) marker C-KIT was 
performed in Bouins fixed human fetal gonads, alongside co-localization with a 
mature germ cell marker VASA (Anderson et al., 2007; Castrillon et al., 2000; Kerr et 
al., 2008a; Kerr et al., 2008b). In Bouins fixed human fetal gonads, the immature germ 
cell (PGC) marker C-KIT located in the membrane of undifferentiated germ cells 
(Brown, Fig 3.14 A and B). The H3K9ac-positive ovarian and testicular germ cells in 
the Bouins fixed human fetal gonads displayed intense C-KIT staining (Black arrow, 
Fig 3.14 A and B). On the other hand, cytoplasmic staining of VASA was observed in 
the center of ovary or the edge of testicular cords (White arrow, Fig 3.14 C and D). 
H3K9ac, which was seen to stain the immature germ cells on the periphery of the 
ovary or in the center of the testicular cords, did not co-localized with VASA in Bouins 
fixed human fetal ovary or testis (White arrow, Fig 3.14 C and D). 
Figure 3.14 Dual-immunohistochemistry of H3K9ac with immature germ cell marker 
C-KIT and the mature germ cell marker VASA in Bouins fixed human fetal ovaries and 
testes. A, co-localization of H3K9ac and C-KIT at 9wga human fetal ovary; B, co-localization of 
H3K9ac and C-KIT at 14wga human fetal testis; C, double-immunostaining of H3K9ac and 
VASA at 18wga human fetal ovary; D, double-immunostaining of H3K9ac and VASA at 18wga 
human fetal testis. The staining of C-KIT and VASA were showed in brown, while the staining of 
H3K9ac was present in blue. Black arrows represent the co-localization of H3K9ac and C-KIT, 
while white arrows represent the non-co-localization of H3K9ac and VASA. The scale bars 
equal to 5µm in D panel; 10µm in B and C panels, 20µm in A panel. 
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3.2.8 The distribution of H3K9ac in NBF fixed human fetal and postnatal 
ovaries 
The observations in Bouins fixed human fetal gonads showed that H3K9ac was 
restricted to the smaller and undifferentiated germ cells. In order to identify whether 
different fixatives affected the antigen-binding ability, the H3K9ac antibody was also 
used in NBF fixed human ovaries (Fig 3.15).  
Surprisingly, the distribution of H3K9ac was different between Bouins fixed and NBF 
fixed human fetal ovaries at the same gestations. In bouins fixed human fetal ovaries, 
the H3K9ac staining was only observed in the smaller undifferentiated germ cells 
during 2nd trimester (14wga and 18wga) (Fig 3.12D-I). Contrarily, in the NBF fixed 
human fetal ovaries, nearly all the ovarian germ cells, including the smaller 
undifferentiated germ cells at the periphery of the ovary and the more differentiated 
germ cells located at the center of the ovary, were H3K9ac-positive during 2nd 
trimester (14wga and 18wga)(Black arrow, Fig 3.15A-F). The distribution of H3K9ac 
was also identified in the NBF fixed human postnatal ovaries (Fig 3.15 G-I). The 
mature oocytes in the NBF fixed postnatal ovaries displayed intense H3K9ac staining 
also (Fig 3.15 G-I). Two totally different distributions of H3K9ac were observed in 
Bouins and NBF fixed human fetal ovaries. The mature fetal ovarian germ cells in the 
bouins fixed human fetal ovaries were H3K9ac-negative; while the mature ovarian 
germ cells in the NBF fixed human fetal ovaries were H3K9ac-positive.  
Difference of H3K9ac staining was also observed in the ovarian somatic cells. At the 
2nd trimester, most of the mesenchymal somatic cells, which displayed H3K9ac 
staining in the bouins fixed human fetal ovaries (Fig 3.12), were negative for H3K9ac 
in NBF fixed human fetal ovaries (White arrowhead, Fig 3.15A-F). The pre-granulosa 
and granulosa cells in the NBF fixed human ovaries were H3K9ac-positive (Black 
arrowhead, Fig 3.15F-I). 
Dynamic Epigenetic Modifications during Human Fetal Germ Cell Development 




Figure 3.15 Distribution of H3K9ac in NBF fixed human ovaries. A and B, 16wga human 
fetal ovarian sections; C, negative control; D, E and F, 18wga human fetal ovarian sections; G, 
H and I, 16~36-year-old human postnatal ovarian sections. Black arrows represent 
H3K9ac-positive germ cells. While black and white arrowheads represent H3K9ac-positive and 
negative somatic cells, respectively. The asterisk represents the primordial follicle. The scale 
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3.3.1 Distinct localization of H3K9ac, H3K4me3, H3K9me2, H3K9me3 and 
H3K27me3 in human seminoma-derived TCam-2 cells 
In TCam-2 cells, the distributions of H3K9ac, H3K4me3, H3K9me2, H3K9me3 and 
H3K27me3 were different from each other (Fig 3.1). However, the distribution of 
these five histone marks were consistent with what has been shown in the antibody 
datasheets (Abcam, H3K9ac; Abcam, H3K9me2; Abcam, H3K9me3; CellSignaling, 
H3K4me3; CellSignaling, H3K27me3); with the active H3K9ac and H3K4me3 
(Barski et al., 2007; Nishida et al., 2006) being excluded from the condensed 
chromocenters; the silent euchromatic histone mark H3K9me2 preferentially localized 
to the euchromatin rather than the heterochromatin (Rice et al., 2003); the 
heterochromatic histone marks H3K9me3 and H3K27me3 (Boyer et al., 2006; 
Lachner et al., 2001) being accumulated preferentially in the inactive heterochromatin 
domains. All these observations in TCam-2 cells suggest that these five histone marks 
localized as expected, indicating their antigen-binding specificities. 
3.3.2 Dynamic changes of H3K4me3, H3K27me3, H3K9me2, and H3K9me3 
in human fetal gonads are different from the changes in mouse  
The studies in human fetal gonads here showed that the global levels of H3K4me3, 
H3K27me3, H3K9me2, and H3K9me3 underwent dynamic changes in the 
post-migratory human fetal germ cells (Fig 3.16). The histone modifications 
mentioned above were strikingly different from those reported in mouse fetal germ 
cells (Hajkova et al., 2008; Seki et al., 2005). Compared to the progressive decrease of 
H3K4me3 and H3K27me3 in human fetal gonads, methylated H3K4 and H3K27me3 
dynamically fluctuated in mouse PGCs (Hajkova et al., 2008; Seki et al., 2005). 
Methylated H3K4 significantly increased in mouse PGCs around the time of their 
arrival at the genital ridge, and subsequently decreased to the same levels found in the 
surrounding somatic cells by E12.5 (Hajkova et al., 2008; Seki et al., 2005). Levels of 
H3K27me3 in mouse germ cells increased after E8.0, reached a maximum level by 
E9.5, and briefly decreased between E11.0-E12.0, afterwards, increased again (Seki et 
al., 2005). Different to the peak expression of H3K9me2 in human fetal ovarian germ 
cells, H3K9me2 had already been erased in mouse nascent PGCs soon after germ cell 
specification (Hajkova et al., 2008; Seki et al., 2005). Unlike the increasing levels of 
H3K9me3 in human fetal ovarian germ cells, H3K9me3 transiently decreased in 
mouse germ cells around E11.5–E12.0, and were re-elevated afterwards (Hajkova et 
al., 2008; Seki et al., 2005). The findings above indicate that the extensive changes of 
histone modifications in fetal germ cells are strikingly different between human and 
mouse, suggesting that the species differences in histone modifications do exist 
between human and mouse, and hence, further emphasizing the importance of human 
study. 
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Figure 3.16. Dynamic changes of H3K4me3, H3K27me3, H3K9me2 and H3K9me3 in 
human fetal germ cells across the gestational period 8-20wga. Levels of H3K4me3 and 
H3K27me3 were progressively decreased in human fetal ovarian and testicular germ cells with 
maturation of germ cells. In human fetal ovarian germ cells, level of H3K9me2 was low at 9 and 
19wga.Shortly after the onset of meiosis, the levels of H3K9me2 peaked in human ovarian 
germ cells at around 15wga. On the other hand, H3K9me2 was undetectable in human fetal 
testicular germ cells at all detected gestations. For the case of H3K9me3, level of H3K9me3 
was progressively increased with germ cell maturation in human fetal ovarian germ cells. 
Contrarily, human fetal testicular germ cells displayed weak H3K9me3 expression at all 
detected stages. The pink bars represent the levels of histone marks in human fetal ovarian 
germ cells (GCs), while the blue bars represent the levels of histone marks in human fetal 
testicular germ cells (GCs). 
3.3.3 The restriction of H3K4me3 and H3K27me3 in smaller and 
undifferentiating human fetal germ cells may be associated with the 
expression of pluripotency-associated genes and the repression of 
developmental genes in early stages of germ cell development 
In previous studies, H3K4me2/3 was observed in a small proportion of human fetal 
testicular germ cells from 21wga onwards (Almstrup et al., 2010). In the studies here, 
the distribution of H3K4me3 was extended to different gestations in both human fetal 
ovary and testis. However, we did not investigate human fetal gonads from 20wga 
onwards due to lack of availability of samples. 
The studies present here showed that H3K4me3 was restricted to the smaller fetal 
germ cells and declined in human fetal germ cells as ovary and testis differentiation. 
Previous study in undifferentiated human ESCs showed that high levels of H3K4me3 
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have been found to be involved in the maintenance of the pluripotency-related genes 
POU5F1, NANOG and SOX2 (Pan et al., 2007). Thus the restriction of H3K4me3 in 
the smaller and undifferentiating human fetal germ cells may be associated with the 
expression of pluripotency-associated genes.  
The study by Gkountela and colleagues showed that the repressive histone mark 
H3K27me3 was enriched in human early PGCs in both sexes (Gkountela et al., 2013). 
From 11wga onwards, H3K27me3 was globally erased from human fetal PGCs 
(Gkountela et al., 2013). Consistent with the previous findings, the study present here 
also showed high levels of H3K27me3 in early human PGCs. Similarly, in the study 
here, the reduction in H3K27me3 was initiated in human fetal germ cells by 14wga, 
which is in accordance with what has been observed by Gkountela et al. Gkountela et 
al also reported that the testicular PGCs regained H3K27me3 at around 17wga. 
However, in Almstrup et al’s study, H3K27me3 was undetectable in testicular germ 
cells between 21wga and 24wga (Almstrup et al., 2010). In the study here, 
re-expression of H3K27me3 was also not detected in testicular germ cells at later 
gestations. These different findings in later fetal testicular germ cells may be 
associated with the different sensitivities in DAB immunohistochemistry used by 
Almstrup and here, versus the fluorescent detection used by Gkountela.  
In undifferentiated ESCs, H3K27me3 has been found to play an important role in 
repressing developmental genes; the erasure of H3K27me3 led to de-repression of 
these developmental genes and initiated the differentiation of ESCs (Boyer et al., 2006; 
Lee et al., 2006).  The restriction of H3K27me3 in the undifferentiated fetal germ 
cells in human may be associated with the repression of developmental genes in early 
stages of germ cell development. 
The activating H3K4me3 and repressing H3K27me3 here displayed similar trends in 
human fetal germ cells, they both declined during germ cell development and were 
both restricted to the smaller, undifferentiated germ cells. In mouse ESCs, H3K4me3 
and H3K27me3 have been found to co-exist at the same genomic domains, which are 
referred to as bivalent domains (Bernstein et al., 2006). The co-existence of H3K4me3 
and H3K27me3 in the undifferentiated ESCs are considered to poise timely activation 
of developmental genes (Bernstein et al., 2006; Mikkelsen et al., 2007). In the absence 
of differentiation signals, developmental genes were maintained in a temporary silent 
state by the presence of both H3K27me3 and H3K4me3 in undifferentiated ESCs. 
Though silent, the genes present in these bivalent domains can become activated 
immediately in response to downstream developmental signals, and do not require 
epigenetic reprogramming (Bernstein et al., 2006; Mikkelsen et al., 2007). Upon 
differentiation, H3K27me3 was removed while H3K4me3 was retained, leading to the 
expression of these bivalent genes (Boyer et al., 2006; Lee et al., 2006). In contrast, 
other bivalent genes, in which H3K4me3 was erased and H3K27me3 was retained, 
remained silenced (Bernstein et al., 2006). Co-modification of the 
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development-associated genes by the bivalent histone marks H3K27me3 and 
H3K4me3 have also been observed in undifferentiated human ESCs (Pan et al., 2007).  
Inferring from the knowledge above, the similar trend of H3K4me3 and H3K27me3 in 
human fetal germ cells may be associated with the bivalent modifications of 
developmental genes in early germ cells, which need further inverstigation. 
3.3.4 The sex-specific distribution of H3K9me2 and H3K9me3 in human 
fetal germ cells may be associated with the suppression of the 
pluripotency-associated genes and the onset of germ cell 
differentiation and /or meiosis 
In Almstrup et al’s study, transcriptional repressive mark H3K9me2 was undetectable 
in human testicular germ cells between 21wga and 24wga (Almstrup et al., 2010). Due 
to lack of availability of samples, human fetal gonads from 20wga onwards were not 
investigated. In the present studies, the distribution of H3K9me2 was investigated in 
both human fetal ovary and testis across different gestations and showed a sex-specific 
distribution.  
A previous study in differentiating murine ESCs indicated that H3K9me2 contributed 
to the suppression of pluripotency-associated gene Pou5f1 (Feldman et al., 2006). In 
addition, another study in murine germ cells showed that G9a, a H3K9 mono- and 
dimethylatransferase, played an important role in meiotic prophase (Tachibana et al., 
2007). According to the previous findings and the observation of H3K9me2 here, the 
specific increase of H3K9me2 in the early 2nd trimester human ovarian germ cell may 
be associated with the suppression of the pluripotency-associated genes and the 
initiation of meiosis.  
In Bartkova et al’s study, the distribution of H3K9me3 was identified in human 
testicular germ cells, which displayed a very low level of H3K9me3 during 16-24wga 
(Bartkova et al., 2010). In the study here, the human testicular germ cells also 
displayed low levels of H3K9me3 at all examined stages. On the other hand, 
H3K9me3 was found to be restricted to the more mature ovarian germ cells.  
Previous study in mice showed that H3K9 trimethyltransferase Suv39h and its 
modified chromatin H3K9me3 are critical for germ cell meiosis (Peters et al., 2001). 
Double deletions of Suv39h1 and Suv39h2 in mice cause the absence of H3K9me3 and 
abnormal meiosis in both male and female (Peters et al., 2001). On the basis of the 
previous findings in mice and the observation here, the accumulation of H3K9me3 in 
mature human fetal ovarian germ cells may be associated with the onset of germ cell 
differentiation and /or meiosis in humans. 
3.3.5 The distribution of H3K9ac is different between Bouins and NBF fixed 
human fetal gonads at comparable gestations 
In Bouins fixed human fetal testes, levels of H3K9ac were reduced in testicular germ 
cells as they differentiated. The observations here were different from the findings in 
Almstrup et al’s study, in which most of the NBF fixed gonocytes were positive for 
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H3K9ac at later gestations (Almstrup et al., 2010). H3K9ac was also decreased in 
Bouins fixed human fetal ovarian germ cells with differentiation. During 2nd trimester, 
most of Bouins fixed human fetal ovarian germ cells were negative for H3K9ac; only 
the smaller, undifferentiated PGC-like cells displayed this histone mark. Contrarily, 
nearly all of the NBF fixed human fetal ovarian germ cells displayed H3K9ac-staining 
at these later gestational ages.  
When an immunostaining is performed, an ideal fixation can immobilize antigens and 
allow the antibodies to bind the antigens. The fixative is determined by the balance 
between morphological preservation and accessibility of antigen-antibody binding. 
Bouins was usually used for fetal gonads as it usually gave both good morphological 
and antigenicity preservation. NBF also gave good preservation of antigen, but usually 
had an inferior preservation of morphology. The different distributions of H3K9ac in 
Bouins and NBF fixed human fetal suggested that fixation may affect the cellular 
structure or accessibility of antigen-antibody binding. It cannot determine which 
fixation method gave accurate results for H3K9ac in human gonads on the basis of 
these studies. Thus, the results of H3K9ac here were unreliable and further 
investigation is required. 
The distribution of H3K9ac in human fetal germ cells can be further detected in future 
work. In further studies, human fetal gonads could be disaggregated into a single-cell 
suspension by mechanical and enzymatic dispersion (Childs et al., 2010; Coutts et al., 
2008). The cell suspension, which consists of both somatic and germ cells, can be 
fluorescently labeled with PGC marker OCT4 and mature germ cell marker VASA. 
The OCT4 or VASA-labeled human fetal germ cells can be sorted from the unlabeled 
somatic cells by Fluorescence-Activated Cell Sorting (FACS) (Mozdziak et al., 2005; 
Woods and Tilly, 2013). The isolated human fetal germ cells can be collected for 
protein extraction and western blotting can be performed to determine the levels of 
H3K9ac in these isolated fetal germ cells. These detections can be performed in 
human fetal gonads across different gestations, giving a further robust method for 
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Chapter4. Dynamic reprogramming of DNA methylation during 
human germ cell development  
4.1 Introduction 
DNA methylation is a heritable epigenetic mark which is associated with 
transcriptional silencing (Bird and Wolffe, 1999). In multicellular eukaryotes, DNA 
methylation takes place at the fifth carbon of the cytosine pyrimidine ring and its 
outcome is 5mC (Su et al., 2011). In mammals, DNA methylation has been found to 
play an essential role in numerous biological processes (Bird, 2002; Egger et al., 2004; 
Stringer et al., 2013). For sexual reproduction, mouse germ cells undergo dynamic 
changes of DNA methylation during development. (Borgel et al., 2010; Hajkova et al., 
2002; Maatouk et al., 2006b; Seisenberger et al., 2012; Shen et al., 2007; Weber et al., 
2007; Yamaguchi et al., 2013). At the early embryonic stage, PGC precursor cells 
display similar DNA methylation levels with the somatic epiblast cells. At this point, 
the pluripotency genes and CpG island-associated germline-specific genes are tightly 
repressed by DNA methylation in the PGC precursor cells (Borgel et al., 2010; 
Maatouk et al., 2006b; Seisenberger et al., 2012; Shen et al., 2007; Weber et al., 2007). 
In order to erase somatic cell fate, generate germ cell potency and activate key 
pluripotency markers, genome-wide DNA demethylation occurs in early mouse PGCs 
from E8.5 to E13.5 (Hajkova et al., 2002; Seisenberger et al., 2012; Yamaguchi et al., 
2013). During the process of DNA demethylation in mouse germ cells, passive DNA 
demethylation, which is DNA replication-dependent, are identified to be an essential 
mechanism (Kagiwada et al., 2013); meanwhile, TETs and 5hmC are also believed to 
be involved (Hackett et al., 2013; Yamaguchi et al., 2013). After sex determination, 
DNA methylation is re-established in mouse germ cells in a sex-specific pattern (Abe 
et al., 2011; Saitou and Yamaji, 2012; Sasaki and Matsui, 2008). In mouse testicular 
germ cells, levels of 5mC increase from E15.5 onwards (Abe et al., 2011; Kota and 
Feil, 2010). DNA de novo methylation in mouse testicular germ cells is completed at 
birth and then maintained throughout many cycles of mitotic divisions before the cells 
enter into meiosis (Davis et al., 2000). In contrast, DNA de novo methylation is not 
initiated until after birth in mouse ovarian germ cells, which are arrested in prophase 
of meiosis I (Abe et al., 2011; Kota and Feil, 2010).  
According to the observation in mouse germ cells, the human germ cells may also 
undergo genome wide reprogramming of DNA methylation to regain the underlying 
totipotency in PGCs and prepare for the subsequent germ cell-specific developmental 
process. Therefore, it is also important to understand the reprogramming processes of 
DNA methylation during human germ cell development. However, the studies about 
DNA methylation in human germ cells are very limited (Almstrup et al., 2010; 
Gkountela et al., 2013; Wermann et al., 2010). In order to establish a definitive 
timescale of DNA methylation reprogramming in human germ cells, more 
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investigations have been performed in the study here. The investigation of dynamic 
changes of 5mC has been expanded from 6wga to 37-years old human ovaries by 
immunohistochemistry and immunofluorescence. Meanwhile, TETs and 5hmC were 
also explored in human gonads across these different stages.  
4.2 Results 
4.2.1 Distinct distribution of 5mC and 5hmC in mouse ESCs 
5hmC is one of the oxidized derivatives of 5mC; the antibodies against 5mC and 
5hmC are easy to cross-reacting. In order to discriminate 5mC and 5hmC, the 
antibodies against 5mC and 5hmC were detected in the NBF fixed mouse ESCs before 
being performed in the human tissues (Fig 4.1). Different distributions of 5mC and 
5hmC have been observed in some mouse ESCs, in which the chromocenters are 
intense for 5mC but absent of 5hmC staining (Fig 4.1, white arrow). The different 
distribution of 5mC and 5hmC in mouse ESCs indicates that the 5mC antibody has no 
detectable cross-reactivity to 5hmC.  
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Figure4.1. Distribution of 5mC and 5hmC in NBF fixed mouse ESCs. A, The merged image 
for 5mC and 5hmC； B, 5mC； C, 5hmC; the staining of 5mC is shown in blue while the 
staining of 5hmC is shown in red. White arrows represent the mouse ESCs, in which the 
chromocenters were positive for 5mC but negative for 5hmC. The scale bars equal to 50µm in 
all panels. 
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4.2.2 Dynamic changes of 5mC in human fetal and adult ovaries 
As the limitation of taking early human embryo sample, only one 6wga human female 
embryo has been detected. At around 6wga in human, some of the migrating PGCs 
have reached the genital ridge and started to colonize the gonads (Francavilla et al., 
1990; Fujimoto et al., 1977) (Fig 4.2A). The H&E staining of this 6wga human female 
embryo is showed in Fig 4.2B, in which the dashed box indicates the region of genital 
ridges (Fig 4.2B).  
In this Bouins fixed 6wga human female embryo, double immunofluorescence was 
used to detect the distribution of 5mC (Fig 4.3). In order to label the PGCs, an 
anti-OCT4 antibody was used in this 6wga human embryo (Fig 4.3, Green). The 
inserted panel in Fig 4.3A shows the whole 6wga embryo, in which nearly all the cells 
are 5mC-positive (Fig 4.3A, inserted panel). Fig 4.3A is a higher resolution image, in 
which the migrating PGCs are clearly labeled by OCT4 antibody (Fig 4.3A, Green). 
Fig 4.3B is a much higher resolution image, in which nearly all OCT4-negative 
somatic cells were 5mC-positive at this 6wga human embryo (Fig 4.3B). Meanwhile, 
in this 6wga human embryo, the staining of 5mC was clearly observed in the 
OCT4-positive PGCs (Fig 4.3 B, Red). However, compared with the surrounding 
somatic cells, the 5mC staining in the PGCs is less intense, suggesting that DNA was 
hypomethylated in PGCs when compared to that in somatic cells at 6wga (Fig 4.3 B). 
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Figure 4.2 Schematic diagram and H&E staining of Bouins fixed 6wga human female 
embryo. A, A schematic diagram of 6wga human embryo showing the migrating PGCs and 
genital ridge. B, H&E staining of 6wga human female embryo. The head of this embryo had 
been removed for SRY detection. The dashed box represents the regions of genital ridge in the 
embryo. Panel A is reproduced from (Kousta et al., 2010) 
B 
A
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Figure 4.3 Distribution of 5mC in Bouins fixed 6wga human female embryo. A, low 
resolution image of the 6wga human embryo, the dashed box shows migrating PGCs in this 
6wga human embryo; the inserted image in A is the lower resolution image, which shows the 
staining of the whole embryo; B, a higher resolution image of the 6wga human embryo. The 
staining of OCT4 is shown in green, while the staining of 5mC is shown in red. White arrow 
represents the PGCs which were positive for both OCT4 and 5mC. The scale bars equal to 
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The distribution of 5mC was also detected in human post-migratory fetal and adult 
ovaries by DAB immunohistochemistry.   
Different from the 6wga human female PGCs, which was positive for 5mC staining, 
most of the human ovarian PGCs were 5mC-negative at 8wga (Fig 4.4 A, White 
arrow), even though a few of them displayed weak 5mC staining (Fig 4.4 A, Black 
arrow). From 14wga onwards, 5mC was below the level of detection at all stages of 
fetal ovarian germ cell development (Fig 4.4 B and C, White arrow). This observation 
implied that global deletion of 5mC has been initiated by 8wga and completely by 
early 2nd trimester in human fetal ovarian germ cells.  
The levels of 5mC in the human fetal ovarian somatic cells were relatively stable and 
displayed intense 5mC staining from 8 to 18wga (Fig 4.4 A-C, Black arrowhead). The 
negative control is shown in Fig 4.4 D.  
Figure 4.4 Distribution of 5mC in Bouins fixed human post-migratory fetal ovaries. A. 
8wga human fetal ovary; B, 14wga human fetal ovary; C, 18wga human fetal ovary; D, 
negative control; Black and white arrows represent 5mC-positive and negative germ cells, 
respectively. While black arrowheads represent 5mC-positive somatic cells. The scale bars 
equal to 20µm in all panels.  
 
Notably, 5mC was regained in human postnatal oocytes (Fig 4.5), although a few of 
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nucleolus were 5mC-positive (Fig 4.5 A, B and C), while some of them were 
5mC-negative (Fig 4.5 D and F). These findings indicated that DNA de novo 
methylation has been initiated in human ovarian germ cells after birth. 
The somatic cells in human postnatal ovaries are not all positive for 5mC. In human 
postnatal ovaries, most of the granulosa cells were 5mC-positive (Fig 4.5, Black 
arrowhead), while some of the mesenchymal somatic cells are clearly 5mC-negative 
(Fig 4.5, White arrowhead). 
Figure 4.5 Distribution of 5mC in NBF fixed human postnatal ovaries. A, C and E: primary 
follicles in 12~15-year old human ovaries; B, D and F: primary follicles in 31~37-year old 
human ovaries. Black and white arrowheads represent 5mC-positive and negative somatic 
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4.2.3 Dynamic changes of 5mC in human fetal testis 
In Bouins fixed human fetal testes, 5mC was undetectable in germ cells at both 8wga 
and 14wga (Fig 4.6 A and B, White arrow). At 18wga, most of the testicular germ cells 
remained 5mC-negative (Fig 4.6 C and D, White arrow). Meanwhile, some testicular 
germ cells stated to display 5mC staining at this stage (Fig 4.6 C and D, Black arrow). 
A similar distribution of 5mC was also observed in 19wga human testis (Fig 4.6 E). 
The negative control is shown in Fig 4.6 F.  
Figure 4.6 Distribution of 5mC in Bouins fixed human fetal testes. A, 8wga; B, 14wga; C 
and D, 18wga; E, 19wga; F, Negative control; Black and white arrows represent 5mC-positive 
and negative germ cells, respectively. While black arrowheads represent 5mC-positive somatic 
cells. The scale bars equal to 20µm in C panel，50µm in A,B,D,E and F panels.  
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4.2.4 Dynamic changes of 5hmC in human fetal and adult ovaries 
In Bouin fixed 6wga human fetamle embryo, 5hmC, the oxidized derivative of 5mC, 
was also detected by double immunofluorescence. In this 6wga human female embryo, 
PGCs were marked by OCT4 antibody (Fig 4.7, Green). High resolution images are 
shown in Fig 4.7 B. Most of the OCT4-positive human PGCs displayed 5hmC staining 
(Fig 4.7 B, White arrow). However, OCT4-positive and 5hmC-negative/weak PGCs 
were also detected in the 6wga human embryo (Fig 4.7 B, White arrowhead). Nearly 
all the OCT4-negative somatic cells were positive for 5hmC in this 6wga human 
embryo (Fig 4.7). 
The distribution of 5hmC was examined by DAB immunohistochemistry in both fetal 
and adult ovaries (Fig 4.8 and 4.9).  Most of the Bouin fixed human fetal ovarian 
germ cells did not displayed 5hmC staining from 8 to 18wga (Fig 4.8, A-C, White 
arrow), apart from very few ovarian germ cells which displayed weak 5mC staining at 
8wga (Fig 4.8 A, Black arrow). Interestingly, most of the oocytes in the NBF fixed 
human postnatal ovaries were 5hmC-positive (Fig 4.9). Some of the nucleolus in the 
5hmC-positive oocytes were 5hmC-positive (Fig 4.9, A and B), while some of them 
were 5mC-negative (Fig 4.9, B-D).  
The ovarian somatic cells displayed strong 5hmC staining throughout all the fetal 
gestations that we examined (Fig 4.8, Black arrowhead). Different from the human 
fetal ovaries, some ovarian somatic cells in human postnatal ovaries are 
5hmC-negative (Fig 4.9, White arrowhead). However, the granulosa cells in human 
postnatal ovaries were mostly 5hmC-positive (Fig 4.9, Black arrowhead).  
A negative control was shown in Fig 4.8D.  
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Figure 4.7 Distribution of 5hmC in Bouins fixed 6wga human female embryo. A, low 
resolution image of the 6wga human embryo; the dashed box shows the migrating PGCs in this 
6wga human embryo; the insert photo in A is the lower resolution image of A; B, high resolution 
images of the 6wga human embryo. White arrow represents PGC which were positive for both 
OCT4 and 5hmC, while the white arrowhead shows a PGC which was positive for OCT4 but 
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Figure 4.8 Distribution of 5hmC in Bouins fixed human fetal ovaries. A-C: human fetal 
ovaries from 8wga to 18wga; D, Negative control. Black and white arrows represent 
5hmC-positive and negative germ cells, respectively. While black arrowheads represent 
5hmC-positive somatic cells. The scale bars equal to 50µm in all panels. 
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Figure 4.9 Distribution of 5hmC in NBF fixed human postnatal ovaries (12~24-year old 
human ovaries). A, 12-year-old; B and C, 15-year-old; D, 24-year-old; the nucleuses of the 
oocytes were all 5hmC positive. Black and white arrowheads represent 5hmC-positive and 
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4.2.5 The distribution of 5hmC in human fetal testes 
In human fetal testes, the majority of testicular germ cells were 5hmC-negative from 
8-18wga (Fig 4.10 A, B and C, White arrow). However, a few strongly 5hmC-positive 
fetal testicular germ cells were observed throughout these gestations (Fig 4.10 A, B 
and C, Black arrow).  
The testicular somatic cells were 5hmC-positive at 8wga (Fig 4.10 A, Black 
arrowhead), however, from 14wga onwards, some Sertoli cells displayed only weak 
5hmC staining, whilst peritubular cells surrounding cords were intensely 
5hmC-positive (Fig 4.10 B and C). The negative control is shown in the Fig 4.10 D.   
Figure 4.10 Distribution of 5hmC in Bouins fixed human post-migratory fetal testes. 
Black and white arrows represent 5mC-positive and negative germ cells, respectively, while 
black and white arrowheads represent 5hmC-positive and negative somatic cells, respectively. 
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4.2.6 Global changes in TET1, 2 and 3 mRNA levels in human fetal gonads 
To determine the mRNA levels of TET1, 2 and 3 during human fetal ovarian and 
testicular development, QRT-PCR was performed for TET1, 2 and 3 across different 
gestations (Fig 4.11 and 4.12). Human fetal gonads were grouped into three 
gestational stages, 1st trimester (8-11wga), early 2nd trimester (13-16wga), and late 2nd 
trimester (17-20wga). Statistical analysis was performed using GraphPad Prism 5 
software (La Jolla, CA, USA).  
In human fetal ovaries, the mRNA levels of TET1, TET2 and TET3 all significantly 
decreased with increasing gestations (Fig 4.11, data were analyzed using one-way 
ANOVA analysis of variance with linear trend post-hoc test for statistical significance, 
P <0.05). In human fetal ovaries, the mRNA levels of TET1, TET2 and TET3 all 
significantly decreased in early and late 2nd trimester when compared to 1st trimester. 
There is no significant difference between early and late 2nd trimester for the 
expression of TET1, TET2 and TET3 in human fetal ovaries (Fig 4.11, data were 
analyzed using one-way ANOVA analysis of variance with Newman-Keuls Multiple 
Comparison post-test to determine significant changes between gestational values, 
P <0.05).  
In human fetal testes, the mRNA levels of TET1 and TET3 all fell significantly with 
increasing gestations. However, the mRNA level of TET2 did not significantly change 
across the examined gestations in fetal testes (Fig 4.12, data were analyzed using 
one-way ANOVA with linear trend post-hoc test for statistical significance, P <0.05). 
In human fetal testes, the expression of TET1 and TET3 all significantly decreased in 
early and late 2nd trimester when compared to 1st trimester. There is no significant 
difference between early and late 2nd trimester for the expression of TET1 and TET3 in 
human fetal testes (Fig 4.12, data were analyzed using one-way ANOVA with 
Newman-Keuls Multiple Comparison post-test to determine significant changes 
between gestational values, P <0.05).  
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Figure 4.11 mRNA levels of TET1, 2 and 3 in human fetal ovaries across different 
gestations. The expression of TET1, 2 and 3 was analyzed by QRT-PCR across different 
gestations and split into three age groups: 8-11wga, 13-16wga and 17-20wga. The sample 
number was between 4-6 ovaries from individual fetuses per gestational group. Error bars in 
histograms represent ±SEM.  In order to allow quantitative comparisons, the expression of 
TET1, 2 and 3 was normalized to that of the housekeeping gene B2M, which remained stable 
across gestation. Data were analyzed utilizing the One-way ANOVA with Newman-Keuls 
Multiple Comparison post-test to determine significant changes between gestational values. 
One-way ANOVA with linear trend post-test was also used to determine significant changes 
across gestations.  
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Figure 4.12 mRNA levels of TET1, 2 and 3 in human fetal teses across different 
gestations. The expression of TET1, 2 and 3 was analyzed by QRT-PCR across different 
gestations and split into three age groups: 8-11wga, 13-16wga and 17-20wga. The sample 
number was between 6-8 testes from individual fetuses per gestational group. Error bars in 
histograms represent ±SEM. In order to allow quantitative comparisons, the expression of 
TET1, 2 and 3 was normalized to that of the housekeeping gene B2M, which remained stable 
across gestation. Data were analyzed utilizing the One-way ANOVA with Newman-Keuls 
Multiple Comparison post-test to determine significant changes between gestational values. 






4.3.1 Global 5mC changes dynamically in human germ cells 
As elucidated earlier, it has been found that in the case of mouse PGCs they cause 
sequential epigenetic changes and genome-wide DNA demethylation to change the 
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epigenome for totipotency (Hajkova et al., 2002; Seisenberger et al., 2012; Yamaguchi 
et al., 2013). This provides one of the potential mechanistic bases to understand the 
global changes of 5mC in human germ cells (Hackett et al., 2013). 
In previous studies, by immunohistochemistry (Wermann et al., 2010) and 
immunofluorescence (Gkountela et al., 2013), 5mC was undetectable in the human 
fetal ovarian germ cells from 6 to 19wga; 5mC was also not detected even in human 
postnatal oocytes (Wermann et al., 2010). In Gkountela et al’s study, human testicular 
germ cells were also 5mC-negative from 6wga to 19wga (Gkountela et al., 2013).  
Similar to these previous reports, my investigation showed that nearly all of the human 
post-migratory ovarian and testicular germ cells were 5mC-negative. However in 
contrast to these previous reports, PGCs in a 6wga human female fetus did display 
5mC staining, postnatal human oocytes were shown to regain 5mC staining and fetal 
testicular germ cells also regained 5mC staining from 18 to 19wga (Fig 4.13). In 
previous studies, 5mC detection by immunohistochemistry (Wermann et al., 2010) and 
immunofluorescence (Gkountela et al., 2013) was performed without permeabilization 
and DNA denaturization. As 5mC is localized in the 5-position of DNA cytosine, it is 
difficult to detect with antibodies; permeabilization and DNA denaturization can 
improve binding affinity of the 5mC antibodies. The undetectable 5mC in 6wga 
human ovarian germ cells (Gkountela et al., 2013), postnatal oocytes (Wermann et al., 
2010) and later fetal testicular germ cells (Gkountela et al., 2013), may be associated 
with the absence of permeabilization and DNA denaturization during 5mC detection.  
The findings here on the global changes of 5mC in human germ cells were consistent 
with what has been reported in mouse germ cells (Abe et al., 2011; Hajkova et al., 
2010; Seki et al., 2005), suggesting that the reprogramming of global DNA 
methylation is conserved between human and mouse germ cells.  
The DNA of human PGCs appears to be methylated at 6wga. During this early stage, 
almost all the human PGCs are positive for the pluripotent marker OCT4 and negative 
for the post-migratory germ cell markers VASA and DAZL (Anderson et al., 2007). In 
the post-migratory human fetal ovarian and testicular germ cells, global DNA 
demethylation is initiated after germ cell migration in human. From 13wga, the 
expression of VASA significantly increased in both ovarian and testicular germ cells 
(Anderson et al., 2007). The genome-wide erasure of DNA methylation, which is 
associated with gene repression (Deaton and Bird, 2011; Meissner et al., 2008), may 
be associated with the upregulation of post-migratory germ cell markers in human 
post-migratory fetal germ cells. 
DNA de novo methylation was initiated asynchronously in human male and female 
germ cells. 5mC was detected again in the later fetal testicular germ cells but regained 
in the human oocytes after birth. After 11wga, the expression of the meiosis-associated 
gene DAZL was significantly increased in the human ovaries and some human oogonia 
start to enter into meiosis (Anderson et al., 2007; He et al., 2013). The expression of 
Dynamic Epigenetic Modifications during Human Fetal Germ Cell Development 




DAZL has been found to be activated by DNA demethylation in mammalian germ cells 
(Linher et al., 2009; Maatouk et al., 2006a). Human fetal ovarian germ cells 
maintained a demethylated state until birth, which may be associated with the further 
upregulation of DAZL and the meiotic process in human fetal ovarian germ cells. DNA 
remethylation was initiated in the later human fetal testicular germ cells, which 
undergo mitotic arrest rather than meiosis. In a word, the delay of DNA remethylation 
in human ovarian germ cells may be associated with the expression of meiotic genes 
in human fetal ovary. 
Figure 4.13 Dynamic changes of 5mC and 5hmC in human fetal germ cells from 6wga to 
20wga. Red bars represent the expression of 5mC or 5hmC in ovarian germ cells (GCs), while 
blue bars represent the expression of 5mC or 5hmC in testicular germ cells.  
4.3.2 Global 5hmC changes dynamically in human germ cells 
In the research that was undertaken here, it was found that the presence of 5hmC in the 
OCT4-positive PGCs at 6wga was consistent with previous findings, in which 5hmC 
was detectable in OCT4A-positive ovarian and testicular PGCs at 7wga (Gkountela et 
al., 2013). In later fetal gestations, 5hmC was undetectable in human fetal ovarian 
germ cells by immunohistochemistry, which is different from what was found in 
Gkountela et al’s study, in which 5hmC was detectable in the OCT4A-positive ovarian 
PGCs from 7-19wga by immunofluorescence (Gkountela et al., 2013). The lack of 
detection of 5hmC in here in post-migratory human fetal ovarian germ cells may be 
associated with the sensitivity of the immunohistochemistry used here.  In human 
fetal testes, 5hmC was also detectable in OCT4-positive testicular PGCs, which 
showed 5hmC staining at 8 and 17wga, but were negative for 5hmC at 13.5-16wga 
(Gkountela et al., 2013). But here, 5hmC was detectable in throughout all these 
gestations.  This may be because Gkountela et al. only used OCT4A to mark human 
fetal PGCs (Gkountela et al., 2013), however, in the later gestation, some mature germ 
cells are OCTA-negative, and whether they displayed 5hmC or not would not be 
detected in that study.  
5hmC is the oxidative derivative of 5mC, and the generation of 5hmC depends on the 
pre-existence of 5mC. This conversion is initiated by the TET1 protein (Ito et al., 
2011). It was observed that both 5mC and 5hmC were present in human 6wga female 
PGCs. From 8 to 18wga, both 5mC and 5hmC were erased in human fetal ovarian 
germ cells. In these stages, the female germ cells show low methyalted and low 
Dynamic Epigenetic Modifications during Human Fetal Germ Cell Development 




hydroxymethylated levels, suggesting that 5hmC may be further processed to 5fC or 
5caC, or even unmodified cytosine in these post-migratory fetal ovarian germ cells. 
The loss of 5hmC appeared rapid in human post-migratory fetal ovarian germ cells. 
Postnatal human oocytes, which regained 5mC, also displayed 5hmC staining. 
Post-migratory human testicular germ cells displayed low DNA methylated levels by 
18wga. However, some testicular germ cells still displayed intense 5hmC staining 
throughout these gestations, indicating that the excision of 5hmC in human fetal 
testicular germ cells was slower or less complete than in ovarian germ cells. At later 
gestations, both 5mC and 5hmC were detectable in some testicular germ cells. 
From the findings above, the existence of 5mC and 5hmC in human germ cells were 
synchronous rather than alternate, the presence or the erasure of 5hmC followed 
closely that of 5mC. All these findings suggest that rather than playing an important 
role in DNA demethylation, 5hmC may play other unknown role in human fetal germ 
cell development, which need further investigation.  
4.3.3 Global changes of TETs in human fetal gonads 
In Gkountela et al’s study, TET1, 2 and 3 were expressed in C-KIT-positive human 
PGCs at 16-16.5wga by RNA-Sequencing (Gkountela et al., 2013). In the study here 
detected by qPCR, TET1, 2 and 3 were also expressed in the human fetal gonads 
across different gestations, including 16-16.5wga.  
In human fetal ovaries, the mRNA levels of TET1, TET2 and TET3 all significantly 
decreased with increasing gestations. Compared to the ovaries in 1st trimester, the 
mRNA levels of these three TETs all significantly decreased in early and late 2nd 
trimester. During these stages, the decrease in TETs may be associated with the global 
loss of 5hmC in human fetal ovarian germ cells, which were negative for 5hmC at 
these stages. Tet1 has been found to be involved in the mouse meiosis, as deficiency in 
Tet1 led to loss of meiotic genes in mouse ovarian germ cells (Yamaguchi et al., 2012). 
The decrease of TET1 in human fetal ovaries was coincident with the initiation of 
meiosis. However, whether the decrease of TET1 was restrict to the ovarian germ cells 
or not was unknown. So the relationship of TET1 and meiosis in ovarian germ cells 
still need further investigation.   
In human fetal testes, the mRNA levels of TET1 and TET3 all significantly decreased 
with increasing gestations. Compared to the testes in 1st trimester, the mRNA levels of 
TET1 and TET3 all significantly decreased in early and late 2nd trimester. During these 
stages, the decrease in TET1 and TET3 may be associated with the global loss of 
5hmC in human fetal testicular germ cells, most of which were negative for 5hmC at 
these stages. Notably, the mRNA level of TET2 did not change across gestation in 
human fetal testes, suggesting that TET2 may play a less important role in the human 
fetal testes.  
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Chapter5.  The impact of chemical DNA demethylation in the 
expression of germ cell-specific genes and meiotic genes in human 
5.1 Introduction 
Germ cells have a unique ability to undergo meiosis, which generates haploid gametes. 
In mammals, the timing of meiotic entry is different between male and female germ 
cells. The mouse ovarian germ cells enter into meiotic prophase I prenatally, while the 
testicular germ cells do not enter into meiosis until puberty (Hilscher et al., 1974; 
McLaren and Southee, 1997). The extrinsic signaling molecule RA, derived from the 
adjacent mesonephros, is critically required for meiotic initiation in the developing 
mouse fetal ovary (Anderson et al., 2008; Bowles et al., 2006; Koubova et al., 2006). 
In addition to extrinsic signals, Dazl has been identified as an intrinsic factor for germ 
cells to acquire the competence to respond to RA signals (Lin et al., 2008; Lin and 
Page, 2005; Seligman and Page, 1998). However, in the mouse fetal testis, RA is 
degraded by Cyp26b1 and the mouse fetal testicular germ cells enter mitotic arrest for 
the remaining embryonic period (Bowles et al., 2006; Koubova et al., 2006; Menke 
and Page, 2002; Western et al., 2008).  
In the human fetal ovary, at around 11wga, some central localized oogonia start to 
enter into meiotic prophase I while the fetal testicular germ cells undergo mitotic 
arrest (Gondos et al., 1986; Le Bouffant et al., 2010). Gonad-derived RA has been 
found to contribute to the initiation of meiosis in the human fetal ovarian germ cell 
(Childs et al., 2011; Le Bouffant et al., 2010). The RA-responsive gene, STRA8, is 
significantly increased in human fetal ovaries at around the onset of meiosis; on the 
other hand, STRA8 is present in a very low level across all gestations in human fetal 
testes (Childs et al., 2011; Le Bouffant et al., 2010). From 2nd trimester, the expression 
of DAZL was increased in human fetal ovaries and DAZL protein was trans-located 
from the nucleus to the cytoplasm in pre-meiotic human fetal oogonias (Anderson et 
al., 2007). Low expression of DAZL was detected in human fetal testes across all 
gestations (Anderson et al., 2007). 
The observations above indicate that RA is required for germ cells meiosis in both 
mice and human. During mouse embryo development, RA is distributed widely in 
many embryonic tissues (Mark et al., 2009), however, only germ cells respond to RA 
by entering meiosis. This leads to the question as to what makes germ cells become 
competent to upregulate Stra8 and enter into meiosis in response to RA. Some 
particular epigenetic mechanisms have been suggested that may be associated with 
germ cell meiotic competence to respond to RA (Bowles and Koopman, 2010).  
Global DNA demethylation is initiated in migrating mice PGCs, and completed by 
E13.5, after which PGCs enter meiosis in females and mitotic arrest in males (Hackett 
et al., 2012; Hajkova et al., 2002; Seki et al., 2005). At around the onset of meiosis, 
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global methylation levels are significantly lower in female germ cells than in male 
(Popp et al., 2010). DNA demethylation loosens the chromatin conformation and 
increases chromatin accessibility, and may be associated with the establishment of 
meiotic competence in mice fetal germ cells (Popp et al., 2010). During mouse fetal 
germ cell development, DNA demethylation has been found to regulate the temporal 
expression of germ cell-specific genes and meiotic genes (Maatouk et al., 2006a). 
Even though global DNA demethylation has occurred in mouse fetal germ cells upon 
entry into the gonad, postmigratory germ cell-specific genes and meiotic genes, such 
as Mvh, Dazl and Sycp3, remained DNA methylated (Maatouk et al., 2006a). In the 
later gestation, the promoters of these genes undergo DNA demethylation and these 
genes become highly expressed. The delayed DNA demethylation in these genes may 
be associated with the appropriate activation timing for these genes (Maatouk et al., 
2006a). In the Dnmt1 deficient mice embryos, in which global genomic DNA 
methylation is lost, the expression of Mvh, Dazl and Sycp3 increases much earlier than 
normal, indicating that the activation timing of these genes is controlled by DNA 
methylation (Maatouk et al., 2006a). Thus, although RA is a key regulator of meiosis, 
the appropriate DNA methylation status in the developing germ cells is also essential 
for the meiosis initiation and early progression of meiosis. 
According to the studies described in chapter 4, postmigratory human fetal germ cells 
all undergo global DNA demethylation. This leads to a question as to whether DNA 
demethylation also regulates the expression of postmigratory germ cell-specific genes 
and meiotic genes in human. In order to answer this question, TCam-2 cells, an 
in-vitro PGC model, were chemically demethylated by 5-azacytidine, which prevents 
further DNA methylation in living cells by forming a covalent adduct with DNA 
methyltransferases (Jones and Taylor, 1980). After that, the expression of 
postmigratory germ cell-specific genes and meiotic genes was quantified in the DNA 
demethylated TCam-2 cells. In order to further identify whether DNA demethylation is 
associated with the RA responsiveness in human fetal germ cells, chemical DNA 
demethylated TCam-2 cells were further treated with RA and the expression of meiotic 
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5.2.1 The expression of postmigratory germ cell-specific genes and meiotic 
genes in chemical DNA demethylated TCam-2 cells  
In order to detect whether DNA demethylation regulates the expression of 
postmigratory germ cell-specific genes and meiotic genes in human, TCam-2 cells 
were used as an in-vitro PGC model. Chemical DNA demethylation in TCam-2 cells 
was performed by treatment with different doses of 5-azacytidine for 5 days; 
meanwhile, control TCam-2 cells were incubated with DMSO respectively. 
After 5µM of 5-azacytidine treatment for 5 days, the morphology of the TCam-2 cells 
appeared normal and the number of floating cells was similar to the control TCam-2 
cells (Fig 5.1 A-D), suggesting that 5µM of 5-azacytidine is below the toxic dosage for 
TCam-2 cells.  
The levels of 5mC were investigated in TCam-2 cells as a test of the effect of 
treatment. The control TCam-2 cells, incubated with DMSO, displayed high levels of 
5mC (Fig 5.1E). However, after the treatment with 5µM of 5-azacytidine for 5 days, 
5mC was barely detectable in the TCam-2 cells (Fig 5.1F), indicating that most of the 
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Figure5.1. Live photos and the staining of 5mC in TCam-2 cells, which were cultured 
respectively with DMSO and 5-azacytidine for 5 days. A and B, the live photos of TCam-2 
cells cultured respectively with DMSO and 5-azacytidine on Day01; C and D, the live photos of 
TCam-2 cells cultured respectively with DMSO and 5-azacytidine on Day05; E and F, the 
staining of 5mC in the TCam-2 cells cultured respectively with DMSO and 5-azacytidine for 5 
days. The staining of 5mC is shown in green; the PI nuclear counterstaining is shown in red. 
The scale bars equal to 200µm in A, B, C and D panels; 20µm in E and F panels. 
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After cultured with different dosages of 5-azacytidine, DAZL, a germ cell-intrinsic 
meiotic competence factor, was detected in TCam-2 cells (Fig 5.2).  
The mRNA levels of DAZL in TCam-2 cells were detected by qRT-PCR. In the control 
TCam-2 cells, which were incubated with DMSO for 5days, the mRNA of DAZL was 
below the detectable levels. However, after chemical DNA demethylation by 
5-azacytidine, the mRNA levels of DAZL increased significantly in the 5-azacytidin  
(doses of 2μM，3μM, 4μM and 5μM ) treated TCam-2 cells, when compared to the 
control TCam-2 cells (Fig 5.2A, data were analyzed using Paired T-test to determine 
significant changes between control cells and the 5-azacytidine treated cells, all the 
results were compared with the 0μM TCam-2 cells, P <0.05).  Interestingly, the 
mRNA levels of DAZL significantly increased with the increasing dose of 
5-azacytidine in TCam-2 cells (Fig 5.2A, data were analyzed using one-way ANOVA 
with linear trend post-test to determine significant changes in TCam-2 cells across 
different dosages of 5-azacytidine treatment, P <0.05). 
Detecting by Western Blot, the expression of DAZL proteins were undetectable in the 
control TCam-2 cells. However, after the treatment by 3μM, 4μM and 5μM 
5-azacytidine, respectively, the expression of DAZL proteins became detectable in the 
chemical DNA demethylated TCam-2 cells (Fig 5.2 B). Among these DNA 
demethylated TCam-2 cells, which were incubated with different doses of 
5-azacytidine, the 5μM treated TCam-2 cells expressed the highest level of DAZL 
proteins (Fig 5.2 B).  
From the results above, the mRNA and protein levels of DAZL were increased in a 
dose response pattern in the 5-azacytidine treated TCam-2 cells, and the most effective 
dosage for TCam-2 cells is 5µM (Fig 5.2). 
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Figure5.2. mRNA and protein levels of DAZL in TCam-2 cells treated with different doses 
of 5-azacytidine for 5 days. A. The mRNA levels of DAZL in TCam-2 cells were detected by 
qRT-PCR. Error bars in histograms represent ±SEM. The expression of DAZL was normalized 
to that of the housekeeping gene B2M, which remained stable between treatments. Data were 
analyzed using Paired T-test to determine significant changes between control cells and the 
5-azacytidine treated cells; all the results were compared with the 0μM TCam-2 cells. Data 
were also analyzed using one-way ANOVA with linear trend post-test to determine significant 
changes in TCam-2 cells across different dosage of 5-azacytidine treatments. The expression 
of DAZL was increased in a dose response pattern; the maximum increase was observed in 
the TCam-2 cells treated with 5µM of 5-azacytidine. n=3; * P ≤ 0.05; ** P ≤ 0.01; *** P ≤ 0.001. 
B. By Western Blot, the DAZL proteins were undetectable in the control TCam-2 cells, the 1μM 
and 2μM 5-azacytidine treated TCam-2 cells; and became detectable in the TCam-2 cells 
treated with 3µM, 4µM and 5µM of 5-azacytidine; the 5µM treated TCam-2 cells expressed the 
highest level of DAZL protein.  
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In control TCam-2 cells, the expression of postmigratory germ cell-specific genes and 
meiotic genes, STRA8, VASA, SYCP3, SYCP1 and BOLL; were present in a low level 
or barely detectable (Fig 5.3). However, after chemical DNA demethylation by 
5-azacytidine, the mRNA levels of STRA8, VASA, SYCP3 and BOLL increased 
significantly in the 5-azacytidin (2μM，3μM, 4μM and 5μM ) treated TCam-2 cells, 
when compared to the control TCam-2 cells (Fig 5.3A, B, C and E, data were analyzed 
using Paired T-test to determine significant changes between control cells and the 
5-azacytidine treated cells, all the results were compared with the 0μM TCam-2 cells, 
P <0.05). Similar to DAZL, the expression of STRA8, VASA, SYCP3 and BOLL were 
increased in a dose response pattern in the 5-azacytidine treated TCam-2 cells (Fig 
5.3A, B, C and E). After treated with different dosages of 5-azacytidine, the expression 
of STRA8, VASA, SYCP3 and BOLL were significantly upregulated with the increasing 
dose of 5-azacytidine in TCam-2 cells (Fig 5.3A, B, C and E, data were analyzed 
using one-way ANOVA with linear trend post-test to determine significant changes in 
TCam-2 cells across different dosage of 5-azacytidine treatment, P <0.05). The 
expression of SYCP1 only increased significantly after treated with 4μM 5-azacytidine 
and did not change significantly in a dose pattern in TCam-2 cells (Fig5.3 D).  
The results above indicated that the expression of postmigratory germ cell-specific 
genes and meiotic genes DAZL, STRA8, VASA, SYCP3 and BOLL were all upregulated 
by DNA demethylated agent 5-azacytidine in TCam-2 cells (Fig 5.2 and Fig 5.3). 
 
Dynamic Epigenetic Modifications during Human Fetal Germ Cell Development 





Figure 5.3 mRNA levels of postmigratory germ cell-specific genes and meiotic genes in 
the TCam-2 cells treated with different doses of 5-azacytidine for 5 days. A, STRA8; B, 
VASA; C, SYCP3; D, SYCP1; E, BOLL; mRNA levels of these genes were detected by 
qRT-PCR in TCam-2 cells. Error bars in histograms represent ±SEM. The expressions of these 
genes were normalized to that of the housekeeping gene B2M. Data were analyzed using 
Paired T-test to determine significant changes between control cells and the 5-azacytidine 
treated cells; all the results were compared with the 0μM TCam-2 cells. Data were also 
analyzed using one-way ANOVA with linear trend post-test to determine significant changes in 
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TCam-2 cells across different dosage of 5-azacytidine treatments. The expressions of STRA8, 
VASA, SYCP3 and BOLL were increased in a dose response pattern. 
 
Nevertheless, the data above leads to the question whether Chemical DNA 
demethylation in TCam-2 cells increases the expression of all the genes or just 
upregulates some specific genes. In order to answer this question, other types of genes 
were also investigated in the 5-azacytidine treated TCam-2 cells. The 
pluripotency-associated genes OCT4 and NANOG (Fig5.4 A and B) and epigenetic 
genes TET1, 2 and 3 (Fig5.4 C, D and E) were detected in TCam-2 cells. In TCam-2 
cells, the mRNA of these genes was present in a high level. After treated with 
5-azacytidine, the expression of these genes did not significantly change (Fig5.4). The 
human AFP (Alpha-fetoprotein) gene, which encodes a major plasma protein produced 
by the yolk sac and liver during fetal development (Mizejewski, 2001), was also 
detected (Fig5.4 F). As a positive control, high levels of AFP were detected in the 
human fetal liver; however, AFP remained undetectable in the TCam-2 cells no matter 
treated with or without 5-azacytidine (Fig5.4 F).  
The findings above indicated that chemical DNA demethylation by 5-azacytidine 
specifically increased the expression of postmigratory germ cell-specific genes and 
meiotic genes in TCam-2 cells rather than increasing the expression of all genes. 
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Figure 5.4 mRNA levels of OCT4, NANOG, TET1, TET2, TET3 and AFP in the TCam-2 
cells treated with different doses of 5-azacytidine for 5 days. A,OCT4; B,NANOG; C,TET1; 
D,TET2 ; E,TET3; F, AFP; mRNA levels of these genes were detected by qRT-PCR in TCam-2 
cells. Error bars in histograms represent ±SEM. The expressions of these genes were 
normalized to that of the housekeeping gene B2M. The expression of OCT4, NANOG, TET1, 
TET2 and TET3 did not significant change in TCam-2 cells after 5-azacytidine treatment. AFP 
was present in a high level in the human fetal liver, but was undetectable in the TCam-2 cells 
even after 5-azacytidine treatment. 
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5.2.2 The correlation between chemical DNA demethylation and RA 
responsiveness in TCam-2 cells  
According to the results above, 5-azacytidine specifically increased the expression of 
postmigratory germ cell-specific genes and meiotic genes in TCam-2 cells. However, 
whether chemical DNA demethylation associated with RA responsiveness and further 
upregulated the expression of meiotic genes in human fetal germ cells was still 
unknown.  
In order to investigate this, further RA treatment was performed in the chemical DNA 
demethylated TCam-2 cells. The control TCam-2 cells were incubated with DMSO for 
3 days firstly; afterwards, all these control TCam-2 cells were treated with different 
doses of RA (0, 0.1 and 1nM) for 2 days. Meanwhile, the treated TCam-2 cells were 
incubated with 5µM of 5-azacytidine for 3days to erase the methylated DNA; 
afterwards, all these DNA demethylated TCam-2 cells were treated with different 
doses of RA (0, 0.1 and 1nM) for 2 days. After all the incubations, the live photos on 
Day05 showed that the morphology of all the TCam-2 cells, including the control and 
treated TCam-2 cells, appeared normal; and the number of floating dead cells was 
similar between the control and treated TCam-2 cells (Fig 5.5), indicating that RA 
treatment used in these studies was below the toxic dosage for the TCam-2 cells.  
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Figure 5.5 Live photos of the control and DNA demethylated TCam-2 cells, which were 
treated with different doses of RA for 2days. A, C and E, the live photos of TCam-2 cells 
which were incubated with DMSO for 3 days and then with 0, 0.1 and 1nM of RA for 2days; B, 
D and F, the live photos of TCam-2 cells which were cultured with 5-azacytidine for 3 days and 





A 0nM RA B 0nM RA 
D 0.1nM RA 0.1nM RA C
F 1nM RA 1nM RA E
DMSO  5µM 5-azacytidine 
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After RA treatment, the mRNA levels of germ cell-specific genes and meiotic genes 
DAZL, VASA, STRA8, SYCP3, SYCP1, DMC1 and BOLL were all detected in the 
control and DNA demethylated TCam-2 cells (Fig 5.6 and Fig 5.7). The mRNA levels 
of these genes were detected by qRT-PCR in TCam-2 cells. The expressions of these 
genes were normalized to that of the housekeeping gene B2M. 
In the control TCam-2 cells, RA treatment did not significantly change the expression 
of these germ cell-specific genes and meiotic genes (Fig 5.6, data were analyzed using 
Paired T-test to determine significant changes between the TCam-2 cells treated with 
and without RA, all the results were compared to the 0nM RA TCam-2 cells).  
In the DNA demethylated TCam-2 cells, which were cultured with 5-azacytidine 
firstly, RA treatment significantly increased the mRNA levels of pre-meiotic gene 
STRA8 and further increased its putative targets SYCP3 and VASA. However, other 
germ cell-specific genes and meiotic genes, such as DAZL, SYCP1, DMC1 and BOLL, 
did not significantly change after different doses of RA treatment (Fig 5.7, data were 
analyzed using Paired T-test to determine significant changes between the TCam-2 
cells treated with and without RA, all the results were compared to the 0nM RA 
TCam-2 cells).  
Among the DNA demethylated TCam-2 cells, the cells treated with 0.1nM RA all 
significantly increased the expression of VASA, STRA8 and SYCP3; however, the cells 
treated with 1nM RA only significantly increased the expression of VASA and STRA8, 
but not SYCP3 (Fig 5.7 B, C and D). These results suggested that 0.1nM RA was a 
more effective dose for the treatment in TCam-2 cells.  
Intriguingly, the expression of RAR-β significantly increased after RA treatment in 
both of the DMSO and 5-azacytidine treated TCam-2 cells (Fig 5.6 H and Fig 5.7 H), 
suggesting that all these cells were receiving and transducing RA signals.  
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Figure 5.6 mRNA levels of DAZL, VASA, STRA8, SYCP3, SYCP1, DMC1, BOLL and 
RAR-β in the control TCam-2 cells, which were cultured with DMSO firstly and then 
treated with different doses of RA for 2 days. A, DAZL; B, VASA; C, STRA8; D, SYCP3; E, 
SYCP1; F, DMC1; G, BOLL; H, RAR-β; error bars in histograms represent ±SEM. Data were 
analyzed using Paired T-test to determine significant changes between the cells treated with 
and without RA; all the results were compared with the 0nM RA TCam-2 cells.  
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Figure 5.7 mRNA levels of DAZL, VASA, STRA8, SYCP3, SYCP1, DMC1, BOLL and 
RAR-β in the DNA demethylated TCam-2 cells, which were cultured with 5-azacytidine 
firstly and then treated with different doses of RA for 2 days. A, DAZL; B, VASA; C, 
STRA8; D, SYCP3; E, SYCP1; F, DMC1; G, BOLL; H, RAR-β; error bars in histograms 
represent ±SEM. Data were analyzed using Paired T-test to determine significant changes 
between the cells treated with and without RA; all the results were compared with the 0nM RA 
TCam-2 cells.  
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The expression of DAZL and SYCP3 proteins were also detected in the control and 
chemical DNA demethylated TCam-2 cells, which were treated with different doses of 
RA afterwards (Fig 5.8 and 5.9).  
In the control TCam-2 cells, which were incubated with DMSO firstly, DAZL protein 
was undetectable even after RA treatment (Fig 5.8 A, C and E). However, the DAZL 
protein was detectable in the DNA demethylated TCam-2 cells, indicating that DNA 
demethylation is required for the expression of DAZL in the TCam-2 cells (Fig 5.8 B, 
D and F). In the DNA demethylated TCam-2 cells, which were treated with 0nM RA 
afterwards, most of the DAZL staining was restricted to the nucleus of the cells (Fig 
5.8 B). However, in the DNA demethylated TCam-2 cells, which were treated with 
0.1nM and 1nM RA afterwards, most of the DAZL staining was restricted to the 
cytoplasm of the cells (Fig 5.8 D and F). 
The expression of SYCP3 was detectable in the control and DNA demethylated 
TCam-2 cells treated with or without RA (Fig 5.9). In the control TCam-2 cells, which 
were incubated with DMSO firstly, most of the SYCP3 staining was localized in the 
cytoplasm (Fig 5.9 A, C and E). However, in the DNA demethylated TCam-2 cells, 
treated with or without RA treatment, most of the SYCP3 staining were localized in 
both nucleus and cytoplasm (Fig 5.9 B, D and F).  
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Figure 5.8. Distribution of DAZL in the control and DNA demethylated TCam-2 cells, 
which were treated with different doses of RA afterwards. The staining of DAZL is shown in 
green; the PI nuclear counterstaining is shown in red. The scale bars equal to 50µm in A, B, C, 
D，E and F panels. 
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Figure 5.9. Distribution of SYCP3 in the control and DNA demethylated TCam-2 cells, 
which were treated with different doses of RA afterwards. The staining of SYCP3 is shown 
in green; the PI nuclear counterstaining is shown in red. The scale bars equal to 50µm in A, B, 
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5.2.3 mStra8 transfection in TCam-2 cells 
The results above indicate that the pre-meiotic gene STRA8 did not respond to RA and 
the expression of meiotic genes was not upregulated in the TCam-2 cells without 
chemical DNA demethylation; however, STRA8 and its putative targets SYCP3 and 
VASA were further increased by RA in the TCam-2 cells with chemical DNA 
demethylation. This leads to a question that whether the further upregulation of SYCP3 
and VASA was affected by the increasing STRA8 or directly by RA in the DNA 
demethylated TCam-2 cells.  
In order to identify this, stra8 vector was transfected into TCam-2 cells, and then the 
expression of its putative targets SYCP3 and VASA, and other meiotic genes were 
detected. The previous research by Miyamoto (Miyamoto et al., 2002) compared the 
amino acid sequences between human STRA8 and mouse Stra8 and identified that 
human STRA8 protein has some homology to mouse stra8 (55% identity overall). As 
there is lacking of human STRA8 vector, and the homology between human STRA8 
and mouse Stra8 is 55%, a mouse pEGFP-C1-Stra8 vector was transfected into 
TCam-2 for 3 days. 
In the control TCam-2 cells, which were transfected with an empty vector 
(pCMV6-Entry), mStra8 was not detectable. However, in the TCam-2 cells, which 
were transfected with mouse Stra8 vector (pEGFP-C1-Stra8), mStra8 was highly 
expressed (Fig 5.10 A, data were analyzed using Paired T-test to determine significant 
changes between the control and mStra8 transfected TCam-2 cells, all the results were 
compared to the pCMV6-Entry transfected TCam-2 cells). The live photos taken by 
fluorescent microscopy showed that mStra8 protein was present both in the nucleus 
and cytoplasm of pEGFP-C1-Stra8 transfected TCam-2 cells (Fig 5.10 B), suggesting 
that mStra8 has been transfected into TCam-2 cells successfully.  
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Figure 5.10 TCam-2 cells transfected with pCMV6-Entry and mouse pEGFP-C1-Stra8 
vectors for 3days. A, the mRNA levels of mStra8 in TCam-2 cells after pCMV6-Entry and 
mouse pEGFP-C1-Stra8 vectors transfection; error bars in histograms represent ±SEM; the 
expressions of mstra8 were normalized to that of the housekeeping gene B2M; B, live photos 
of the transfected TCam-2 cells detected by the fluorescent microscopy. 
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The expression of meiotic and pluripotency-associated genes was detected in the 
control and mouse pEGFP-C1-Stra8 transfected TCam-2 cells by QRT-PCR. 
Compared with the control TCam-2 cells, expression of SYCP3 and DAZL were 
significantly increased after mStra8 transfection, however, the mRNA levels of SYCP1, 
DMC1, VASA and OCT4 did not significantly change (Fig 5.11, data were analyzed 
using Paired T-test to determine significant changes between the control and mStra8 
transfected TCam-2 cells, all the results were compared to the pCMV6-Entry 
transfected TCam-2 cells). The results above indicated that mouse stra8, which has 55% 
homology of human STRA8, can upregulated the expression of STRA8’s putative 
targets SYCP3 and DAZL, but cannot increase all the meiotic genes. 
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Figure 5.11 expression of meiotic and pluripotency-associated genes in the TCam-2 
cells after pCMV6-Entry and mouse pEGFP-C1-Stra8 transfection. A, SYCP3; B, SYCP1; 
C, DAZL; D, DMC1; E, VASA; and F, OCT4; error bars in histograms represent ±SEM; the 
expressions of these genes were normalized to that of the housekeeping gene B2M; data were 
analyzed using Paired T-test to determine significant changes between the control and mStra8 
transfected TCam-2 cells, all the results were compared to the pCMV6-Entry transfected 
TCam-2 cells 
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5.2.4 The expression of postmigratory germ cell-specific genes and meiotic 
genes in the DNA demethylated human fetal gonads 
The in-vitro studies mentioned above showed that chemical DNA demethylation 
specifically increased the expression of postmigratory germ cell-specific genes and 
meiotic genes in TCam-2 cells. However, whether chemical DNA demethylation 
regulates the expression of these genes in human fetal gonads or not was unknown. In 
order to answer this question, human fetal gonads were incubated in 5µM of 
5-azacytidine for 4 days.  
The mRNA levels of DAZL, STRA8, SYCP3, SYCP1, DMC1, VASA and OCT4 were 
detected in the human 1st trimester fetal ovaries by QRT-PCR. During the 1st trimester, 
the expression of postmigratory germ cell-specific genes and meiotic genes was 
present at very low levels in the control ovaries, which were incubated with DMSO. 
Compared with the control 1st trimester ovaries, the mRNA levels of DAZL, SYCP3 
and VASA were all significantly increased in the 5-azacytidine treated 1st trimester 
ovaries (Fig 5.12, data were analyzed using Paired T-test to determine significant 
changes between the control and 5-azacytidine treated human 1st trimester fetal ovaries, 
all the results were compared to the DMSO incubated ovaries). However, in the human 
2nd trimester ovaries, in which some germ cells have already entered into meiosis, the 
expression of these genes were already in high levels. After being treated with 
5-azacytidine, the expression of these genes did not significantly change in the human 
2nd trimester ovaries (Fig 5.13). All these results suggested that the expression of 
DAZL, SYCP3 and VASA were all repressed by DNA methylation in 1st trimester 
human fetal ovaries. Surprisingly, the pluripotency-associated gene OCT4, which was 
already present in a high level in human 1st trimester fetal ovaries, was also further 
upregulated by chemical DNA demethylation (Fig 5.12 G). However, during 2nd 
trimester, expression of OCT4, which has already decreased in human fetal ovaries, 
was not affected by DNA demethylation (Fig 5.13 G).  
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Figure 5.12. mRNA levels of postmigratory germ cell-specific genes, meiotic genes and 
pluripotent gene in human 1st trimester ovaries (9-10wga), which were incubated with 
DMSO and 5µM of 5-azacytidine, respectively, for 4 days. A, DAZL; B, STRA8; C, SYCP3; 
D, SYCP1; E, DMC1; F, VASA and G, OCT4; error bars in histograms represent ±SEM; the 
expressions of these genes were normalized to that of the housekeeping gene B2M  
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Figure 5.13. mRNA levels of postmigratory germ cell-specific genes, meiotic genes and 
pluripotent gene in human 2nd trimester ovaries (13-15wga), which were incubated with 
DMSO and 5µM of 5-azacytidine, respectively, for 4 days. A, DAZL; B, STRA8; C, SYCP3; 
D, SYCP1; E, DMC1; F, VASA and G, OCT4; error bars in histograms represent ±SEM; the 
expressions of these genes were normalized to that of the housekeeping gene B2M 
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After incubated in 5µM of 5-azacytidine for 4 days, the mRNA levels of DAZL, 
STRA8, SYCP3, SYCP1, DMC1, VASA and OCT4 were also detected in the human 1st 
trimester fetal testes by QRT-PCR (Fig 5.14).  
During the 1st trimester, the expression of postmigratory germ cell-specific genes and 
meiotic genes was present at very low levels in the control testes, which were 
incubated with DMSO. After being treated with 5-azacytidine, the mRNA levels of 
DAZL and SYCP3 were significantly increased in the 1st trimester testes (Fig 5.14, data 
were analyzed using Paired T-test to determine significant changes between the control 
and 5-azacytidine treated human 1st trimester fetal testes, all the results were compared 
to the DMSO incubated testes).  
The expression of DAZL and SYCP3 proteins were detected in the DMSO and 
5-azacytidine treated 9wga human fetal testis (Fig 5.15). The staining of DAZL 
protein was detected in the germ cell nucleus of control testis, which was incubated 
with DMSO for 4days (Fig 5.15 A). In the 5-azacytidine treated 9wga human fetal 
testis, the staining of DAZL became much stronger, and most of the DAZL staining 
remained restricted to the germ cell nucleus (Fig 5.15 B), suggesting that DNA 
demethylation increased the expression DAZL but did not change the distribution of 
DAZL in the 9wga human fetal testis. However, SYCP3 was undetectable in the 9wga 
human fetal testis no matter with or without 5-azacytidine treatments (Fig 5.15 C and 
D), suggesting that the expression of meiotic protein SYCP3 was not activated by 
DNA demethylation in the 9wga human fetal testis.  
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Figure 5.14. mRNA levels of postmigratory germ cell-specific genes, meiotic genes and 
pluripotent gene in human 1st trimester testes (8-9wga), which were incubated with 
DMSO and 5µM of 5-azacytidine, respectively, for 4 days. A, DAZL; B, STRA8; C, SYCP3; 
D, SYCP1; E, DMC1; F, VASA and G, OCT4; error bars in histograms represent ±SEM; the 








n=4; * P ≤ 0.05 
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Figure 5.15. Expression of DAZL and SYCP3 proteins in the 9wga human fetal testis; 
which was incubated with DMSO and 5µM of 5-azacytidine, respectively, for 4 days; The 
insert panel in A shows the expression of DAZL in 14wga human fetal ovaries, which 
represents a positive control of DAZL. The insert panel in C shows the expression of SYCP3 in 
18wga human fetal ovaries, which was used as a positive control. The staining of 
DAZL/SYCP3 is shown in green, the PI nuclear counterstaining is shown in red. The arrows in 
A and B represent the DAZL-positive testicular germ cells, while the arrowheads in C and D 
represents the SYCP3-negative testicular germ cells. The scale bars equal to 50µm in A, B, C 
and D panels. 
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5.2.5 The correlation between chemical DNA demethylation and RA 
responsiveness in human 1st trimester fetal gonads 
The in-vitro studies in TCam-2 cells showed that expression of meiotic genes (STRA8 
SYCP3 and VASA,) were further upregulated by RA in the chemical DNA 
demethylated TCam-2 cells. In addition, the ex-vivo studies in human 1st trimester 
gonads showed that most of the postmigratory germ cell-specific genes and meiotic 
genes (DAZL, SYCP3 and VASA) were specifically upregulated by DNA demethylation. 
However, whether chemical DNA demethylation associated with RA responsiveness 
and further upregulated the expression of meiotic genes in human fetal gonads or not 
was still unknown.  
In order to answer this question, the 1st trimester human fetal gonads were separated 
into 4 pieces and cultured with different treatments. Two of them were used as controls, 
which were incubated with DMSO for 4 days and then treated with or without 1nM 
RA for another 2 days. The other two pieces were incubated with 5µM of 
5-azacytidine for 4 days and then treated with or without 1nM RA for another 2 days. 
The mRNA levels of DAZL, STRA8, SYCP3, SYCP1, DMC1, VASA and OCT4 were 
also detected in the human 1st trimester fetal ovaries and testes by QRT-PCR (Fig 
5.16-5.19). 
In the control 1st trimester gonads, which were incubated with DMSO firstly, the 
expression of DAZL and SYCP3 were increased by RA in ovaries and testes, 
respectively (Fig 5.16 and 5.18, data were analyzed using Paired T-test to determine 
significant changes between the control and RA treated human 1st trimester fetal 
gonads, all the results were compared to the 0nM incubated gonads). In the DNA 
demethylated 1st trimester gonads, which were incubated with 5-azacytine firstly, the 
expression of postmigratory germ cell-specific genes and meiotic genes did not 
significantly change by RA treatment (Fig 5.17 and 5.19).  
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Figure 5.16. mRNA levels of postmigratory germ cell-specific genes, meiotic genes and 
pluripotent gene in human 1st trimester ovaries (8-10wga), which were incubated with 
DMSO for 4 days, and then treated with or without RA. A, DAZL; B, STRA8; C, SYCP3; D, 
SYCP1; E, DMC1; F, VASA and G, OCT4; error bars in histograms represent ±SEM; the 
expressions of these genes were normalized to that of the housekeeping gene B2M 
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Figure 5.17 mRNA levels of postmigratory germ cell-specific genes, meiotic genes and 
pluripotent gene in human 1st trimester ovaries (8-10wga), which were incubated with 
5-azacytidien for 4 days, and then treated with or without RA. A, DAZL; B, STRA8; C, 
SYCP3; D, SYCP1; E, DMC1; F, VASA and G, OCT4; error bars in histograms represent ±SEM; 
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Figure 5.18 mRNA levels of postmigratory germ cell-specific genes, meiotic genes and 
pluripotent gene in human 1st trimester testes (8-9wga), which were incubated with 
DMSO for 4 days, and then treated with or without RA. A, DAZL; B, STRA8; C, SYCP3; D, 
SYCP1; E, DMC1; F, VASA and G, OCT4; error bars in histograms represent ±SEM; the 
expressions of these genes were normalized to that of the housekeeping gene B2M 
* 
Paired T-test 
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Figure 5.19 mRNA levels of postmigratory germ cell-specific genes, meiotic genes and 
pluripotent gene in human 1st trimester testes (8-9wga), which were incubated with 
5-azacytidien for 4 days, and then treated with or without RA. A, DAZL; B, STRA8; C, 
SYCP3; D, SYCP1; E, DMC1; F, VASA and G, OCT4; error bars in histograms represent ±SEM; 






 n=4; * P ≤ 0.05 
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5.3.1 Chemical DNA demethylation specifically upregulated the expression 
of postmigratory germ cell-specific genes and meiotic genes; and also 
increased RA responsiveness in TCam-2 cells 
These in-vitro studies in TCam-2 cells revealed that 5-azacytidine significantly 
increased the expression of germ cell-specific genes and meiotic genes (DAZL, STRA8, 
SYCP3, VASA and BOLL). Chemical DNA demethylation also has been found to 
increase the RA responsiveness and further upregulate the expression of STRA8, 
SYCP3 and VASA in TCam-2 cells.  
In previous studies, Dazl has been found to be repressed by DNA methylation in early 
mice PGCs, and become demethylated when it is expressed in the later germ cells 
(Maatouk et al., 2006a). Other findings by Linher et al (Linher et al., 2009) also 
demonstrated that Dazl promoter activity is regulated by DNA demethylation in 
porcine PGCs. The in-vitro study here revealed that DAZl, which was undetectable in 
TCam-2 cells, was significantly increased by DNA demethylating agent 5-azacytidine 
at both mRNA and protein levels. This finding demonstrated that the activation of 
DAZL was regulated by DNA methylation in TCam-2 cells, which is consistent with 
the previous findings. However, DAZL was not further upregulated by RA in either the 
DMSO or 5-azacytidine treated TCam-2 cells, suggesting that DAZL is not a 
RA-regulated gene in TCam-2 cells. Without DNA demethylation, RA neither 
increased the DAZL expression nor affected the DAZL distribution of DAZL in the 
control TCam-2 cells. However, in the DNA demethylated TCam-2 cells, RA affected 
the distribution of DAZL by transferring DAZL from nucleus to cytoplasm in some 
DNA demethylated TCam-2 cells. The cytoplasmic location of DAZL has been 
identified as an essential factor for meiotic entry (Anderson et al., 2007; Reijo et al., 
2000), suggesting that chemical DNA demethylation increase the RA responsiveness 
and facilitate the meiotic entry in this human TCam-2 cell model.  
Stra8 was first identified as a RA responsive gene in mouse P19 embryonic carcinoma 
cells (Bouillet et al., 1995; Oulad-Abdelghani et al., 1996). Stra8 has been 
demonstrated to be required for pre-meiotic DNA replication and subsequent meiotic 
progression in both spermatogenesis and oogenesis (Anderson et al., 2008; Baltus et 
al., 2006; Mark et al., 2008). In-vitro studies in TCam-2 cells here have shown that 
STRA8 is also increased by DNA demethylation. In TCam-2 cells, STRA8 was barely 
detectable; however, the mRNA levels of STRA8 were significantly increased by 
5-azacytidine treatments. STRA8 was not upregulated by RA in control TCam-2 cells. 
However, in TCam-2 cells incubated with 5-azacytidine, STRA8 expression, which has 
already increased by DNA demethylation, was further upregulated by RA. All these 
results suggested indicate the indispensable role of DNA demethylation for STRA8 
induction and RA responsiveness in TCam-2 cells.    
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During mice germ cell meiosis, Sycp3 and Sycp1 are required for synaptonemal 
complex assembly (de Vries et al., 2005; Yuan et al., 2000), and Dmc1 is critical for 
meiotic DSB repair (Pittman et al., 1998; Yoshida et al., 1998). VASA also has been 
identified as a key factor to induce human meiotic progression in-vitro (Medrano et al., 
2012). BOLL, a member of DAZ-family proteins, is expressed in human oocytes 
during mid-to-late meiotic prophase I (He et al., 2013). In TCam-2 cells, the mRNA 
levels of SYCP3, VASA and BOLL were extremely low. After DNA demethylation, the 
expression of these meiotic genes were all significantly upregulated in TCam-2 cells, 
suggesting that DNA methylation is associated with repression of these genes in 
TCam-2 cells. RA did not significantly change the expression of VASA, SYCP3, 
SYCP1, DMC1 and BOLL in the control TCam-2 cells. However, in the DNA 
demethylated TCam-2 cells, RA further increased the expression of SYCP3 and VASA. 
SYCP3, a synaptonemal complex protein (Moens and Spyropoulos, 1995), was also 
detected in TCam-2 cells. No significant change in SYCP3 was observed in TCam-2 
cells after DNA demethylation, but the distribution of this protein was changed: 
cytoplasmic SYCP3-positive cells were decreased while the nuclear and cytoplasmic 
SYCP3-positive cells were increased. In human fetal oocytes, SYCP3 is specifically 
expressed in typical nuclear patterns from pre-meiosis to diplotene (Roig et al., 2004). 
However, the nucleus-localized SYCP3 protein was undetectable in the DNA 
demethylated TCam-2 cells after RA treatment. In the DNA demethylated TCam-2 cell, 
only VASA and SYCP3 were upregulated by RA, other meiotic genes SYCP1, DMC1 
and BOLL were all remained at low levels. Meanwhile, the nucleus-localized SYCP3 
protein was undetectable in the DNA demethylated TCam-2 cells after RA treatment. 
All the data above suggest that DNA demethylation may increase the RA 
responsiveness, but not enough to initiate robust meiotic entry in this TCam-2 cell 
model. This may need longer treatment here, which needs further investigation. 
In the mStra8 transfected TCam-2 cells, the expression of STRA8’s putative targets 
SYCP3 and DAZL were upregulated, but other detected meiotic genes did not 
significantly change, suggesting that the upregulation of SYCP3 in the DNA 
demethylated TCam-2 cells after RA treatment, may be associated with the increasing 
STRA8.  
RAR and RXR have been demonstrated to be necessary for the induction of Stra8 and 
the initiation of meiosis in mice (Boulogne et al., 1999; Bowles et al., 2006; Dufour 
and Kim, 1999; Koubova et al., 2006). RA induces the expression of Stra8 by binding 
to two nuclear receptors, RAR and RXR, which are bound to RAREs in the Stra8 
promoters (Duester, 2008). Intriguingly, the expression of RAR-β was significantly 
increased by 0.1nM RA in both the DMSO and 5-azacytidine treated TCam-2 cells, 
confirming that all these cells were receiving and transducing RA signals, and that this 
was not dependent on DNA demethylation.  
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5.3.2 DNA demethylation specifically upregulated the expression of 
postmigratory germ cell-specific genes and meiotic genes in human 1st 
trimester gonads 
The mRNA levels of DAZL, SYCP3 and VASA were very low in 1st trimester human 
fetal ovaries, but was markedly increased in the 2nd trimester human fetal ovaries, 
which initiate the meiotic entry (Anderson et al., 2007; Childs et al., 2011; Le 
Bouffant et al., 2010). In ex-vivo studies here, the low expression of DAZL, SYCP3 
and VASA were significantly increased by DNA demethylating agent 5-azacytidine in 
1st trimester ovaries. However, in the 2nd trimester ovaries, no significant change in 
these genes was observed after 5-azacytidine treatments. These findings indicate that 
DNA methylation contributes to the repression of these genes in the 1st trimester 
human ovaries; and DNA demethylation is associated with the up-regulation of these 
genes in the 2nd trimester ovaries. This observation is consistent with previous findings 
in mice ovarian germ cells, in which the activation of Dazl, Sycp3 and Mvh was also 
regulated by DNA demethylation (Maatouk et al., 2006a). All these findings lead to a 
conclusion that DNA demethylation controls the activation of these post-migratory 
germ cell-specific genes and meiotic genes and this is conserved in human and mouse 
fetal ovary. 
The expression of DAZL and SYCP3 remained low in both 1st and 2nd trimester testis 
with no significant difference between gestations (Anderson et al., 2007; Childs et al., 
2011; Le Bouffant et al., 2010). In ex-vivo studies here, the low expression of DAZL, 
SYCP3 were all upregulated by DNA demethylation in human 1st trimester testes. 
Among them, DAZL increased nearly 2-fold, which is much less marked than that seen 
in 1st trimester ovaries. The expression of DAZL and SYCP3 proteins were detected in 
the DMSO and 5-azacytidine treated 9wga human fetal testis. DNA demethylation 
increased the expression of DAZL but did not change the nuclear localization of 
DAZL in the 9wga human fetal testis. The expression of meiosis-related protein 
SYCP3 was not activated by DNA demethylation in the 9wga human fetal testis. 
Testicular germ cells do not enter into meiosis during fetal life, and the pre-meiotic 
gene STRA8 was nearly undetectable in human fetal testis (Childs et al., 2011; Le 
Bouffant et al., 2010). The lower responsiveness to DNA demethylation in human 1st 
trimester testes may be associated with an unknown mechanism in the testis 
environment, which is antagonistic to meiosis initiation and was not affected by DNA 
demethylation. All the data above suggested that DNA demethylation did not confer 
meiosis component to testicular germ cells in this ex-vivo model.  
Surprisingly, the pluripotency-associated gene OCT4, which was already present at a 
high level in human 1st trimester fetal ovaries, was also further up-regulated by 
chemical DNA demethylation, suggesting that part of the OCT4 promoter is still 
suppressed by DNA methylation at this stage. Previous studies in mice ESCs also 
indicate that the expression of Oct4 is regulated by DNA methylation (Gu et al., 2006; 
Hattori et al., 2007; Hattori et al., 2004; Sato et al., 2006). The observation in human 
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1st trimester fetal ovaries confirmed the essential role of DNA demethylation in OCT4 
activation in early human PGCs. However, during 2nd trimester, expression of OCT4, 
which was slightly deceased in human fetal ovaries, did not markedly change with 
DNA demethylation. The observation in 2nd trimester ovaries suggested that the OCT4 
promoter has already undergone complete DNA demethylation, and the decrease of 
OCT4 in 2nd trimester ovaries is regulated by other unknown mechanisms.  
In the 1st trimester ovaries or testes with or without DNA demethylation, nearly all the 
detected post-migratory genes and meiotic genes were not significantly changed by 
RA treatment, suggesting that DNA demethylation did not increase the RA 
responsiveness and further facilitate meiotic entry in in this experimental model. 
From the studies above, chemical DNA demethylation has been found to be associated 
with expression of postmigratory germ cell-specific genes and meiotic genes in both 
of the TCam-2 cells and 1st trimester human fetal ovaries. However, chemical DNA 
demethylation only increase the RA responsiveness in the TCam-2 cell model, but not 
in the ex-vivo cultured human fetal gonads model. Other mechanisms, like Tet1 
(Yamaguchi et al., 2012) and histone acetylation (Wang and Tilly, 2010) have been 

























Dynamic Epigenetic Modifications during Human Fetal Germ Cell Development 




Chapter 6. General Discussion 
6.1 Introduction 
In mammals, epigenetic modifications are involved in the regulation of germ cell 
development and aberrancies may lead to aberrant germ cell development and 
apoptosis (Stringer et al., 2013). Therefore, understanding the accurate epigenetic 
modifications in human germ cells is important for the further investigation on the 
germ cell tumors, fertility problems and the epigenetic origin of reproductive 
disorders.  
Among known epigenetic modifications, DNA methylation and histone modification 
are the most significant (Berger et al., 2009). Gene expression can be either activated 
or repressed by histone modifications. For example, some modifications of histone, 
H3K4me3 (Barski et al., 2007) and H3K9ac (Nishida et al., 2006), up-regulate the 
expression of genes through transcriptional activation. On the other hand, other 
histone modifications such as H3K27me3 (Boyer et al., 2006), H3K9me2 (Rice et al., 
2003) and H3K9me3 (Lachner et al., 2001), can act as crucial histone marks for the 
transcriptional repression. Expression of genes can also be repressed through 
methylating cytosine to 5mC (Deaton and Bird, 2011; Meissner et al., 2008). Another 
modified cytosine variant, 5hmC, and the enzymes responsible for it, members of the 
TETs family, may be involved in the process of DNA demethylation (Ito et al., 2010; 
Tahiliani et al., 2009).  
In mouse fetal germ cells, dynamic and extensive epigenetic reprogramming, which 
includes histone modifications and DNA methylation, has been investigated (Hajkova 
et al., 2008; Hajkova et al., 2010; Popp et al., 2010; Seisenberger et al., 2012; Seki et 
al., 2005). In addition, the appropriate DNA methylation status in the developing germ 
cells has also been found to be essential for meiotic progression in mice (Maatouk et 
al., 2006a). In line with epigenetic reprogramming in mouse fetal germ cells, human 
fetal germ cells may also undergo global reprogramming of histone marks and DNA 
methylation. However, observations about these epigenetic modifications in human 
fetal germ cells are limited (Almstrup et al., 2010; Bartkova et al., 2010; Gkountela et 
al., 2013; Wermann et al., 2010).  
In order to establish a more accurate timeline of epigenetic reprograming in human 
germ cells, I have characterized a definitive trend of 5 important histone marks 
(H3K9me2, H3K9me3, H3K27me3, H3K4me3, H3K9ac) in human fetal germ cells. 
The accurate time of DNA demethylation and DNA remethyaltion in human germ 
cells have also been detected. Furthermore, the relationship between DNA 
demethylation and human germ cell meiosis has been investigated in vitro and ex vivo. 
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6.2 General Discussion 
6.2.1 Dynamic histone modifications in human germ cell development  
The in-vivo studies were conducted to understand about the genome wide 
posttranslational histone modifications in human fetal germ cells. In human fetal 
ovarian and testicular germ cells, the levels of permissive histone mark H3K4me3 and 
repressive histone mark H3K27me3 were progressively reduced with maturation of 
human fetal gonads. In later gestation, H3K4me3 and H3K27me3 were restricted to 
the smaller and undifferentiating human fetal germ cells. In this work, repressive 
histone mark H3K9me2 and H3K9me3 displayed distinct and sex-specific 
distributions in human fetal germ cells. At approximate 14wga, shortly after the onset 
of meiotic germ cell differentiation, H3K9me2 was transiently peaked in the human 
fetal ovarian germ cells. At other detected gestations, the fetal ovarian germ cells 
displayed low levels of H3K9me2. On the other hand, H3K9me2 was undetectable in 
testicular germ cells at all detected gestations. For the case of H3K9me3, similar trend 
are found in human fetal testicular germ cells at all detected stages. However, 
H3K9me3 was present at a low level in human ovarian germ cells at early gestations, 
and then increased and accumulated to the more mature ovarian germ cells at later 
gestations. The histone modifications mentioned above were strikingly different from 
those reported in mouse fetal germ cells (Hajkova et al., 2008; Seki et al., 2005), and 
hence suggesting the existence of species differences in histone modifications between 
human and mouse, which further emphasize the importance of human study.  
Previous studies in undifferentiated human ESCs have shown that H3K4me3 is 
associated with the maintenance of pluripotency (Pan et al., 2007), while H3K27me3 
contributes to the repression of developmental genes (Boyer et al., 2006; Lee et al., 
2006). Inferring from this knowledge, the restriction of H3K4me3 and H3K27me3 in 
the smaller and undifferentiating human fetal germ cells may be associated with the 
expression of pluripotency-related genes and the repression of developmental genes, 
respectively.  
In the differentiating murine ESCs, H3K9me2 is associated with the suppression of 
pluripotency-associated gene Oct3/4 (Feldman et al., 2006). Moreover, H3K9 
dimethylatransferase, G9a, plays an important role in meiotic prophase of mouse 
(Tachibana et al., 2007). According to the previous findings and the observation of 
H3K9me2 here, the specific upregulation of H3K9me2 in the early 2nd trimester 
human ovarian germ cell may be associated with the suppression of the 
pluripotency-associated genes and the initiation of meiosis.  
In mice, H3K9 trimethyltransferase Suv39h and its modified chromatin H3K9me3 are 
critical for germ cell meiosis (Peters et al., 2001). Double deletions of Suv39h1 and 
Suv39h2 in mice cause the absence of H3K9me3 and aberration of meiosis in both 
male and female (Peters et al., 2001). On the basis of the previous findings in mice and 
the observation here, the accumulation of H3K9me3 in mature human fetal ovarian 
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germ cells may be associated with the onset of germ cells differentiation and /or 
meiosis in humans.   
It should be noted that, with different types of fixation, the distribution of H3K9ac in 
human fetal ovaries was different. Consequently, the results of H3K9ac here were 
unreliable and further investigation is required. 
6.2.2 Reprogramming of DNA methylation in human germ cell development 
The studies of DNA methylation in human in this work revealed that global 
reprogramming of DNA methylation is largely conserved between human and mouse. 
Before mouse germ cell specification, the DNA methylated features are similar in the 
pluripotent epiblast cells and PGC precursor cells (Hajkova et al., 2002; Saitou et al., 
2002). In order to avoid somatic fate and generate germ cell potency, the novel mouse 
PGCs begin to lose genome-wide DNA methylation (Hajkova et al., 2002; Saitou et al., 
2002). In 6wga human ovary, the DNA of migrating PGCs was hypomethylated 
compared with neighboring somatic cells, suggesting that PGCs at this stage started to 
lose 5mC to adopt the germ cell fate. DNA methylation has been found to be 
associated with the repression of pluripotent gene Pou5f1 in mouse ESCs (Gu et al., 
2006; Hattori et al., 2007; Hattori et al., 2004; Sato et al., 2006). The low methylated 
levels in 6wga PGCs may also be associated with the activation of the pluripotency 
genes in human. My research based on only one 6wga human embryo sample due to 
the limited availability of such tissue. More samples are required to confirm the global 
levels of 5mC in migrating human PGCs in the future studies. 
In mice, DNA demethylation has been found to regulate the temporal expression of 
postmigratory germ cell-specific genes such as Mvh (Maatouk et al., 2006a). In human, 
the mature germ cell-specific gene VASA was almost undetectable in early PGCs, and 
significantly increased in both ovarian and testicular germ cells at later gestational 
ages (Anderson et al., 2007). Moreover, the studies for human in this work revealed 
that 5mC was barely detected in the postmigratory human fetal germ cell. All these 
observations suggested that genome-wide erasure of DNA methylation in the 
postmigratory human fetal germ cells may be associated with the upregulation of 
mature germ cell-specific gene expression in human. 
In mice, the expression of meiosis-related genes Dazl and Sycp3 are also regulated by 
DNA methylation (Maatouk et al., 2006a). In human, the mRNA of DAZL and SYCP3 
were up-regulated in the late-gestational fetal ovaries (Anderson et al., 2007; He et al., 
2013; Houmard et al., 2009), but remained low in the late-gestational fetal testes 
(Anderson et al., 2007; He et al., 2013; Houmard et al., 2009). The DNA methylation 
studies in human here showed that 5mC was redetected in some of the later fetal 
testicular germ cells, but remained undetectable in the fetal ovarian germ cells across 
all the detected gestations. Thus, the delay of DNA de novo methylation in human 
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ovarian germ cells may correlate with further upregulation of DAZL and the activation 
of meiotic genes in human fetal ovary. 
5hmC is generated through oxidation of 5mC by Tets enzymes (Ficz et al., 2011; 
Szwagierczak et al., 2010). Genome-wide mapping in mouse and human ESCs reveals 
that 5hmC mainly gatheres around euchromatic regions, and may be positively 
correlated to transcriptional activity (Ficz et al., 2011; Pastor et al., 2011; Williams et 
al., 2011; Wu et al., 2011; Xu et al., 2011; Yildirim et al., 2011). However, the exact 
function of 5hmC is still not fully elucidated. One hypothesis raised from mouse 
studies indicates that 5hmC may serve as an intermediate in the process of DNA 
demethylation (Guo et al., 2011; He et al., 2011; Inoue and Zhang, 2011; Iqbal et al., 
2011; Ito et al., 2011; Wossidlo et al., 2011; Wu and Zhang, 2010; Xu et al., 2011). 
Different from the findings in mouse PGCs (Hackett et al., 2013; Yamaguchi et al., 
2013), the studies in human adult liver show that 5hmC tends to co-localize with 5mC 
in the hepatocyte nucleus (Ivanov et al., 2013). The genomic study in mammalian cells 
also indicates that 5mC and 5hmC often coexist at the same cytosine in the cells with a 
steady state (Yu et al., 2012). 
The studies in human germ cells here demonstrated that the existence of 5mC and 
5hmC were synchronous rather than alternate. At 6wga, 5hmC was also present in the 
OCT4-positive human PGCs. In human ovary, 5hmC was undetectable in most of the 
postmigratory fetal ovarian germ cells, and was regained after birth. In human testis, 
5hmC was detected only in a few of fetal testicular germ cells. According to the 
previous studies and the finding in human germ cells of this work, the synchronous 
presence of 5hmC and 5mC in human germ cells suggests that rather than being 
involved in DNA demethylation, 5hmC may play an important role in the development 
of germ cell with its unique epigenetic regulatory functions, which need further 
investigation.  
In mammal, Tets enzymes mediate the conversion of 5mC to 5hmC, and may be 
associated with DNA demethylation (Ito et al., 2010; Ito et al., 2011; Ko et al., 2010; 
Tahiliani et al., 2009). During mouse PGC development, Tet1 and 2 have been found 
to be involved in oxidizing 5mC to 5hmC (Hackett et al., 2013; Yamaguchi et al., 
2013).  
In the 1st trimester human fetal gonads, mRNA levels of TET1, 2 and 3 were all at a 
very high level, which may be associated with the erasure of 5mC. Notably, the level 
of TET2 is much lower than TET1 and TET3 across all the gestation; therefore, TET2 
may play a less important role in human fetal gonads. In human fetal testes, TET2 did 
not change across gestations. Notably, TET1 and TET3 fell significantly in the early 
2nd trimester and remained stable thereafter. The significant fall in TET1 and TET3 
may be associated with the global erasure of 5hmC in most of the human testicular 
germ cells. With increasing gestational age, the expression of these three TETs genes 
decreased in the postmigratory human fetal ovaries, which may be related to the loss 
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of 5hmC in the postmigratory human fetal ovarian germ cells. Tet1 has been found to 
be involved in the mouse meiosis, as deficiency in Tet1 led to loss of meiotic genes in 
mouse ovarian germ cells (Yamaguchi et al., 2012). In human fetal ovaries, the mRNA 
levels of TET1 decreased coincident with meiotic initiation. However, whether the 
decrease of TET1 protein was restrict to the ovarian germ cells or not was unknown. 
So the relationship of TET1 and meiosis in ovarian germ cells still need further 
investigation. 
6.2.3 Chemical DNA demethylation regulate the expression of 
postmigratory germ cell-specific and meiotic genes in human 
In PGC-like cells derived from mouse ESCs, DNA demethylation caused by Dnmt1 
deficiency up-regulates the expression of PGC-related genes (Mochizuki et al., 2012). 
In mouse ESCs, DNA demethylation is associated with the activation of pluripotent 
genes Pou5f1 and Nanog (Gu et al., 2006; Hattori et al., 2007; Hattori et al., 2004; 
Sato et al., 2006). DNA demethylation also has been found to be associated with the 
high expression of postmigratory germ cell-specific and meiotic genes Mvh, Dazl and 
Sycp3 in mouse fetal germ cells (Maatouk et al., 2006a).  
In-vitro studies in TCam-2 cells here revealed that the silenced postmigratory germ 
cell-specific and meiotic genes were specifically up-regulated by DNA demethylating 
agent 5-azacytidine. Chemical DNA demethylation also has been found to increase the 
RA responsiveness by further facilitating RA to increase the mRNA levels of STRA8, 
SYCP3 and VASA, and also the cytoplasmic localization of DAZL in TCam-2 cells. 
In human fetal ovaries, the expression of DAZL, STRA8, SYCP3, SYCP1, DMC1 and 
VASA was low at 1st trimester and was significantly increased at 2nd trimester. In the 
ex-vivo study here, most of these low-expressing genes (DAZL, SYCP3 and VASA) 
were all significantly increased by DNA demethylating agent 5-azacytidine in the 1st 
trimester ovaries. However, the expression of these genes was not significantly 
changed by DNA demethylation in the 2nd trimester ovaries, in which the expression 
of these genes has already been increased. The responsiveness to DNA demethylation 
was much more lower in human 1st trimester testes, in which testicular germ cells do 
not enter into meiosis during fetal life, and the pre-meiotic gene STRA8 was nearly 
undetectable in human fetal testis (Bendsen et al., 2003; Gaskell et al., 2004). DNA 
demethylation did not further facilitate RA to increase meiotic genes in 1st trimester 
human fetal ovaries and testes.  
From the studies above, chemical DNA demethylation has been found to be associated 
with expression of postmigratory germ cell-specific genes and meiotic genes in both 
of the TCam-2 cells and 1st trimester human fetal ovaries. However, chemical DNA 
demethylation only increase the RA responsiveness in the TCam-2 cell model, but not 
in the ex-vivo cultured human fetal gonads model. Other mechanisms, like Tet1 
(Yamaguchi et al., 2012) and histone acetylation (Wang and Tilly, 2010) have been 
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found to regulation germ cell meiosis in mice, are worthy to be explored in human as 
well.  
6.2.4 Link between histone modification and DNA methylation in human 
fetal germ cells 
In mice, DNA demethylation have been found to associate with the activation of 
pluripotent genes, the high expression of postmigratory germ cell-specific and meiotic 
genes in mouse fetal germ cells (Gu et al., 2006; Hattori et al., 2007; Hattori et al., 
2004; Maatouk et al., 2006a; Mochizuki et al., 2012; Sato et al., 2006). The studies in 
human fetal gonads here showed that the undifferentiated human PGCs displayed high 
levels of H3K4me3 and H3K27me3 and low levels of 5mC, which may be associated 
with the expression of pluripotency-related genes. In human, the mature fetal ovarian 
germ cells displayed high levels of H3K9me3 and were 5mC-negative, which may be 
associated with the onset of germ cells differentiation and /or meiosis in humans. 
Histone modification is associated with short-term modifications and is reversible, 
while DNA methylation is associated with stable long-term repression (Ng, and Adrian, 
1999). Histone modifications and DNA methylation are inextricably linked as the 
regulation of transcriptional control depends significantly on DNA methylation as well 
as on histone modifications (Kouzarides, 2007; Lande-Diner et al., 2007). As 
explained by Cedar et al. (Cedar and Bergman, 2009), the DNA methylation pattern is 
established with the contribution of some histone modifications, while the 
maintenance of some histone modifications patterns requires DNA methylation.  
In mice, a correlation has been established between high levels of DNA methylation as 
well as H3K9 trimethylation and pericentric heterochromatin (Lehnertz et al., 2003; 
Lewis et al., 1992; Peters et al., 2001). Furthermore, Esteve et al. (Esteve et al., 2006) 
demonstrated that there is a direct interaction between the H3K9me2-specific 
methyltransferase G9a-Glp complex and Dnmt1, while Dong et al. (2008) reported 
that this complex is also necessary for the de novo DNA methylation of 
retrotransposons in ESCs. Several researchers highlighted the anti-correlation between 
genome wide H3K4 methylation and DNA methylation (Erfurth et al., 2008; Ooi et al., 
2007). The unmethylated CpG sequences in CpG islands are bound by the H3K4 
methyltransferase MLL, which can also oppose DNA methylation in the binding 
location (Erfurth et al., 2008). The researches in cancer cells and ESCs indicated that 
the correlation of DNA methylation and H3K27 methylation depends on cell type 
(Vire et al., 2006) (Kondo et al., 2008; Mendenhall et al., 2010; Mohn et al., 2008). 
Therefore, the dynamic histone modifications and reprogramming of DNA 
methylations in human fetal germ cells are all related to each other, and the 
mechanism of this link need further investigation.  
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This thesis revealed that dynamic histone modifications occurring during human fetal 
germ cells development are strikingly different from those reported in mouse fetal 
germ cells (Hajkova et al., 2008; Seki et al., 2005). Dynamic reprogramming of global 
DNA methylation in human germ cells was consistent with that in mouse germ cells 
(Abe et al., 2011; Hajkova et al., 2010; Seki et al., 2005). The in-vitro and ex-vivo 
culture studies in TCam-2 cells and human fetal gonads indicated that treatment with 
known DNA demethylating agents is also associated with the activation of the 
postmigratory germ cell-specific and meiotic genes in human. 
6.4 Future Directions 
Although this thesis has identified the dynamic histone modifications and DNA 
methylation reprogramming during the development of human fetal germ cell, further 
work is required to fully understand the mechanisms and overall function of these 
epigenetic modifications in human fetal germ cell, which are shown as follows: 
6.4.1 The biological significance of H3K4me3, H3K27me3, H3K9me2 and 
H3K9me3 in human fetal germ cells 
The studies in human fetal germ cells here showed that histone marks underwent 
dynamic modifications. However, the biological significance of these histone 
modifications still needs further investigation.  
The studies here suggested that H3K4me3 and H3K27me3 might be associated with 
the undifferentiated status in human fetal germ cells. To investigate whether H3K4me3 
is associated with the expression of pluripotency-related genes in human fetal germ 
cells, double immunofluorescence analysis for H3K4me3 and pluripotent markers 
(Such as OCT4) can be carried out in human fetal gonads across different gestations. 
Triple immunofluorescence analysis for H3K27me3, pluripotent markers and mature 
germ cell markers (Such as VASA, DAZL) can be performed to determine whether 
H3K27me3 is associated with the repression of developmental genes in human fetal 
germ cells.   
The studies in human here revealed that H3K9me2 and H3K9me3 might be associated 
with the suppression of pluripotency-associated genes, onset of differentiation and 
initiation of meiosis in human ovarian germ cells. The role of H3K9me2 and 
H3K9me3 in human fetal germ cell can be further explored by performing the double 
or triple immunofluorescence with pluripotent markers, mature germ cell markers or 
meiotic markers (Such as SYCP3).  
6.4.2 Dynamic change of H3K9ac during human fetal germ cell 
development 
It is worth noting that H3K9ac distributed differently in Bouins and NBF fixed human 
ovaries at comparable gestational ages. During 2nd trimester, most of Bouins fixed 
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human fetal ovarian germ cells were negative for H3K9ac; only the smaller, 
undifferentiated PGC-like cells displayed this histone mark. Contrarily, nearly all of 
the NBF fixed human fetal ovarian germ cells displayed H3K9ac-staining at these 
later gestational ages.  
The results of H3K9ac here were unreliable, and needed further investigation. Human 
fetal gonads can be disaggregated into a single-cell suspension by mechanical and 
enzymatic dispersion (Childs et al., 2010; Coutts et al., 2008). The cell suspension, 
which consists of both gonadal somatic and germ cells, can be fluorescently labeled 
with PGC marker OCT4 and mature germ cell marker VASA. The OCT4 or 
VASA-labeled human fetal germ cells can be sorted from the unlabeled somatic cells 
by Fluorescence-Activated Cell Sorting (FACS) (Mozdziak et al., 2005; Woods and 
Tilly, 2013). The isolated human fetal germ cells can be collected for protein 
extraction; and western blotting can be performed to determine the levels of H3K9ac 
in these isolated fetal germ cells. These detections can be performed in human fetal 
gonads across different gestations, and then the dynamic changes of H3K9ac in human 
fetal germ cells can be identified reliably.  
6.4.3 Role of 5hmC in human germ cell development 
The studies here suggested that 5hmC may not be involved in DNA demethylation 
during human germ cell development, and may play an important role in germ cell 
development with its unique epigenetic regulatory functions. The genome-wide 
mapping of 5hmC can be further investigated in human germ cells by sodium and 
oxidative bisulfite sequencing to identify the epigenetic regulatory functions of 5hmC 
in human germ cells (Booth et al., 2013).  
The studies in mouse PGCs showed that 5hmC is enriched in the promoter of Dazl 
gene (Hackett et al., 2013), which is activated by promoter DNA demethylation 
(Hackett et al., 2012; Maatouk et al., 2006b). However, global 5hmC is present in the 
early migrating PGCs and erased in the postmigratory human germ cells, suggesting 
that 5hmC may not be involved in the activation of DAZL in human. The distribution 
of 5hmC at the promoters of DAZL, PGC genes and other postmigratory germ 
cell-specific genes can be detected by hmeDIP-Sequencing and 
glucosyltransferase-quantitative polymerase chain reaction (Glu-qPCR) (Hackett et al., 
2013) to identify whether the presence of 5hmC in human germ cells facilitate the 
activation of these genes or not.  
6.4.4 The relationship between DNA demethylation and meiotic prophase I 
in human fetal ovaries  
In the DNA demethylated TCam-2 cell, only STRA8, VASA and SYCP3 were further 
upregulated by RA, other meiosis-related genes SYCP1, DMC1 and BOLL did not 
respond to RA induction. In the DNA demethylated 1st trimester human fetal ovaries 
and testes, only STRA8 was further upregulated by RA, other meiosis-related genes 
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did not respond to RA induction. The in-vitro and ex-vivo findings above suggested 
that DNA demethylation may increase the RA responsiveness, but not enough to 
facilitate germ cells to enter into meiosis in response to RA, in this experimental 
model. These findings led to a question that whether the incubating time of RA is 
associated with the initiation of meiosis in DNA demethylated human fetal gonads. In 
the future studies, the DNA demethylated human fetal gonads can be cultured with RA 
for a longer period and the expression of meiotic genes can be further detected, which 
can lead to a conclusion of whether DNA demethylation is associated with meiotic 
prophase I in human fetal ovaries.  
6.4.5 Other epigenetic mechanisms in prophase I in human fetal ovaries  
Other mechanisms, like Tet1 (Yamaguchi et al., 2012) and histone acetylation (Wang 
and Tilly, 2010), which also have been found to regulate germ cell meiosis in mice, are 
worthy to be explored in human as well.  
The role of TETs in human germ cell meiosis can be demonstrated by TETs-knockout 
studies in human fetal ovaries via RNA interference. After that, the DNA methylation 
status and the expression of meiotic genes can be further detected in the 
TETs-deficiency human fetal ovaries.  
In addition, the human fetal ovaries can be cultured with the histone deacetylase 
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